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Abstract 
This thesis aimed to enhance clinical understanding of treatment for psychopathic 
offenders by examining existing empirical evidence on treatment non-completion for this high-
risk group of offenders and evaluating the effectiveness of the Chromis programme. Chapter 1 of 
this thesis established context by providing a review of relevant literature on the conceptualisation 
and assessment of psychopathy in clinical practice, with a particular focus on the PCL-R and a 
critical review of empirical literature on treatment for psychopathic offenders. Chapter 2 presents 
a systematic review with an overarching aim of synthesising empirical research on treatment non-
completion among psychopathic offenders. Seven of the thirteen included studies explicitly 
reported attrition rates, providing a median non-completion rate for psychopathic offenders of 
46%. Whilst synthesised empirical evidence suggested an association between psychopathy as 
measured by the PCL-R and treatment non-completion, variable findings between the PCL-R 
construct (facets) and treatment non-completion raises doubt over the reliability of the observed 
psychopathy (PCL-R total score) and treatment non-completion association. Furthermore, scant 
evidence established that the predictive relevance of psychopathy and treatment non-completion 
to recidivism was inconclusive. The systematic review makes a unique contribution to the clinical 
understanding of treatment attrition among psychopathic offenders and provides needed insight 
into empirical ambiguities and pertinent clinical issues. In order to further existing research, 
Chapter 3 examined the treatment responsivity of psychopathic offenders, by examining the 
effectiveness of a violence treatment programme (Chromis), implemented within a high-security 
personality disorder treatment service.  A high attrition rate (44%) was evident within the 
availability sample of 120 offenders who had engaged in treatment, with PCL-R total (and factor) 
scores for this sample not being significantly associated with treatment non-completion. Group- 
and individual-level analysis of self-reported measures showed treatment gains across the 
evaluated outcomes; however, this was not moderated by psychopathy level (moderate or high). 
The findings add to the research around the treatability of psychopathic offenders. Contrary to 
clinical lore, certain aspects of treatment can deliver a positive outcome with respect to risk-
related treatment need areas for psychopathic offenders. Finally, an overall discussion of the work 
is presented (Chapter 4), drawing together the main findings and implications for future research 
and practice.                                                  
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Chapter One: Introduction 
 
Contextual background and overview of thesis 
Extensive research has been conducted on psychopathic offenders with regard to the risk 
they pose, the nature of their disorder and the effectiveness of treatment methods. Despite this, 
the clinical understanding of psychopathy1 and the practice of addressing the risk posed by this 
unique offender population remain contentious issues. This is a serious concern – the prevalence 
of psychopathy in prison populations has been estimated at between 7% and 25% (Blair, Mitchell 
& Blair, 2005; Coid et al., 2009; Hare, 1996; Hare, Clark, Grann & Thornton, 2000), and it is 
estimated that this unique offender population perpetrates twice as many violent crimes as non-
psychopathic offenders (Hare, 1996; 1999; Porter, Birt & Boer, 2001). It is easy to understand 
why psychopathy has been described as ‘the single most important clinical construct in the 
criminal justice system’ (Hare, 1998, p. 99), a sentiment echoed by researchers including Vien 
and Beech (2006) and Vitacco, Lishner and Neumann (2012).  
 
The treatment of psychopathic offenders has been plagued with pessimism, with a long-
standing view that such offenders are ‘untreatable’ (Howells & Tennant, 2010) and with evidence 
suggesting that treatment may increase the risk posed by those with high levels of psychopathic 
traits (Harris & Rice, 2006; Rice, Harris & Cormier, 1992). These findings had significant 
implications for policy and practice, and have contributed to the prevailing view that those with 
high levels of psychopathic traits should be excluded from treatment (Tyrer et al., 2010). Due to 
increased clinical concern over risk management and treatment in cases involving psychopathic 
offenders, the United Kingdom government initiated a programme for the assessment and 
                                                 
1 Psychopathy is described in greater detail within this chapter, but in brief, is considered to reflect a complex set of dimensions and 
is rendered a disorder that is difficult to capture and define (Ogloff, 2006). This difficulty is further compounded by the lack of 
agreement among researchers as to what constitutes the essence of psychopathy and by a lack of agreed diagnostic criteria for the 
disorder. Nevertheless, a common working definition conceptualises psychopathy as a personality disorder that includes a cluster of 
interpersonal, affective, lifestyle, and antisocial traits and behaviours.  
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treatment of offenders considered to have a dangerous and severe personality disorder234 (DSPD 
programme, 2004).  The concept of ‘dangerousness’ was described as posing a ‘high risk’ of 
causing significant harm to others. The severity of personality disorder was classified as the 
presence of psychopathic traits either to a sufficient degree or a sufficient number of different 
personality disorders (DSPD programme, 2004). The DSPD programme was delivered in four 
forensic secure units: two in special hospitals (Rampton and Broadmoor) and two in high-security 
prisons (HMP Frankland and HMP Whitemoor). In the context of the equivocal evidence 
surrounding the effectiveness of the DSPD units (e.g., Barrett & Byford, 2012; Barrett et al., 
2009; Burns, 2011; Howells et al., 2011; Kirkpatrick et al., 2010; Tyrer et al., 2007, 2009, 2010), 
the services were reviewed, and a new strategy was published in 2011. The Offender Personality 
Disorder (OPD) pathway (Joseph & Benefield, 2012) was implemented as the joint responsibility 
of the Department of Health and the National Offender Management Service (NOMS).  These 
services took a coordinated approach to the commissioning and development of personality 
disorder pathway services and treatment interventions across community and custodial settings.  
The OPD differs from the DSPD programme in that it provided a treatment pathway within the 
criminal justice system, which enables progression through different environments and levels of 
security (Joseph & Benefield, 2012). 
 
The OPD pathway is considered an important development in the treatment of offenders 
with personality disorder (Skett, Goode & Barton, 2017). Whilst research into the effectiveness 
                                                 
2 The DSPD programme was initiated following a tragic killing and the subsequent conviction of an offender, who was said to have 
a severe personality disorder and was allegedly denied access to psychiatric care. Whilst this tragic event may have been the 
immediate precipitant to the DSPD introduction, there was also a more general and widespread dissatisfaction with how 
psychiatrists responded to individuals with high levels of psychopathic traits (Marden, 2007).   
3 The definition of personality disorder does differ depending on source, however, the official criteria for diagnosing personality 
disorders are listed in the Diagnostic and Statistical Manual of Mental Disorder (DSM) and the International Classification of 
Diseases (ICD). In brief, personality disorders are classified as mental disorders, and characterised by enduring maladaptive patterns 
of behaviour, cognition, and inner experience, exhibited across context and deviating from those accepted by the individual’s 
culture. Personality disorders are reflected as an impairment in both self-organization and interpersonal relations, caused by 
pathological (extreme) personality traits. 
4 There is no definite definition of severe personality disorder within the DSM and ICD, both being unable to categorise those with 
severe personality disorder due to a lack of any scientific evidence and creditability (Tyrer & Johnson 1996). During the 
development of the DSPD it was emphasised that severe personality disorder was not a clinical category or classification. The 
working definition was determined by an individual presenting a significant risk (of serious physical or psychological harm from 
which it would be difficult or impossible for the victim to recover), a significant disorder of personality, and for the presented risk 
to be functionally linked to the personality disorder (Department of Health et al, 2004).  
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of services within the OPD pathway is scant, preliminary indicators from evaluations to date are 
positive (Brown, Beeley Patel, & Vollm, 2015; Bruce, Horgan, Kerr, Cullen & Russell, 2017; 
Clark & Chuan, 2016). As services, treatment and research related to personality disorders have 
increased, empirical evidence has become available to suggest that the pessimistic view of the 
effectiveness of treatment was fuelled by the failure of inappropriately applied interventions 
(Vien & Beech, 2006) and by outdated and poorly designed studies (Wong & Olver, 2015). 
Important recent advances in both treatment design and empirical research have yielded more 
positive outcomes (Chakhssi et al., 2010; Thornton & Blud, 2007; Tock, Johnson & Gibson, 
2018; Salekin, Worley & Grimes, 2010), challenging the view of psychopathic offenders as 
‘untreatable’.  
 
Despite such shifts in empirical findings and clinical understanding, the manifest 
challenges (DeSorcy, Olver & Wormith, 2016; Hobson, Shine & Roberts, 2000; Ogloff, Wong 
& Greenwood, 1990) of working clinically with psychopathic offenders has helped to sustain 
pessimistic views among clinicians about the treatability of this complex group of offenders. 
Further empirical research is needed to enhance clinical understanding and practice, in the hope 
of diminishing the long-standing pessimism and developing effective approaches to addressing 
the risk posed by this group. 
 
This introduction (Chapter 1) aims to establish the context for this thesis by setting out a 
review of the relevant literature on conceptualising and assessing psychopathy in clinical practice, 
with particular focus on the Psychopathy Checklist (PCL) (Hare, 1991; 2003).  Chapter 1 will 
also discuss literature on the effectiveness of treatment for this unique population, giving 
consideration to theoretical propositions and empirical findings on treatment engagement and 
non-completion. The next chapter (Chapter 2) details a systematic review with the overarching 
aim of synthesising empirical research on treatment non-completion5 among psychopathic 
                                                 
5 Treatment non-completion refers to the premature cessation of treatment and it may take three forms: exclusion due to inappropriate 
behaviour, administrated exit for transfer or release, or patient-initiated dropout (Howell & Day, 2007; Wormith & Olver, 2002). 
  
4  
offenders. The thesis will then go on, in Chapter 3, to investigate the clinical effectiveness of a 
violence treatment programme (Chromis), delivered within the high-security personality disorder 
treatment service at HMP Frankland (Westgate unit). The study’s findings on the short-term 
evaluation of treatment needs and desired outcome will also be discussed. Following this, Chapter 
4 will provide an overall discussion of the work presented, drawing together the main findings 
and considering the implications for future research and practice. The final chapter (Chapter 5) 
of the thesis will provide a reflective account of the author’s development and growth in 
competence as a research practitioner.  
 
 
History and conceptualisation of psychopathy 
Psychopathy is a disorder with a substantial history in clinical and forensic psychology. 
Originally, the term was used to describe a wide variety of emotional traits and mental disabilities 
(Koch, 1891). Over time more refined formulations were developed, with conceptions reflecting 
normal mental abilities with some combination of traits, whether behavioural (e.g. explosive or 
reckless behaviour), affective (e.g. shallow affect, emotional coldness) or interpersonal (e.g. 
charm, social dominance, persuasiveness) (Kraepelin, 1904, 1915; Pinel, 1962; Prichard, 1835; 
Schneider, 1950, 1958).  
 
In the development of the psychopathy construct, the most influential formulation came 
from Hervey Cleckley, who developed the first comprehensive list of characteristics (Cleckley, 
1941, 1988). These included superficial charm and good intelligence; absence of delusions and 
neurotic manifestations; unreliability and untruthfulness; lack of remorse and shame; 
inadequately motivated antisocial behaviour; pathological egocentricity and incapacity for love’ 
and deficits in affective reactions, insights and interpersonal relations. Based on Cleckley’s 
conceptualisation, Patrick (2006) formulated three categories of traits: positive adjustment, 
behavioural deviance and emotional-interpersonal deficits.  
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Cleckley’s checklist inspired the development of contemporary models of psychopathy. 
The most commonly known model is that created by Robert Hare, which conceptualised 
psychopathy as a pattern of destructive traits, relating to interpersonal, affective, cognitive and 
behaviour problems. In this construct, interpersonally, psychopaths are superficially charming, 
grandiose, deceitful and manipulative. Affectively, psychopaths are callous, lack empathy or 
guilt, have a shallow range of emotion and fail to accept responsibility. And behaviourally, 
psychopaths live an impulsive irresponsible lifestyle (Hare, 1991; 2003). Hare’s model has been 
critical to the modern conceptualisation of psychopathy and underpins the most widely used 
instrument in clinical practice – the PCL (Hare, 1991; 2003). The PCL is discussed in further 
detail in the next sub-section.  
 
Although Hare’s psychopathy model was based on Cleckley’s criteria, critics noted that 
there were substantial differences between Cleckley’s psychopath and the construct depicted in 
Hare’s main PCL measurement instruments (Skeem, Polaschek, Patrick & Lilienfeld, 2011). It 
was contended that in comparison with Cleckley’s psychopath, Hare’s model reflected a colder, 
angrier and more thoroughly antisocial individual. This concept of psychopathy more closely 
resembled a formulation by Cleckley’s contemporaries McCord and McCord (1964), who 
described a more antisocial, callous and aggressive psychopath with the same lack of emotion 
and impulsive tendencies as Cleckley’s depiction. Unsurprisingly, both Hare and the McCords 
developed their concepts using prison samples, whereas Cleckley’s psychopath was developed 
by studying psychiatric patients. Hare later acknowledged that his model was not solely based on 
Cleckley’s criteria and that he took into account the opinions of other clinicians as well as many 
years of empirical research during the development of his measurement instrument (Hare & 
Neumann, 2008).  
 
The debate regarding the construct of psychopathy is deeply rooted in the literature. In 
brief, psychopathy is often associated with a constellation of affective, interpersonal, and 
behavioural traits (Skeem, et al., 2011), however, there remains a lack of consensus over the role 
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of certain core features of psychopathy, notably the nature and manifestation of antisocial 
behaviour (Skeem et al, 2011). Moreover, opinions diverge regarding whether seemingly 
adaptive features (e.g. emotional resilience, social poise and lack of anxiety) are part of the 
psychopathy construct (Lilienfeld et al., 2012; Miller & Lynam, 2012; Skeem et al., 2011). It is 
postulated that these conceptual uncertainties stem partly from the dominance of the main 
assessment tool, PCL-R6 (Hare, 1991; 2003) in the field over the past three decades. Critics argue 
that the heavy focus on antisocial and criminal behaviour in PCL-based instruments has 
contributed to an under-emphasis on affective and interpersonal features in psychopathy (Skeem 
& Cooke, 2010).  
 
Given the apparent clinical importance of psychopathy, it is pertinent that the prevailing 
view is that the disorder is confusingly defined and poorly understood (Skeem et al., 2011). The 
clinical uncertainty about the disorder is in part underpinned by the lack of consensus regarding 
the construct of psychopathy itself, and by a lack of agreed diagnostic criteria for psychopathy in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM) (American Psychiatric 
Association, 1994; 2013). In addition, psychopathy is often misperceived as synonymous with 
antisocial personality disorder as defined by the DSM-5 (American Psychiatric Association, 
2013) and its precursors (Berg et al., 2013). However, antisocial personality disorder diagnostics 
mostly reflect a list of socially deviant and criminal behaviours, whilst ignoring the crucial 
affective and interpersonal component of psychopathy. Thus, these two conditions have disparate 
implications for violent and criminal behaviour (Lilienfeld, 1994; Hare, 2003).  
 
Despite the aforementioned issues relating to the conceptualisation of psychopathy, it is 
a disorder that remains accepted in clinical practice (Strickland et al., 2013) and efforts have been 
                                                 
6 The PCL-R is described in greater detail within this chapter but in brief the PCL-R is a 20-item clinical construct rating scale that 
uses a semi structured interview, case history information, and specific scoring criteria to rate each item on a 3-point scale (0, 1, 2) 
according to the extent to which it applies to a given person. The PCL-R total score can range from 0 to 40 and reflect the degree to 
which the person matches the prototypical psychopathic person, in line with recent evidence that, at the measurement level, the 
construct underlying the PCL-R (and its derivatives) is dimensional in nature rather than taxonic. 
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made to strengthen clinical understanding of the disorder. Indeed, new theoretical models have 
been developed that accord greater emphasis to affective and interpersonal psychopathic traits, 
and less emphasis to antisocial and criminal behaviour (Cooke, Hart, Logan & Michie, 2012; 
Patrick, Fowles & Krueger, 2009). Nevertheless, because the PCL psychopathy remains to some 
extent a dominant conception in modern research and practice and the empirical study of this 
thesis is grounded on the PCL-R clinical assessment of psychopathy, it is the concept in focus in 
this thesis. 
 
PCL construct and assessment  
As previously discussed, Hare’s PCL (Hare, 1991; 2003) has been critical to the modern 
conceptualisation of psychopathy. Hare’s team developed the PCL by assessing a prison sample 
using Cleckley’s conception of psychopathy (Hare, 1980). During this procedure, items perceived 
as redundant or difficult to score were removed from the list and preliminary scoring criteria were 
developed for the remaining items. On this basis, 22 items were identified, forming the first PCL 
assessment scale, which was later revised by removing two of the items, altering the names of 11 
items and improving the descriptors and scoring for each of the items, creating the Psychopathy 
Checklist-Revised (PCL-R) (Hare, 2003).  
 
The PCL-R has gained compelling evidence for its reliability and validity (Hare, 1991, 
2003), and the instrument has been considered to be the most reliable tool for assessing 
psychopathy in both clinical and forensic settings (Kiehl & Hoffman, 2011). The PCL-R clinical 
assessment tool is a 20-item clinical rating scale that uses collateral information and an in-depth 
interview to measure personality traits and behaviours related to a conception of psychopathy 
(Hare, 2003). PCL-R scores can vary from 0 to 40, reflecting the extent to which an individual 
shares traits with the prototypical psychopath.  
 
The PCL-R traditionally treats psychopathy as if it were taxonomical, assigning a cut-off 
score to differentiate those who are ‘psychopaths’ from those who are not. A cut-off score of 
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between 25 to 30 on the PCL-R is often used for diagnostic and research purposes (Hare, 1991; 
2003). However, it is important to note that this cut-off score is entirely arbitrary, and that 
research evidence appears to support the conceptualisation of psychopathy as a dimension 
(Edens, Marcus, Lilienfeld & Poythress, 2006; Guay, Knight, Ruscio & Hare, 2018; Guay, 
Ruscio, Knight & Hare, 2007; Walters, Duncan, & Mitchell-Perez, 2007, Walters, Wilson, & 
Glover, 2011). Given the nature of the traits that make up the disorder and the potential for 
differences across individuals, many researchers and practitioners consider that the traits and 
disorder fall on a continuum, further supporting the notion that the construct of psychopathy does 
not represent a discrete taxon. This argument is in line with developments in the wider psychiatric 
practice regarding a move away from discrete diagnosis and a focus more on individual traits 
(Anckarsäter, 2010). Although the weight of evidence clearly supports a dimensional framework, 
many PCL-R-based studies still use cut-off scores to create psychopathic and non-psychopathic, 
or high- and low- risk psychopathy groups (Harris, Rice & Cormier, 1991; Langton, Barbaree, 
Harkins & Peacock, 2006). The use of a cut-off score can make comparison simpler and aid 
clinical decision-making, notably to identify those with higher levels of those traits, and therefore, 
those who are likely to present higher levels of risk or to require a more intensive treatment 
approach. 
 
The PCL-R has been widely researched, and whilst it has gained empirical support, there 
are a number of ongoing debates regarding the structure and nature of PCL psychopathy. One 
such debate relates to whether the underlying structure of the PCL is unitary or multifarious, and 
to the exact number of components that comprise the structure. The PCL was originally 
constructed with the intention of capturing a single syndrome; nevertheless, through analytical 
research, two correlating underlying dimensions were identified (Hare, 1991). The first 
dimension (Factor 1) relates to interpersonal and affective personality traits and the second 
dimension (Factor 2) chronic antisocial and poorly regulated behaviours and unstable or 
dysfunctional lifestyles. Subsequent analytical review by Cooke & Michie (2001) identified a 
three-factor model, in which the traditional Factor 1 (Hare, 1991) was split into two distinct 
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factors, named ‘arrogant and deceitful interpersonal style’ (PCL-R interpersonal items) and 
‘deficient affective experience’ (PCL-R affective items). The third factor comprised the 
‘impulsive and irresponsible behaviour style’, but importantly, excluded antisocial behaviour. 
The authors argued that antisocial behaviour should be seen as a product of psychopathy rather 
than defining the personality features of the disorder (Cooke, Michie, Hart & Clark, 2004; Skeem 
& Cooke, 2010).  
 
Whilst the three-factor model gained empirical support, Hare (2003) critiqued the validity 
of the three-factor model, arguing that the removal of fundamental items would impede upon the 
concept of psychopathy. Subsequently, Hare (2003) developed a two-factor four-facet model. 
The factors reflect higher-order constructs than those in the original two-factor model, with Factor 
1 being divided into two facets (Facet 1: interpersonal items and Facet 2: affective items) and 
Factor 2 being divided into two further facets (Facet 3: lifestyle items and Facet 4: antisocial 
items).  
 
The number of factors indicative of psychopathy continues to be debated, with support 
being found for both the three-factor and the two-factor four-facet models in some studies 
(Cooke, Kosson & Michie, 2001; Hare, 2016; Hoppenbrouwers, Neumann, Lewis & Johansson, 
2015; Neumann, Vitacco & Mokros, 2015; Skeem, Mulvey & Grisso, 2003; Vitacco, Neumann 
& Jackson, 2005; Warren et al., 2003; Weaver, Meyer, Van Nort & Tristan, 2006). When 
compared on their abilities to predict external correlates, the two-factor four-facet model 
outperformed the three-factor model in predicting aggression and violent reconvictions (Walters, 
2012). Whilst the models differ in that the three-factor model excludes criminal behaviour as a 
central component of the psychopathy construct, it is pertinent that these models are very similar 
in including emotional and interpersonal deficits and behavioural components. This thesis will 
focus on the two-factor four-facet model (Hare, 2003) as the most prominent model applied in 
practice so as to make the findings more easily comparable to previous research. Its 
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conceptualisation also encompasses the three-factor model within it, aiding comparisons to that 
literature as well.  
 
In terms of the psychometric properties of the PCL-R, validation studies have revealed 
high internal consistency, and interrater reliability (Hare, 2003) with good to excellent intra-class 
correlation coefficients (ICC) for the total score (.86 to .94), Factor 1 (.69 to .95) and Factor 2 
(.74 to .94) being reported (Cooke, Hart & Michie, 2004; Hare, 2003; Ismail & Looman, 201; 
Laurell & Daderman, 2007;  Porter, Woodworth, Earle, Drugge, & Boer, 2003). In addition, good 
to excellent agreement between research and clinical ratings has been reported for the total score 
in some studies (Declercq, Willemsen, Audenaert & Verhaeghe, 2012; Hare, 2003; Harris, Rice 
& Cormier, 2013). Nevertheless, research examining PCL-R assessments completed in clinical 
practice has observed lower levels of agreement than expected between evaluators and there is 
evidence suggestive of partisan alliance influencing PCL-R scores (Boccaccini, Turner & Murrie, 
2008; DeMatteo et al., 2014; Edens, Cox, Smith, DeMatteo & Sorman, 2015; Lloyd, Clark & 
Forth, 2010; Murrie, Boccaccini, Johnson & Janke, 2008; Murrie et al., 2009). On the basis of 
these findings, it has been reported that PCL-R scoring is affected by the evaluation context, with 
adversarial settings producing scores that diverge much more than would be expected based on 
the ICC statistics reported in the PCL-R professional manual (Hare, 2003). This has raised a 
salient clinical issue: that the predictive validity of the PCL-R found in some empirical research 
studies may not be representative of clinical practice (Murrie, Boccaccini, Caperton & Rufino, 
2012).  
 
With regard to clinical utility, the PCL-R has been found to correlate with a number of 
behavioural measures. Most pertinent is evidence that has demonstrated relationships between 
PCL-R scores and aggression and violent offending (Singh, Grann & Fazel, 2011; Vitacco et al, 
2005; Yang, Wong & Coid, 2010). When the PCL-R is disaggregated into its two factors, the 
prevailing literature indicates that Factor 2 is a stronger predictor of recidivism and violence than 
Factor 1 (Hare, 2016; Hoppenbrouwers et al, 2015; Kennealy, Skeem, Walters & Camp, 2010; 
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Neumann et al., 2015; Olver, Neuman, Wong & Hare, 2013; Walters et al., 2011; Yang et al., 
2010). At the facet level, most research (Walters, Knight, Grann & Dahle, 2008) has indicated 
that Facet 4 is a stronger predictor of general and violent recidivism than the remaining facets, 
which is consistent with research suggesting that Facet 4 is also the subscale that is most reliably 
scored by raters in both basic and field research (Jeandarme, Pouls, Oei, Bogaerts, 2017). It is 
advocated that the predictive relationship between Factor 2 and violent recidivism relates to the 
theoretical view that future behaviour is best predicted by past behaviour (Gendreau, Goggin & 
Smith, 2002) and that the Factor 2 subscale measures broad traits such as impulsivity that are not 
specific to psychopathy but increase the risk for involvement in violence in general (Skeem, 
Polaschek & Manchak, 2005).  
 
Somewhat in contrast to the aforementioned, a recent study by Jeandarme et al., (2017) 
found the PCL-R to hold poor predictive validity within a forensic psychiatric sample (inclusive 
of hospital and prison samples). Neither the PCL-R total score nor Factor 1 predicted general or 
violent recidivism, which is in line with previous empirical findings. Whilst Factor 2 scores 
significantly predicted general recidivism for all groups, Factor 2 scores were only predictive of 
violence for a combined population (prison and hospital scores) with a small effect size reported.  
On the facet level, Facet 3 scores were the only significant predictors of general (all and hospital 
scores) and violent recidivism (all scores), again with a small effect size reported. The observed 
small effects were somewhat surprising, given the good predictive validity of the PCL-R with 
regard to general and violent recidivism in well-controlled research designs in the extant research. 
The authors argue the poor predictive validity may have been due to more effective risk 
management for this high-scoring psychopathic offender sample with high-risk status, which 
could have attenuated effect sizes. Nevertheless, a level of concern over the validity of the clinical 
assessment tool is further warranted given prior research showing the lack of predictive validity 
of the PCL-R in field settings (Murrie et al., 2012; Neal, Miller & Shealy, 2015).  
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Taken together, whilst extensive support for the psychometric properties of the PCL-R 
exists, more recent empirical findings have raised doubt over the reliability and validity of the 
clinical assessment scale. Despite these criticisms and other empirically-supported measures 
being available – such as the Psychopathy Checklist: Screening Version (PCL: SV) by Hart, Cox 
& Hare (1995) and the Personality Inventory (PPI) by Lilienfeld & Fowler (2006) – the PCL-R 
remains the most widely used tool in the clinical assessment of psychopathy.  
 
 
Effectiveness of offence-focused treatment for psychopathic offenders 
 
Systematic review outcomes  
To date there have been a number of broad and comprehensive systematic reviews that 
have explored the effectiveness of treatment for psychopathic offenders. Findings have in part 
been contradictory, and have contributed to the enduring debate about whether psychopathic 
offenders are treatable. In 2002, Salekin published a meta-analysis featuring 42 studies ranging 
between large-scale evaluations of programmes featuring several hundred patients to single case 
studies. The included studies represented over 60 years of therapeutic research. The conclusion 
was that there was a significant mean rate of successful interventions for psychopathic offenders, 
with approximately 62% of patients having benefited from treatment. The authors reported that 
the highest success rates were often reported for studies of single interventions featuring single 
case design; however, within larger studies, more favourable outcomes were observed for 
psychoanalytic methods (59% success rate) and cognitive behavioural therapy (CBT) (62% 
success rate). In contrast, the review observed less effective outcomes for electroconvulsive 
therapy (22% success rate), Therapeutic Community (TC) (25% success rate), and unspecified 
treatment (17% success rate). Whilst on the surface the findings appeared encouraging, the results 
further confirmed conclusions from previous reviews (Dolan & Coid, 1993; Hemphill & Hart, 
2002; Wong, 2000) that many of the studies included were neither well-designed nor carried out 
with acceptable scientific rigour. Nevertheless, the authors concluded that the widely held belief 
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that psychopaths did not respond to treatment was unfounded and that psychopaths could benefit 
from treatment.  
 
However, Salekin’s (2002) review was subsequently criticised for the over-inclusiveness 
of studies in the meta-analysis. Harris and Rice (2006) argued that there were a number of critical 
considerations of Salekin’s (2002) review that impeded upon the trustworthiness of the review’s 
conclusions. Firstly, few studies included within the review used validated assessments of 
psychopathy such as the PCL-R, and frequent reference was made to studies that used ambiguous 
criteria for psychopathy. Furthermore, only eight studies included untreated control or 
comparison groups. Hare (2006) postulates that only controlled studies can be informative 
regarding treatment efficacy and that no conclusions can be drawn from uncontrolled studies. 
Hare (2006) reported that few studies (< 20%) within Salekin’s (2002) review assessed outcomes 
in terms of criminal behaviour, that even fewer (< 10%) mentioned violence or aggression, and 
that the evaluation of effectiveness was most often (> 70%) based on therapist impressions. Hare 
and Rice (2006) contended that therapists’ impressions of clinical progress could not be robust 
measures of treatment effectiveness for psychopathic offenders, and that independent measures 
of criminal conduct must be at least part of the outcome of an evaluation of psychopathic 
offenders. Based on these considerations, Harris and Rice (2006) concluded that there was no 
evidence that any treatment was effective in reducing violence for psychopathic offenders, and 
that in fact, some treatment had demonstrated harmful effects for psychopaths.  
 
A subsequent systematic review (D’Silva, Duggan & McCarthy, 2004) examined 
whether individuals with high PCL-R scores showed a negative response to treatment. The review 
adopted a search strategy of treatment outcome studies that had applied the PCL-R or its 
derivatives, including the PCL:SV (Hart, et al, 1995) and the Psychopathy Checklist: Youth 
Version (PCL:YV) (Forth, Kosson & Hare, 2003). The review identified 24 studies but only 10 
met the study’s Adequate Study Rating. As in previous reviews, the authors reported upon the 
methodological weakness of the included studies. Notably, only three studies were considered to 
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be of an appropriate design, of which only one used a suitable control group. The authors reported 
that the studies had been widely cited in support of the proposition that psychopaths were 
untreatable, an erroneous conclusion given the methodological weakness of the studies. The 
authors established that, based on available evidence, a conclusion as to whether high-scoring 
psychopaths have a negative response to treatment could not be made at that time.  
 
In a more recent review of psychopathy literature, Salekin, Worley, and Grimes (2010) 
reviewed a number of treatment studies published subsequent to Salekin’s (2002) review. Their 
review was based on 13 studies (eight treatment studies on adults and five studies on children and 
youth) that utilised a coherent operationalisation of psychopathy and employed relevant outcome 
criteria and a contemporary model of intervention such as CBT or variations of TC. They found 
that treatment effects tended to be small, with children and adolescents generally deriving greater 
benefit. Salekin et al., (2010) reiterated the lack of sound evidence of treatment efficacy and 
theories to guide treatment for this specific group of offenders.  
 
A review of the literature evaluating treatment efficacy specifically for violent 
psychopathic offenders (Reidy, Kearns & DeGue, 2013) reported that, despite strong views for 
and against the effectiveness of treatment, there is a relative dearth of research, particularly when 
addressing violence as an outcome. The review was based on 16 studies of the effectiveness of 
violence treatment within adult and adolescent forensic populations. The authors expressed that 
the lack of consensus on whether psychopaths can be effectively treated is underpinned by 
existing studies being beset by methodological weakness, a sentiment that has resonated within 
previous reviews. More specifically, the authors reported that only two published studies within 
the review employed a no-treatment control group (that is, those by Abracen, Looman, Ferguson, 
Harkins & Mailoux (2011) and by Rice, Harris & Cormier (1992)), albeit each study was marked 
by significant limitations. Nevertheless, the authors report that the extant research suggests that 
with intense and rigorous intervention, the risk of violence can be reduced for this unique offender 
population (Caldwell, Skeem, Salekin & Rybroek, 2006; Caldwell, 2011).  
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  When considering the limitations of preceding reviews of psychopathic treatment 
literature, it becomes pertinent that the lack of methodologically sound studies impeded upon the 
development of robust conclusions regarding the effectiveness of treatment for psychopathic 
offenders. Nevertheless, a level of guarded optimism is presented (Reidy et al, 2013; Salekin et 
al., 2010). In the remainder of this chapter, I will discuss some of the studies from the 
aforementioned reviews and assess more recent studies that have evaluated treatment 
effectiveness for adult male violent offenders. In doing so, a critical evaluation of current 
understanding regarding the treatability of psychopathic offenders will be provided.  
 
Measuring treatment effectiveness through recidivism outcomes 
Statistical methods for evaluating treatment efficacy have typically focused on 
comparing the recidivism rates of treatment completers and non-completers or comparison 
participants. Outcomes from these studies have provided variable findings with regard to the 
treatment effectiveness for psychopathic offenders. Seto and Barbaree (1999) conducted the 
earliest study on this subject; the study examined recidivism (both violent and sexual) in 438 
male sexual offenders (sample PCL-R mean = 16.6 (Standard Deviation (SD) = 7.1)) as an 
outcome of treatment, with progress assessed via therapist ratings. Psychopathy was correlated 
with recidivism showing both an increased amount of and a shorter time to reoffending. More 
specifically, psychopaths who made better-than-average progress were more likely to reoffend 
violently within the 32-month follow-up period. The authors concluded that psychopathy is 
related to poorer outcomes compared to non-psychopathy among treated participants. In 
evaluating this study, it is pertinent to acknowledge that the definitional threshold for high 
psychopathy applied within this study (PCL ≥ 15) was unique and well below the cut-off score 
of 30 (Hare, 1991), thus, the misclassification of some non-psychopathic offenders as 
psychopathic offenders is conceivable, impeding upon the validity of the study’s findings. 
Furthermore, the lack of an untreated comparison group does not allow for a determination of the 
degree to which participants gained from treatment. Notably, although psychopaths showed 
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higher recidivism rates after treatment, it could be the case that they still gained from treatment 
as much as, or more than, the non-psychopathic offenders. 
 
Barbaree (2005) conducted a follow-up study to that by Seto and Barbaree (1999) and 
whilst essentially the same sample was used, the outcome measure differed both by the amount 
of follow-up (62 months) and by the use of more accurate reconviction data via a national 
database of criminal charges and convictions. Based on the same PCL-R (≥ 15) definitional 
threshold, the study found that psychopathy was related to recidivism for a lengthier follow-up 
period, but not for the shorter time period of three years, which is contrary to Seto and Barbaree’s 
(1999) findings. The study further observed that whilst psychopathy continued to be a significant 
predictor of general and serious recidivism, treatment behaviour was no longer related to either 
general or serious recidivism, and that there was no statistically significant interaction observed 
between psychopathy and treatment behaviour. The authors report that the variation in findings 
from the previous study (Seto & Barbaree, 1999) could be explained by the use of more accurate 
recidivism data. The authors concluded that psychopathy is related to serious recidivism after 
treatment, at least over longer time periods. Nevertheless, the methodological approach taken by 
Seto and Barbaree (1999) remains an issue, and impedes upon the robustness of the study’s 
conclusions.  
 
Developing on these findings, Wong and Gordon (2006) compared 34 male treatment 
completers with untreated controls matched on PCL-R scores (psychopathy group mean PCL-R 
= 28.6 and control group mean PCL-R = 28), age, past criminal history and length of follow-up 
(mean of 7.4 years). The study found that the treated and matched control group did not 
significantly differ in the number of violent reconvictions. However, treated men subsequently 
received significantly shorter sentences, with sentence length being perceived as a reasonable 
proxy for the level of violence or severity of offending. The study concluded that whilst treatment 
does not aid the desistance from offending for those with significant levels of psychopathy or 
even decrease the frequency of reoffending, treatment did reduce the severity of reoffending. 
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These findings were supported by Wong, Gordon, Gu, Lewis & Olver (2012) who found no 
differences in reconviction rates between treatment completers (n = 32) and an untreated control 
group (n = 32) who had been matched on PCL-R scores (PCL-R mean = 28.60 and 28 
respectively). The authors concluded that high-risk psychopathic offenders do not appear to cease 
reoffending following intensive treatment; however, they do appear to commit less severe 
offences, suggesting significant harm reduction as an effect of treatment. The authors interpret 
the study’s findings in relation to the theoretical understanding of desistance, in particular 
desistance as a gradual reduction of reoffending (Kazemian, 2007). On this basis, the authors 
suggested that psychopathic offenders receive more intense treatment and further support in their 
transition into the community to aid the desistance process. Whilst both controlled studies (Wong 
& Gordon, 2006; Wong et al., 2012) provide valuable insight, it is notable that they are based on 
small samples, a fact that impedes upon the robustness of their findings and the persuasive power 
of the studies. Furthermore, whilst matching procedures were applied, including a range of 
criteria, other unknown and unmatched variables, such as readiness for change could have 
impacted upon reoffending.  
 
Overall, whilst empirical studies on evaluating treatment efficacy through measuring 
recidivism outcomes provide a level of insight into treatment effectiveness, there are a number 
of methodological weaknesses associated with this type of research design that warrant 
consideration. Pertinently, treatment completion does not guarantee that attendees achieve the 
changes required to reduce recidivism (Olver & Wong, 2013), a perspective that is readily 
supported by the fact that recidivism rates are often relatively high among those who complete 
treatment (Polaschek, 2011). Furthermore, this approach limits clinical insight into the 
mechanism of change within offenders as an effect of treatment, thus limiting insight into the 
psychological process of treatment and into the treatment effect on attributes directly associated 
with violent behaviour, namely dynamic risk factors (McGuire, 2008).    
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Moreover, the use of recidivism as the primary outcome measure of treatment 
effectiveness is inherently problematic. Notably, whilst officially documented recidivism has 
high specificity, it is accepted that many offences go underreported, therefore providing an 
underestimation which could impede upon reliable evaluation of treatment effect (Hanson, 1997). 
It is also crucial to consider that recidivism is a distal outcome, and pays limited attention to 
extraneous factors that could influence reoffending after treatment. It is now widely understood 
and supported by empirical evidence, that the presence of external protective factors is 
fundamental in the transitional process from custody to the community, and supports desistance 
from further offending. Therefore, it is prudent to consider that the absence of external protective 
factors may impede upon the effect of prior treatment in managing reoffending (Jung & Gulayets, 
2011; Serin, Lloyd, Helmus, Derkzen & Luong, 2013), a salient point that is not considered or 
indeed evaluated within recidivism studies.  
 
Within-treatment change of dynamic risk factors and recidivism outcome 
In light of the aforementioned limitations, more recent evaluation studies of treatment for 
offenders have begun to examine within-treatment change, that is, proximal change within 
treatment (Beggs, 2010). It is advocated that moving from a sole between-groups analysis to a 
within-person analysis is essential in understanding the mechanism of change, and aids with 
better gauging of treatment effectiveness (Kroner & Yessine, 2013; Olver & Wong, 2013). 
 
In one of the first studies to evaluate within-treatment change in a sample of psychopathic 
offenders, Hildebrand and de Ruiter (2012) found no pre-treatment differences between 
psychopathic (PCL-R > 22, n = 43) and non-psychopathic (PCL-R < 22, n = 44) patients on 
measures of negative attitudes and lack of insight (measured by the Minnesota Multiphasic 
Personality Inventory–2 (MMPI-2), Butcher et al., (1989) and the Interpersonal Checklist-
Revised (IL-R), and by LaForge & Suczek (1955)). This was despite significantly higher scores 
on egocentrism, hostility and impulsivity (measured by the MMPI-2) in the psychopathy group 
at baseline. The authors concluded that contrary to their expectations, psychopaths and non-
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psychopaths showed more similarities than differences in dynamic risk factors at baseline. The 
study also observed no differential treatment responses between the psychopathic and non-
psychopathic clients on the assessed indicators of dynamic risk after 20 months of treatment. This 
was despite an increase in interpersonal aggression, dominance and assertiveness within the 
sample. The authors suggested that the lack of significant differences between the two groups 
might have been related, in part to the relatively low cut-off PCL-R score of 22 to divide the 
sample into psychopathic and non-psychopathic, albeit using a cut-off score of 26 and 30 also 
revealed that psychopathy was not related to treatment progress. The authors further elucidated 
that the limited change in dynamic risk observed within the study may have been related to serious 
personality pathology within the sample, suggesting that dynamic risk change may be hard to 
accomplish. The authors acknowledged the small sample size of the study and thus the lower 
statistical power of their analysis. They further clarified that the measures employed may not 
have been sensitive enough to evaluate changes in dynamic risk variables within the evaluated 
sample and the complex treatment regime of the study.  
 
A multiple (five offenders) case study evaluation of the Chromis programme (Tew, 
Dixon, Harking & Bennett, 2012) found a reduction in self-reported anger as measured by the 
Novaco Anger Scale and Provocation Inventory (NAS-PI) (Novaco, 1994), with all five cases 
demonstrating significant improvement in their overall NAS scores and on the behavioural and 
arousal subscales. Across all cases, a reduction in physical incidents across time was observed, 
with the exception of one offender who had a peak in physical aggression mid-treatment. In 
addition, whilst verbal aggression reduced across time, it was observed that four offenders 
showed significantly more acts of verbal aggression than expected during treatment, and that all 
five perpetrated more acts after leaving the Personality Disorder Treatment Service (PDTS). The 
findings provide a positive indicator for the effectiveness of Chromis in reducing violence; 
however, it is crucial to recognise that the evidence presented provides a narrow evaluation based 
on a small sample. 
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A further study by Young et al., (2013) demonstrated that in a sample of 16 male 
psychopathic offenders (PCL-R = 28.21, SD = 4.26), significant improvements as a result of 
treatment were observed on the Social Problem-Solving Inventory-Revised: Short Form (SPSI-
R:SF) (D’Zurilla, Nezu & Maydeu-Olivares, 2002), subscales of impulsivity, avoidance and total 
scores, with no significant change on the rational, positive and negative problem-solving scales. 
A consistent pattern of results was observed by Clarke, Cullen, Walwyn and Fahy (2010) and 
Cullen et al., (2011) who had evaluated the same mode of treatment (Reasoning and 
Rehabilitation programme) with mentally disordered offenders. Collectively the authors assert 
that treatment impacts the varied functional modalities on the SPSI-R:SF. Notably, the problem 
areas most improved appear to be those related to problem-solving style rather than to positive 
or negative orientations. In other words, treatment held a tendency to reduce maladaptive 
approaches when solving problems, which suggests that offending may be reduced by improved 
self-control in accordance with the theory of crime (Gottfredson & Hirschi, 1990). Furthermore, 
the study observed significant improvements on the arousal and behavioural domains of anger on 
the NAS-PI, a finding that was not observed by Cullen et al., (2011).  
 
In a retrospective evaluation study of an emotion modulation component of treatment 
(Bowes & Johnson, 2016) delivered by a high-security prison PDTS (Westgate unit), significant 
change was observed in the assessed treatment need areas; understanding, modulating and 
managing emotions (measured by the Emotional Control Questionnaire (ECQ) (Roger & 
Najarian, 1989) and the State–Trait Anger Expression Inventory–II (STAXI-II) (Balsamo, 2013). 
Furthermore, within the sample of 48 male offenders who had completed treatment, the study 
observed that psychopathy scores (moderate PCL-R group ≤ 29, n = 18 and high PCL-R group ≥ 
30, n = 30) did not moderate treatment gain effects across the evaluated treatment need areas. A 
further retrospective evaluation study, but of a social competence treatment programme also 
delivered at the Westgate PDTS, observed significant improvements in some but not all of the 
assessed treatment need areas (Mullan, Johnson & Tomlinson, 2017). With an availability sample 
of 44 male treatment completers, the study observed statistically significant change across the 
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treatment need areas of identifying and monitoring personal patterns of social behaviour and 
ability to demonstrate socially competent behaviour (measured by the Inventory of Interpersonal 
Problems (IIP) (Horowitz, Alden, Wiggins & Pincus, 2000) and perspective-taking (measured by 
the Interpersonal Reactivity Index (IRI) (Davis, 1980). The study observed no statistically 
significant improvement in empathic concern as measured by the IRI. The authors concluded that 
whilst addressing empathy deficits is an integral aim of the treatment component, doing so 
provides comparatively less focus to this treatment need area. It is concluded by the authors that 
some treatment need areas may be unable to be addressed, a notion that has previously been 
conceded (Harpur & Hare, 1994; Howells & Tennant, 2010; Rice et al., 1992). The study further 
explored treatment change between moderate (PCL-R ≤ 29, n = 22) and high psychopathy (PCL-
R ≥ 30, n = 21) groups, with no statistical differences observed, other than for the treatment need 
area of self-esteem (measured by the Self-esteem Scale (Thornton, Beech & Marshall, 2004)). It 
was found that whilst the moderate psychopathy group’s self-esteem scores undesirably 
decreased pre- to post- treatment, statistically significant improvement in self-esteem was evident 
for the high psychopathy group. This finding contradicts previous research, which has highlighted 
that clinical change is less for individuals with high levels of psychopathy (Hughes, Hogue, 
Hollin & Champion, 1997; Olver, Lewis & Wong, 2013).  
 
Whilst both studies (Bowes & Johnson, 2016; Mullan et al., 2017) provide respected 
evidence that supports the implementation of both evaluated components of treatment within the 
PDTS, it is important to accept that both studies provide a short-term evaluation of each 
component, with no evaluation of long-term treatment gain. This is a relatively serious concern, 
taking into consideration evidence that suggests that skill retention diminishes more for high-
scoring psychopathic offenders (Blud, Thornton & Ramsey-Heimmermann, 2003). Furthermore, 
the small samples in both studies suggest that the power of the statistical tests for significance 
was low and that the absence of an untreated comparison group impedes upon the robustness of 
conclusions regarding treatment effect.  
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Furthermore, it is pertinent that whilst there is extant research that supports Schema 
Therapy as effective treatment for personality disorder, in particular borderline personality 
disorder (e.g., Farrell, Shaw & Webber, 2009; Giesen-Bloo, et al., 2006, Nadort et al., 2009), 
empirical studies that have examined psychopaths treatment responsiveness in addressing 
maladaptive schemas is scant. A single case study evaluation of Schema Therapy (Chakhssi, 
Kersten, de Ruiter, & Bernstein, 2014) for a client with psychopathic features, observed 
significantly improved scores in four of the five Early Maladaptive Schema (EMS; Young & 
Brown, 1994) domains over a four-year treatment period, with no significant change in the Other-
directedness domain.  The authors concluded that treatment was able to address the clients 
emotional detachment as reflected in significant improvements in the schema domains; 
disconnection, impaired autonomy and limits, and over vigilance. A finding that was consistent 
to an earlier pilot study of forensic patients (Van den Broek, Keulen-de Vos & Bernstein, 2011), 
whereby treatment was found to be effective in addressing the client’s vulnerable emotions.  In 
contrast, Doyle, Tarrier, Shaw, Dunn and Dunn (2015) observed no significant improvement 
across the schema domains within a sample of personality disordered offenders following 
schema-focused treatment.  
 
Empirical studies that have developed based on a sole proximal change within treatment 
evaluation have included behavioural change (recidivism) as a more accurate measure of 
treatment effectiveness. This methodological approach allows for an evaluation of indirect and 
direct measures of treatment effectiveness. If criminogenic needs are functionally related to 
violent behaviour, it is plausible to conclude that positive changes in these violence related 
variables should be accompanied by a concomitant reduction in violent recidivism (Gullhaugen 
& Nøttestad, 2012). For example, Olver and Wong (2009) examined the therapeutic response of 
psychopathic sex offenders (full sample n = 156 of which 45 had a PCL-R score of ≥ 25) in terms 
of therapeutic change as measured by the Violence Risk Scale – Sexual Offender version (VRS-
SO) (Wong, Olver, Nicholaichuk, & Gordon, 2003). The results demonstrated that positive 
treatment change was associated with reductions in both sexual and violent recidivism after 
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psychopathy was controlled, providing evidence that offenders with psychopathic traits can 
reduce their risk of reoffending as a result of treatment. The authors contend that the results do 
not support the notion that psychopaths are untreatable or that treatment makes psychopaths 
worse and more likely to reoffend.  
 
In a comparable study, Olver et al., (2013) examined the interrelationships of PCL-R, 
therapeutic change as measured by the VRS (Wong & Gordon, 2006) and violent recidivism in a 
sample of 152 male offenders, of which 42 met the 30-point PCL-R cut-off and 98 met the criteria 
using the 25-point cut-off. The study found a significant negative correlation between VRS 
therapeutic change scores and PCL-R scores, particularly Factor 1, and the affective facet. 
Furthermore, VRS-assessed change was associated with reductions in violent recidivism after 
controlling for psychopathy. The findings suggest that higher levels of psychopathic traits were 
associated with decreased therapeutic progress; nevertheless, risk-related treatment change 
demonstrated by high-risk psychopathic offenders can be predictive of reductions in violent 
recidivism. Considered together, with the caveats of the studies limitations, evidence presented 
by Olver et al., (2013) and Olver & Wong (2009) lead to a tentative conclusion that psychopaths 
per se may have limited bearing on the success of treatment; they do indeed change, and the 
amount of change they make inversely predicts whether they will be reconvicted.  
 
Individual analysis in evaluating treatment effectiveness 
Whilst examining aggregate differences within a group of treated offenders has 
implications for assessing the efficacy of a programme as a whole, evaluating treatment 
completers as a single cohort provides no indication of how any individual performed in 
treatment; that is whether each individual has changed on an individual case basis (Beggs, 2010). 
Thus, a group-level approach possesses little practical and clinical significance, when considering 
individual offenders. This is an important consideration taking into account that psychopathic 
offenders are not a homogenous group (Brinkley, Newman, Widiger & Lynam, 2004), which 
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accentuates the clinical importance of individual-focused analyses to investigate possible 
differential outcomes within this unique offender population.  
 
One such approach has compared individual change using an outcome measure with a 
reliable change index (RCI) for each measure (Jacobsen & Truax, 1991), allowing for the 
possibility of measurement error. Change scores that exceed the RCI represent statistically 
significant change, thereby allowing estimation of the proportion of the sample that has made 
reliable change using a given treatment. There is a significant controversy within this strand of 
outcome research, centred around the correct method for calculating the RCI, with a developed 
argument that simplified methods, such as the RCI do not provide sufficient control over potential 
sources of errors in the difference scores such as regression to the mean (Wise, 2004). Whilst 
alternative and more conservative formulae for calculating the RCI have been advanced (Heaton 
Temkin, & Dikmen, 2001), in practice the various formulae tend to converge on similar 
outcomes. Therefore, the Jacobsen and Truax (1991) RCI method has been an approach 
advocated in more recent treatment efficacy studies (Chakhssi, de Ruiter & Bernstein, 2010; 
Draycott, Kirkpatrick and Askari, 2012; Tock et al., 2018; Wilson, Freestone, Taylor, Blazey & 
Hardman, 2014), the research findings of which are discussed below.  
 
In a forensic psychiatric sample of 74, of whom 27 had a PCL-R score greater than 26, 
Chakhssi et al., (2010) evaluated the effectiveness of a therapeutic approach in addressing 
treatment needs related to violence. Both psychopathic and non-psychopathic patients 
demonstrated commensurate improvements in social skills, level of insight, attribution of 
responsibility and self-regulation strategies (measured by the BEST-index (Reed, Woods, & 
Robinson, 2000) across repeated follow-ups over a 20-month period. These findings illustrated 
that both psychopaths and non-psychopaths were responsive to forensic treatment, with few 
significant differences between these two groups in terms of change. However, individual 
analysis using the RCI (Jacobson & Truax, 1991) method found that a subset of psychopathic 
offenders – approximately 7% – demonstrated reliable change with regard to violent behaviour. 
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Of this subset, 22% demonstrated reliable deterioration and 70.4% demonstrated uncertain 
change (they neither improved nor deteriorated with regard to violence). The study also observed 
that approximately one-third of the psychopaths showed reliable improvement according to 
BEST-index total scores and factors measuring social skills and insight. Whilst providing a level 
of optimism, the findings suggest that for a subset of psychopathic offenders, treatment is not 
effective or at least that this subset is not amenable to change. The study provides a unique and 
explanatory evaluation of treatment for psychopathic offenders; nevertheless, the lack of a no-
treatment control group hinders firm conclusions regarding treatment change within the sample. 
Whilst it is postulated that a calculation of reliable change indices can go some way towards 
accounting for this limitation, without a control group it is not possible to confidently conclude 
that change is an effect of treatment rather than an attribution of age or external management of 
risk. Furthermore, the study applied a behaviour-based measure to assess change, and whilst 
satisfactory interrater reliability is reported, it is uncertain if and how habituation of the staff to 
patients’ behaviour affected the observed change.  
 
Draycott et al., (2012) examined reliable change using the VRS and Historical Clinical 
Risk Management–20 (HCR-20) (Webster, Douglas, Eaves & Hart, 1997) to assess 29 male 
offenders who participated in the DSPD service for 21 months at a high-security hospital. The 
sample’s average PCL-R score was 25.7 (SD = 5), of which nine patients had a score greater than 
or equal to 30. The study did not report group analysis outcomes, although individual-level 
analysis illustrated few patients demonstrating significant change, with only one patient 
improving across the clinical and risk management subscales of the HCR-20. Of particular 
concern was that none of the patients showed any positive change on the VRS, a measure that 
has been advocated for use with psychopathic offenders (Wong & Gordon, 2006). The findings 
seem to illustrate that risk change within the sample of offenders participating in DSPD services 
was curtailed. It is also pertinent that the clinical risk assessments used to measure treatment 
outcome may be subject to a level of experiment bias, a consideration that is not acknowledged 
by the authors.  
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In a medium secure sample of personality-disordered offenders (n = 47) with a mean 
PCL-R score of 23.61 (SD = 5.41), Wilson et al., (2014) reported statistically significant 
reductions overall in risk scores on the VRS, but not on the HCR-20 clinical and risk management 
subscales. Further analysis of the HCR-20 scores demonstrated an initial improvement over two 
years of treatment leading to an increase in violence risk for patients in the third year of treatment. 
The authors interpret this finding as coinciding with some patients commencing community leave 
in the later stages of treatment, which necessitated a change in scoring the HCR-20 to reflect a 
change in environment from the secure and contained environment of the treatment unit. With 
regard to individual analysis of reliable change within the sample, it was found that 72% of the 
sample made no significant change in the HCR-20 (clinical and risk management combined) 
outcome as a result of treatment, with 21% of the sample making positive change and only 1% 
making negative change. With regard to the VRS, again, a higher proportion of the sample made 
no significant improvement, 42% showed positive change and none negative change. Whilst the 
findings are in contrast to those presented by Draycott et al., (2012), similar methodological 
limitations are seen as in the study by Wilson et al., (2014).  
 
A more recent retrospective empirical study (Tock et al., 2018) found significant 
reductions in scores on the VRS and the HCR-20 clinical and risk management scales within a 
sample of 41 high-risk psychopathic offenders from high-security prison PDTS (Westgate unit). 
The study observed a significant reduction in scores on the VRS scales pre- to post- treatment, a 
finding that is consistent with previous studies (Olver et al., 2013; Wong et al., 2012; Wilson et 
al., 2014). This finding provides support for the notion that high-risk, psychopathic offenders are 
able to reduce risk through engagement in treatment, and that the VRS is sensitive to this change. 
In addition, the significant reduction in scores on the clinical and risk management scales of the 
HCR-20 is in contrast to previous findings (Wilson et al., 2014). The study observed no 
significant interaction between treatment and the psychopathy group (moderate PCL-R ( 29), n 
= 22) and high PCL-R ( 30), n = 30)) across the risk outcomes. The study reported a higher 
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proportion of reliable positive change within the full sample across the risk management scales 
in comparison to previous studies (Draycott et al., 2012; Wilson et al., 2014) with a clear trend 
towards reliable improvement across time. More specifically, 82% of the sample demonstrated 
positive reliable change in VRS dynamic risk scores across their engagement within the PDTS, 
whilst 46% demonstrated reliable change in clinical risk and 49% in risk management as 
measured by the HCR-20. Whilst comparable methodological limitations apply (Chakhssi et al.,, 
2010; Draycott et al., 2012; Wilson et al., 2014), the study findings provide, alongside others 
already discussed, much-needed insight into treatment responsiveness within this complex 
population.  
 
It is apparent that the responsiveness of this high-risk, high-need offender population 
varies, and it is now evident as a result of enhanced research approaches that individual variability 
in psychopaths is masked in group-level analyses. Individual analysis has yielded valuable insight 
into the treatment change of this unique offender population. The evidence suggests that although 
a subset of psychopathic offenders is not amenable to treatment attempts, treatment does not, at 
least, make the majority of psychopaths worse, which is an encouraging finding (Chakhssi et al., 
2010).  
 
When considering treatment effectiveness studies, it is prudent to note that perhaps the 
most critical issue contributing to the lack of consensus on whether psychopathic offenders can 
be effectively treated is that the studies that do exist are beset by methodological problems, which 
understandably temper interpretations (Doreen & Yates, 2008; Reidy et al., 2013). To some 
extent, some methodological difficulties are inevitable and thus evaluating the effectiveness of 
offender treatment will remain a contentious issue. Nevertheless, it is encouraging in terms of 
developing clinical understanding that more recent empirical studies are attempting to address 
the methodological limitations inherent in past research and are using alternative research 
approaches to enhance clinical understanding. The most recent applied method of individual-
focused analysis is yielding meaningful and needed clinical insight into the differential outcomes 
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within this heterogeneous group of offenders. More specifically, in contrast to studies that solely 
explore whether treatment is effective (which must be addressed through randomised control 
trials), individual-level analysis allows for an evaluation to ascertain ‘for whom does this 
treatment work?’ – a more meaningful clinical outcome (Draycott et al., 2012).  
 
 
Treatment non-completion 
 
Offender treatment attrition: defining the problem 
The failure of offenders to complete treatment is a salient clinical concern, which has 
been related to an array of serious implications, notably a decline in treatment outcomes and 
increased risk (Olver, Stockdale & Wormith, 2011; Wormith & Olver, 2002). In addition, it has 
been evidenced that offenders who do not complete treatment are more likely to reoffend in 
comparison to those who have not engaged in treatment at all (McMurran & Theodosi, 2007). 
Treatment non-completion also utilises valuable resources, which is an important consideration 
in the current economic climate as it prevents new admissions from benefitting from such services 
(McMurran, Huband & Duggan, 2008).  
 
Treatment non-completion refers to the premature cessation of treatment and it may take 
three forms: exclusion due to inappropriate behaviour, administrated exit for transfer or release 
or patient-initiated dropout (Howell & Day, 2007; Wormith & Olver, 2002). Comparatively, the 
rates of non-completion for offender treatment programmes have varied substantially. A meta-
analysis revealed a rate of non-completion of cognitive behavioural treatment varying between 
14.6% for institutional samples and 45.5% in community samples (McMurran & Theodosi, 
2007). The authors speculate that higher attrition rates within the community are underpinned by 
there being more available options to discontinue treatment in comparison to secure settings, 
particularly opportunities to reoffend and the risk of arrest. Due to a lack of clarity over reasons 
for non-completion within the included studies, a concrete conclusion could not be drawn. The 
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review further conceptualised that the profiles of offenders who do not complete treatment show 
higher risk, leading the authors to hypothesise that offender treatment programmes do not serve 
the needs of high-risk offenders. Further, it is argued that ‘non-completers do worse in treatment 
than untreated offenders’ (McMurran & Theodosi, 2007, p. 341), an argument that the authors 
raise with caution due to a range of alternative factors also related to risk.  
 
In terms of offender type, attrition rates of between 10% and 86% have been reported for 
sex offender treatment (Browne, Foreman & Middleton, 1998; Craisatti & Beech, 2000; 
Larochelle, Diguer & Laverdiere, 2011; Seto & Barbaree, 1999) and between 12% and 90% for 
violent offender treatment, including domestic violence interventions (Gondolf & Foster, 1991; 
Hornsveld, 2005). In a meta-analysis of 114 studies, representing 41,438 offenders, Olver et al 
(2011) reported significantly higher attrition rates for domestic violence programmes (50.8%) 
across treatment modality, with 32.3% for violent treatment and 29.4% for sexual offender 
interventions. The authors expressed that whilst it was uncertain what may have contributed to 
higher attrition rates in cases relating to domestic violence treatment, all the included studies were 
community-based, which may have been a moderating factor. The review observed lower attrition 
rates for CBT programmes (33.4%), with an attrition rate of 39.6% reported for TC approaches 
to treatment, 44.9% for Duluth programmes and 48% for unspecified treatment approaches. 
Furthermore, lower attrition rates were observed for prison-based interventions (21.5%), with a 
reported attrition rate of 31.5% reported for community-based treatment. As with McMurran and 
Theodosi (2007), the authors expressed that higher attrition rates in community samples might be 
related to limited incentives in comparison to institutional programmes. Both McMurran and 
Theodosi (2007) and Olver et al., (2011) considered the wide variation of attrition rates, and 
suggested that several factors could have contributed to such differences, including different 
criteria and operational definitions of ‘dropout’, the nature of offender groups or programme type, 
and the treatment setting.  
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In light of the implications of treatment non-completion for offenders, a substantial 
amount of research has been devoted to identifying factors that predict dropout. In an extensive 
review of dropout literature, Daly and Pawlowski (2000) found that unemployment, being 
unmarried (or childless), lower income, lower level of education, prior criminal history, substance 
abuse, mental health concerns and relationship difficulties were predictors for treatment non-
completion within domestic violence treatment. Further treatment studies have observed low 
motivation (Latendresse, 2006) and denial (Beykyo & Wong, 2005; Hunter & Figueredo, 1999) 
as contributing factors to treatment dropout. In considering predictors of offender treatment 
attrition, Olver et al., (2011) identified personal characteristics (ethnic minority status, youth, 
single status and lower levels of education) including high risk and high treatment need as strong 
predictors. Furthermore, antisocial personality disorder and psychopathy (both diagnosis and 
dimensional PCL-R (Hare, 2003)) were found to be significant predictors of attrition. 
 
Alongside research into factors related to treatment non-completion, several theoretical 
models have been developed to guide methods of offence-focused treatment, as a means of 
supporting engagement, and thus treatment completion. The treatment interventions that have 
demonstrated the largest effects in reducing various forms of criminal recidivism tend to follow 
the principles of risk, need, and responsivity (RNR) (Andrews & Bonta, 2003; 2010). The RNR 
treatment model has gained empirical support, not only in supporting offender engagement 
(Ward, Day, Howells & Birgden, 2004) but in causing greater reductions in recidivism across 
offence types (Andrews & Bonta, 2010; Andrews & Dowden, 2006; Hanson, Bourgon, Helmus 
& Hodgson, 2009; Hart & Logan, 2011; Koehler, Losel, Akoensi & Humphreys, 2013; 
Landenberger & Lipsey, 2005; Smith, Gendreau & Swartz, 2009). The RNR model is based on a 
broad personality and cognitive social learning perspective of human behaviour and aims to 
identify factors to support treatment effectiveness. The risk principle states that treatment 
intensity or dosage should be matched to the risk level of the offender, with the need principle 
asserting that dynamic risk factors linked to the origin and maintenance of antisocial behaviour 
have the potential to change through treatment. The need principle states that treatment should 
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focus on offenders’ criminogenic needs, which refers to risk factors that can be changed, namely 
dynamic risk factors. The responsivity principle states that treatment should employ cognitive 
behavioural methods of behaviour change, and that treatment should be adapted to the unique 
characteristics of offenders including motivation, cognitive ability and personality. Whilst the 
RNR model has garnered positive outcomes, it has been criticised for lacking clarity regarding 
the construct of responsivity and how it is effectively implemented within clinical practice (Day, 
Casey, Ward, Howells & Vess, 2010).  
 
Despite several reliable predictors of treatment non-completion identified and theoretical 
models of treatment engagement proposed, the problem of offender treatment attrition remains 
an ongoing and serious concern. It is pertinent to acknowledge that identified predictors 
frequently point to important responsivity issues that can impede upon treatment engagement and 
service delivery. A greater acceptance and awareness of these factors among treatment referrals 
should alert service providers to which offenders are at risk of treatment disengagement and 
dropout, so that further efforts may be directed to retain these clients (Andrews & Bonta, 2010). 
 
Psychopathy and treatment non-completion 
Psychopathic offenders as a high-risk, high-need group of offenders and those with 
elevated scores on the PCL-R have been found to be a challenging population to treat, typically 
presenting with limited motivation, greater resistance to change and difficulties in forming 
therapeutic alliances (Hemphill & Hart, 2002; Ogloff et al., 1990). Furthermore, psychopathic 
offenders engage in more disruptive behaviour during treatment when compared to non-
psychopathic offenders (Hildebrand, de Ruiter & Nijman, 2004). Naturally, therapists notice their 
difficult behaviour, rating such clients as less motivated and less malleable (Hobson et al., 2000). 
Furthermore, empirical studies have reported high rates of attrition for such high-risk offender 
populations (DeSorcy et al., 2016; Hobson et al., 2000; Ogloff et al., 1990)  
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Whilst it is crucial to acknowledge the evidence base that affirms psychopathic offenders 
as a challenging group for treatment, it is equally important to acknowledge past evidence that 
has critiqued treatment provision for this group of high-risk offenders (D’Silva et al., 2004; 
Skeem et al., 2009; Vien & Beech, 2006). More specifically, few of these treatment programmes 
followed the principles of RNR, and they would not therefore be likely to be effective in reducing 
risk for any individual convicted of offending, let alone those high in PCL psychopathy 
(Andrews, Bonta & Hogue, 1990; Skeem et al., 2011).  
 
In recent years, however, there have been significant advances in designing psychopathy 
treatment programmes (Wong & Hare, 2005); psychopathic offenders are not only portrayed as 
high-risk individuals with myriad treatment needs but also as individuals with a responsivity 
issue. Whilst more recent treatment efficacy studies have demonstrated positive outcomes, the 
early finding that psychopathic offenders were associated with more difficulties during treatment 
has remained consistent through the research (Langton et al., 2006; Olver et al., 2013; Olver & 
Wong, 2009). Therefore, it is conceded based on collective psychopathy treatment research that 
given the appropriate treatment, individuals with high PCL-R levels are treatable, and on the face 
of it, may be more difficult to treat than similar individuals with low PCL-R levels or non-
psychopathic offenders. Nevertheless, these high-risk offenders are the highest priority for 
treatment, and whilst managing their problematic behaviours in treatment may just be part of the 
process of working therapeutically with them, there is a clinical importance in furthering our 
understanding of the relationship between psychopathy and treatment non-completion.  
 
The standpoint that psychopathy creates challenges for otherwise effective treatment 
processes fits well with psychopathy’s placement in the RNR model as a specific responsivity 
factor that interferes with treatment engagement (Andrews et al., 1990). It is now clinically 
understood that PCL-R Factor 1 traits are associated with treatment interfering behaviours, with 
therapeutic alliance, treatment motivation or readiness, and information processing being 
adversely affected (Wong & Hare, 2005; Wong et al., 2015). More specifically, the interpersonal 
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facet (Facet 1) traits (e.g. grandiosity and deceitfulness) could contribute to resistance to 
engagement and openness, caused by developed beliefs or resistance to change. Facet 2, the 
affective facet, represents a lack of emotion that may impede on therapeutic relationships and 
meaningful engagement with emotion-based components of treatment, or even treatment 
engagement at all (Wong et al., 2012; Wong & Olver, 2015). Overall, these interpersonally 
exploitative and affectively shallow personality traits are resistant to change and behavioural 
manifestation of these traits can significantly interfere with treatment. PCL-R Factor 2 traits have 
been related to the criminogenic needs of treatment, rather than to inherent responsivity issues 
(Wong et al., 2012; Wong & Olver, 2015). This is on the basis that PCL-R Factor 2 has been 
found to be predictive of violent and general recidivism (Hare, 2016; Hoppenbrouwers et al., 
2015; Kennealy et al., 2010; Olver et al., 2013; Walters et al.,  2011; Yang et al., 2010) and 
represents established dynamic risk factors or proxies for dynamic risk factors (Wong et al., 
2012). Empirical support exists, therefore, for the argument that making risk-relevant changes to 
dynamic treatment needs is associated with decreases in most recidivism outcomes (Olver et al., 
2013).  
 
The RNR model and subsequent empirical evidence have provided a theoretical 
foundation for understanding psychopathy as a responsivity factor that hinders treatment 
engagement, therapeutic alliance, motivation and readiness (Wong & Hare, 2005). Nevertheless, 
there is clinical importance in enhancing understanding of the relationship between the construct 
of psychopathy and treatment non-completion.  
 
 
 
Overarching aims of the thesis 
Psychopathy is a prominent area for criminal justice practice. Identifying those with 
higher levels of psychopathic traits and supporting risk management within this complex offender 
population is an extremely important, yet challenging task. Whilst it is now understood that 
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‘psychopathic individuals are not uniquely “hopeless” cases who should be disqualified from 
treatment, but instead are general “high-risk” cases who need to be targeted for intensive 
treatment to maximize public safety’ (Skeem et al., 2011, p. 96), it is evident that the relationship 
between psychopathy, risk and treatment are not straightforward.  
 
It is clinically understood that psychopathic offenders as a high-risk, high-need 
population present an array of challenges that impede upon their engagement in treatment. The 
reported high rate of treatment non-completion for this unique population poses a range of 
adverse consequences. It is inevitable that an approach that minimises the impact of treatment 
non-completion could be to exclude these high-risk offenders or to ‘warehouse’ them as a means 
of managing risk (Tyrer et al., 2010). This is an undesirable outcome and contradicts the 
evidence-based risk principle of engaging high-risk offenders in intensive treatment (Andrews et 
al, 1990). Whilst it is prudent to acknowledge that there have been developments in treatment 
programmes for psychopathic offenders, this unique offender population continues to pose 
challenges to treatment attempts. Whilst acknowledging previous empirical evidence that has 
identified psychopathy as being related to treatment attrition, to date no review has been 
conducted to explicitly explore this postulated association.  
 
Thus, as an important clinical objective, the first aim of this thesis is to systematically 
review the existing literature to explore associations between the construct of psychopathy and 
treatment non-completion (Chapter 2). The following overarching research question is posed: 
 
To what extent is the construct of psychopathy associated with treatment non-
completion, and does this relate to risk?  
In order to answer this, the review will compare treatment attrition rates for this high-risk 
offender population, with comparisons between treatment modalities (treatment approaches) and 
settings (prison and secure hospitals). Secondly, it will identify studies that explored the 
relationship between psychopathy, treatment completion and non-completion with relevant 
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outcomes in order to examine whether treatment non-completion is associated with increased risk 
and recidivism for psychopathic offenders.  
 
With regard to treatment effectiveness for this unique high-risk, high-treatment-need 
group of offenders, it would seem that the pessimistic view of treatment effectiveness for 
psychopathic offenders has been fuelled by methodologically weak research and inappropriately 
designed treatment. However, there have since been significant advances in designing 
psychopathy treatment programmes and more recent empirical studies have provided positive 
outcomes providing support for the position that psychopathic offenders are treatable. Based on 
recent evidence it appears that when appropriately designed treatment programmes are 
implemented, the effectiveness of treatment can be demonstrated. Nevertheless, psychopathy 
treatment literature is still in a condition where no firm conclusions can be drawn about treatment 
efficacy. Thus, there remains clinical importance in developing the understanding of treatment 
for psychopathic offenders, with findings being replicated to strengthen conclusions and to 
support clinical practice.  
 
Therefore, the second overarching aim of the thesis is to empirically examine whether 
psychopathic offenders are amenable to change through contemporary treatment methods based 
on the best available evidence of what works with offenders more generally and psychopathic 
offenders in particular (Chapter 3). The following overarching research question is posed: 
 
To what extent is the Chromis programme effective in producing significant and 
reliable changes in treatment need areas related to violence for individual psychopathic 
offenders?  
As such, Chapter 3 will examine the treatment effectiveness of the Chromis programme 
by examining whether psychopathic offenders show significant improvements in the evaluated 
treatment need areas of problem-solving, anger, impulsivity, locus of control and maladaptive 
schemas following treatment as a whole and the two main treatment components (Cognitive 
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Skills and Enabling Change). This will initially be evaluated through group-level analysis to 
facilitate a comparison with previous literature using this methodology. Although as offenders’ 
responses to treatment are variable, an individual change analysis will also be conducted as means 
of investigating differential outcomes within the group of psychopaths. 
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Chapter Two: Treatment non-completion of psychopathic offenders: – A review of the 
evidence 
 
Abstract 
 
It is postulated that the failure of offenders to complete psychological treatment and interventions 
poses significant problems, such as adversely affecting treatment effectiveness and increasing the 
risk of recidivism. Clinical concerns are inevitably increased by the clinical acceptance that 
psychopathic offenders, as a high-risk, high-treatment-need group of offenders, are more 
challenging to engage in treatment and more likely to disengage or be removed from treatment. 
The main aim of this study was to conduct a systematic review of the literature on 
psychotherapeutic interventions for psychopathic offenders in order to examine the relationship 
between psychopathy and treatment non-completion. Two subsidiary aims were to compare 
treatment attrition rates for psychopathic offenders across treatment modalities and settings, and 
to identify studies that reported on the relationship between psychopathy and treatment non-
completion. Thirteen empirical studies were identified; however, due to variations in design and 
analysis, the included studies could not be considered a homogeneous group for meta-analysis. 
The median non-completion rate for psychopathic offenders was 46%, but only seven of the 
included studies specifically reported attrition rates, which impeded meaningful comparative 
evaluations of modes of treatment and settings for psychopathic offenders. There is varying 
evidence to support psychopathy being a contributing factor to treatment non-completion, albeit 
there is clinical utility to the findings of the included studies. The predictive relevance of 
psychopathy and treatment non-completion to recidivism is inconclusive. Implications for 
clinical practice and research are discussed.   
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Introduction 
 
The fundamental purpose of offender treatment programmes is to reduce the recurrence 
of future offending. Despite past pessimism about treatment effectiveness, there is a growing 
body of research to demonstrate that certain models of offender treatment are effective in 
reducing recidivism following programme completion (Ross, Quayle, Newman & Tansey, 2013). 
Indeed, the adoption of risk, need and responsivity (RNR) principles (Andrews & Bonta, 2003; 
2010) has contributed to increased clinical improvements and positive outcomes for offender 
treatment (Andrews & Bonta, 2010; Andrews & Dowden, 2006; Hanson et al., 2009; 
Landenberger & Lipsey, 2005; Smith et al., 2009; Ward et al., 2004).  
 
Despite developments in treatment models, the non-completion of treatment by offenders 
remains a major clinical concern which has been related to an array of serious implications and 
adverse outcomes – notably reduced treatment effectiveness and disengagement with 
professional services – that hinder progression and risk management (McMurran et al., 2010). 
Furthermore, treatment non-completion has been related to increased recidivism, with evidence 
suggesting that offenders who do not complete treatment are more likely to reoffend than those 
who have not engaged in treatment (Day et al., 2010; McMurran & Theodosi, 2007). More 
specifically, McMurran and Theodosi (2007) reported on a meta-analysis that observed a 
difference of -0.16 in effect size in reoffending (d = -0.16) between offenders who had not 
engaged in treatment (untreated offenders) and treatment non-completers, accentuating that 
failing to complete treatment is associated with elevated levels of reoffending. This is an 
important finding, but it must be interpreted with caution due to the existence of variable factors 
that can influence risk. A theoretical understanding of the association between treatment non-
completion and increased risk remains unclear, although McMurran and Theodosi (2007) 
hypothesise that removal from treatment may contribute to an increase in anti-social attitudes, 
decrease in confidence, a sense of worthlessness, and arrested development of risk management 
strategies: all factors associated with risk of offending.  
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Offender treatment attrition: defining the problem  
The term ‘treatment non-completion’ has been chosen here to include a range of 
definitions of premature termination of treatment, covering service-initiated exclusion (premature 
termination because of non-attendance, disruptive behaviour or failure to engage in treatment) 
and service user-initiated dropout (the individual electing to discontinue treatment). In exploring 
the wider literature base on treatment non-completion, a meta-analysis of psychotherapy attrition 
studies that included few, if any, offenders (Wierzbicki & Pekarik, 1993) reported a mean non-
completion rate of 47%, finding three significant predictors of treatment dropout: ethnic minority 
status, low income and low levels of education. Furthermore, McMurran et al., (2010) reported a 
median non-completion rate of 37% for personality disorder treatment, with variables associated 
with treatment non-completion being: participant characteristics (e.g. youth, unemployment, 
juvenile conviction, emotional neglect in childhood and being in a relationship for less than six 
months); need factors (e.g. diagnoses, lower levels of cognitive functioning, poor problem 
recognition/competencies and increased antisocial aggressiveness); and environmental factors 
(e.g. treatment length and therapeutic relationships).  
 
Treatment attrition rates for offender populations vary substantially, with rates between 
10% and 90% reported (Browne et al., 1998; Gondolf & Foster, 1991; Hornsveld, 2005; 
Larochelle et al., 2011; Seto & Barbaree, 1999). In a meta-analysis of 114 studies that represented 
41,438 offenders, Olver et al., (2011) reported significantly higher attrition rates for domestic 
violence programmes (50.8%), with 32.3% for violent treatment and 29.4% for sexual offender 
interventions. With regard to treatment mode and environment, the review observed lower 
attrition rates for cognitive behavioural treatment programmes (33.4%) and prison-based 
interventions (19.9%). In consideration of predictors of offender treatment attrition, the review 
identified personal characteristics (e.g. ethnic minority, young, single and lower levels of 
education) and status as high-risk and high-need offenders as being strong predictors. 
Furthermore, antisocial personality disorder and psychopathy were found to be significant 
predictors of attrition. This is an important finding, which suggests that further exploration of the 
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relationship between the construct of psychopathy and treatment non-completion is necessary to 
support clinical understanding and practice.  
 
Several factors could potentially be contributing to the evident variation in attrition rates, 
including different criteria for and operational definitions of dropout, nature of offender group or 
programme type and treatment setting (McMurran & Theodosi, 2007; Olver et al., 2011). These 
are all factors that need to be considered when interpreting empirical findings and relating 
evidence to practice. Furthermore, it is apparent that identified predictors of treatment non-
completion frequently point to important responsivity issues that can impede treatment 
engagement and service delivery. A greater acceptance and practical understanding of these 
factors when dealing with treatment referrals would help service providers to determine which 
offenders are at risk of treatment disengagement and drop-out, so they can direct efforts towards 
retaining these clients (Andrews & Bonta, 2003, 2010). 
 
Psychopathy and treatment non-completion  
Psychopathic offenders as a high-risk, high-need group of offenders and those with 
elevated scores on the PCL-R have been found to be challenging populations to treat, typically 
presenting with limited motivation, greater resistance to change and difficulties in forming 
therapeutic alliances (Hemphill & Hart, 2002; Ogloff et al., 1990). Therefore, from a clinical 
perspective it is unsurprising that empirical studies have reported high rates of attrition for these 
high-risk offender populations (DeSorcy et al., 2016; Hobson et al, 2000; Ogloff et al., 1990). 
This is an important concern, considering that psychopathic offenders are reported to be five 
times more likely than non-psychopathic offenders to recidivate violently (Olver & Wong, 2006; 
Salekin, 2008; Serin & Amos, 1995). This already elevated risk may be further increased with 
treatment non-completion, given the association between treatment non-completion and 
increased risk of reoffending (McMurran & Theodosi, 2007). On this basis, treatment non-
completion for this unique offender population is a pertinent clinical concern.  
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There have been significant advances in designing psychopathy treatment programmes 
(e.g. Wong & Hare, 2005) whereby psychopathic offenders are not understood only as high-risk 
individuals with a myriad of treatment needs but also as individuals with significant responsivity 
issues, such as those envisaged by the RNR model (Andrews & Bonta, 2003; 2010). Nevertheless, 
the early finding that psychopathic offenders were associated with having more difficulties during 
treatment has been substantiated through the research (Langton et al., 2006; Olver & Wong, 2009; 
Olver et al., 2013).   
 
Whilst previous empirical evidence has identified psychopathy as being related to 
treatment attrition, to date, no review has been conducted specifically to explore evidence of this 
relationship. The aim of this systematic review is to synthesise existing literature on 
psychotherapeutic treatment for psychopathic offenders, and more precisely, to explore 
associations between the construct of PCL psychopathy and treatment non-completion. In 
addition, there were two subsidiary aims: firstly, to study treatment attrition rates for this high-
risk offender population, with comparisons between treatment modalities and settings. Secondly, 
to identify studies that explored the relationship between psychopathy and treatment non-
completion on the one hand, and relevant outcomes, such as recidivism, on the other. Identifying 
correlates and predictors of attrition for this high-risk, high-need offender population is an 
important clinical objective and may be useful in developing clinical understanding that will 
support the development of strategies for engagement and retention of psychopathic offenders in 
treatment. 
 
Method 
 
Literature search strategy 
Prior to conducting the literature search, the Cochrane Database of Abstracts and 
Reviews of Effects (DARE) was searched to confirm that a similar review had not recently been 
completed. Literature searches took place in July 2018, and involved database searching, hand 
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searching of selected journals, and contacting authors and professionals who might have had 
knowledge of relevant unpublished papers. The author also relied on personal knowledge of 
research on treatment outcomes for psychopathic offenders.  
 
The following databases were searched to identify appropriate studies (published or 
unpublished) conducted up to July 2018: EMBASE, Medline, PsychINFO, Psyarticles and 
Proquest (a database of unpublished dissertations searched to obtain all relevant studies and limit 
publication bias). The search strategy combined terms for the following concepts: psychopathy, 
treatment and non-completion (see Appendix 1 for search strategy terms).  
 
Selection criteria and assessing the quality of included studies 
The obtained studies were screened for topic relevance using their titles and abstract 
content. Irrelevant and duplicate studies were excluded. The remaining potentially relevant 
studies were obtained and  examined for their suitability for inclusion using the following criteria: 
(a) empirical exploration of treatment non-completion7,  completion and/or treatment engagement 
(length of treatment) for psychopathic offenders; (b) any psychotherapeutic treatment or 
intervention provided by forensic services excluding medical treatment; (c) the study of detained 
(convicted or sanctioned) adult offenders (male or female), with no restrictions on offence type; 
(d) use of the PCL-R as the clinical diagnostic assessment of psychopathy, with a sub-set of the 
study sample meeting PCL-R criteria for diagnoses; (e) operationalisation of treatment attrition 
(most frequently coded as a binary variable in which completers were compared to non-
completers or length of time in treatment); (f) examination of the relationship between PCL 
psychopathy and treatment non-completion.   
 
As the review concerned exploring treatment non-completion for psychotherapeutic 
interventions only, studies evaluating medical treatments were excluded. Furthermore, the current 
                                                 
7 As previously discussed, for the purpose of this review, non-completion of treatment includes the premature cessation of treatment 
through client-initiated dropout or exclusion by treatment providers.   
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review aimed to explore the relevance of the PCL psychopathy construct to treatment non-
completion, thus, studies that did not employ the PCL-R (Hare, 1991; 2003) as the clinical and 
diagnostic tool for psychopathy were excluded. The PCL-R has gained compelling support for its 
reliability and validity (Hare, 1991, 2003; Kiehl & Hoffman, 2011), and despite opposing 
evidence that has raised a level of uncertainty over the reliability and validity of the clinical 
assessment tool (DeMatteo et al., 2014; Edens et al., 2015; Jeandarme et al., 2017; Murrie et al., 
2012; Neal et al., 2015), the PCL-R remains the most frequently applied assessment of 
psychopathy within clinical and forensic settings. Nevertheless, other assessment tools are 
available; and as they have garnered empirical support, it is imperative to consider the inherent 
limitations of these tools and the potential effect on outcome with regard to this review. Whilst 
screening assessment tools such as the Psychopathy Checklist: Screening Version (PCL:SV; Hart 
et al., 1995) have been developed, these tools are not considered to be reliable diagnostic 
assessments of psychopathy (Hart et al., 1995), and thus should not be used as an accurate 
measure of psychopathy. Furthermore, with other existing measures of psychopathy there is 
considerable heterogeneity, partly due to the variable scales being based on differing 
conceptualisations of psychopathy. For example, the Psychopathy Personality Inventory or PPI 
(Lilienfeld & Fowler, 2006) is a self-reported measure of psychopathy that does not measure the 
anti-social behaviours related to the disorder. It is also postulated that self-reported assessments 
may not provide an accurate reflection of personality functioning, thus, possibly yielding biased 
results and hindering the reliability of the assessment outcome (Lilienfeld & Fowler, 2006). Thus 
the inclusion criteria of empirical studies that have employed the PCL-R (Hare, 1991; 2003) as 
an assessment of psychopathy, allow for a standardised evaluation of one construct of 
psychopathy in relation to treatment non-completion, whilst reducing the potential for extraneous 
variables to influence outcome. 
  
The studies that met the inclusion criteria were quality assessed using the proforma 
presented in Appendix 2.  The Critical Appraisal Skills Programme (CASP) criteria and the 
Centre for Research and Dissertations (CRD, 2008) guidance were used as guides for developing 
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the quality criteria, to confirm that all recommended areas of assessment were included while 
adapting the criteria to the field of interest. A total of 16 quality criteria were developed and used 
to assess the 13 identified papers. Each criterion was scored accordingly: high quality = 1, 
partially addressed or unclear = 0.5, low quality = 0 and not applicable = 0 and a total score was 
calculated for each paper. Unclear classifications were further investigated by contacting the 
authors. Where no response was received, no scoring adjustments were made. The overall quality 
score for each study was calculated by summing the scores given for each item. Due to the 
scarcity of studies available for review, the purpose of critical appraisal in this review was not to 
exclude papers on methodological grounds but to incorporate this critical review into the analysis 
process by acknowledging the limitations and rigour of each study.   
 
Results 
 
Studies identified 
Electronic searches identified 1330 records, which reduced to 1124 after the removal of 
obvious duplicates. As shown in Figure 1, an additional three records (including one unpublished 
dissertation) were identified following requests from experts, and a further 12 from hand 
searching of reference lists and relevant journals. Detailed inspection of the abstracts resulted in 
the removal of 1083 records, resulting in 56 studies for which a full copy was obtained. After 
inspecting these studies, 43 were removed using the inclusion and exclusion criteria (reasons for 
exclusion are presented in Figure 1). This resulted in 13 studies remaining for the review. Details 
of included studies are presented in Table 1.  
 
The quality assessment was initially carried out independently by the primary author.  A 
second reviewer (a registered forensic psychologist with practice and research experience in the 
field of psychopathy treatment) was used in order to ensure inter-rater reliability. All 13 papers 
were independently reviewed, which resulted in a Kappa co-efficient for overall agreement of 
0.75, indicating adequate inter-rater agreement (Randolph, 2008). All criteria associated with 
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differences between raters were reviewed and amended where appropriate. Appendix 3 presents 
an overview of the main findings pertaining to the quality assessment of included studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: PRISMA flow diagram.  
*Full-text articles were frequently excluded for multiple reasons. The primary reason for exclusion is listed. 
 
The included studies varied markedly in a number of ways, including study design and 
analysis, resulting in statistical heterogeneity. Thus, the data collated could not be considered as 
a homogenous group for the purpose of meta-analysis. In addition, the authors believed that a 
qualitative analysis would be the most meaningful form of analysis due to the paucity of research 
studies found, coupled with overlapping participant sample within the selected studies. Thus a 
narrative synthesis was used as a means of reporting the findings systematically (Popay et al., 
2006). 
Records identified through database 
searching minus duplication  
(n = 1124) 
Additional records identified through 
other sources (n = 15) 
Records screened  
(n=1139) 
Full-text articles assessed for 
eligibility (n=56) 
 
Records excluded by abstract 
(n=1083) 
Studies included in qualitative 
synthesis review (n=13) 
Full-text articles excluded with reason* (n=43).  
- PCL-R not conducted/PCL-R score not 
reported or sub-sample did not meet 
diagnostic cut-off (n = 27) 
- The study did not explore Psychopathy and 
treatment non-completion (n = 15) 
- Review paper (n = 1) 
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Table 1: Included studies – Demographics and summary of outcomes 
 
Author Full sample  PCL-R scores Treatment  Psychopathic Offender 
sample attrition rates 
Main outcomes  
Bennett 
(2015) 
92 male offenders 
(violent and sexual 
offenders)  
Full sample mean 
PCL-R = 30 
High-security prison 
PDTS with a CBT 
approach. Treatment 
length not reported.    
45% non-completers (mean 
PCL-R = 30) vs. 55% 
completers/currently engaged 
in treatment (mean PCL-R 
=29.5) 
 
PCL-R total was not significantly 
predictive of treatment non-
completion (p = .69) with narcissistic 
PD found to be the only predictive 
variable (p<.05).   
Daffern et al., 
(2008) 
51 male offenders 
(general offenders) 
 
 
50 participants PCL-R 
assessed with score 
range of 6 to 30 and a 
mean PCL-R total = 
18.09 (SD = 5.93) 
Medium-security 
psychiatric hospital with a 
CBT approach to 
treatment. Open ended 
treatment (1 month to 4 
years) with median length 
of stay of 10 months.  
 
Not reported PCL-R total, Factor 1 and 2 were not 
significantly associated with dropout 
(p > .05 (exact p value not reported)).  
  
 
 
Daffern et al., 
(2013) 
51 male offenders 
(general offending) 
Full sample PCL-R 
assessed with a score 
range of 6 to 30 and a  
mean PCL-R total = 
18.02 (SD = 5.72) 
Medium-security 
psychiatric hospital with a 
CBT approach to 
treatment. Open ended 
treatment (2 months to 4 
years) with median length 
of stay of 13 months.  
 
Not reported 
 
PCL-R Factor 1 (p < .01) and 
treatment non-completion (p < .01) 
were the only significant predictors 
of reoffending with a mean follow up 
period of 7 years. PCL-R Factor 1 
and non-completion recorded an odd 
ratio of 2.27 and .013 (inversed), 
respectively.  PCL-R Factor 2 was 
almost significant at p=.054.   
 
Dickie (2003) 108 male sexual 
offenders  
Full sample PCL-R 
assessed with a mean 
total of 25.5 (SD = 6.29) 
Psychiatric hospital. CBT 
sex offender treatment.  
47% psychopathic offenders 
(PCL-R ≥ 27) vs. 28% of non-
psychopathic offenders 
Psychopathic offenders were 
significantly more likely to drop out 
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and 24.8% (n= 23) with 
score ≥ 25  
 
Treatment duration not 
reported.  
 
of treatment compared to non-
psychopathic offenders (p < .05).   
 
No significant difference between 
psychopathic and non-psychopathic 
offenders with regard to time spent in 
treatment (p>.05; (exact p value not 
reported)), although PCL-R Factor 1 
was significantly related (p<.01) to 
treatment length.  
 
Hildebrand & 
de Ruiter 
(2012) 
87 male offenders 
(sexual and violent 
offenders). 
Full sample PCL-R 
assessed with 31% (n = 
27) with a score ≥ 26. 
For the purpose of 
analysis a median 
PCL-R split of 22 was 
used with 43 patients 
classified as 
‘psychopathic’ on this 
basis   
 
Psychiatric high- security 
hospital with a 
Therapeutic Community 
(TC) ethos to treatment. 
Treatment length ranged 
between 15 and 36 months 
(median 19 months).  
Not reported PCL-R total for dropouts was 
significantly higher than for 
completers (p <.05). Factor scores 
(Factor 1; p =.119 and Factor 2; 
p=.095) and categorical diagnoses of 
psychopathy (p =.250) did not differ 
significantly.  
 
 
Jeandarme et 
al.,  (2017) 
221 male and 3 female 
offenders (sexual and 
violent) 
 
 
Full sample PCL-R 
assessed with 8.9% (n = 
20) having a PCL-R 
score ≥ 30 and 33.5% (n 
= 75) with a PCL-R 
score ≥ 25  
  
Three medium-security 
units. CBT mode of 
treatment.  
Mean treatment length of 
2 years.  
56.9% of high PCL-R (≥ 25) 
compared to 37.8% for medium 
PCL-R (16-24) and 17.4 % for 
low PCL-R ( 15) 
 
Significantly higher drop-out rates 
for medium and high levels of 
psychopathy cohorts (p < .001).  
 
PCL-R (p < .001), Factor 1 and 2 (p 
< .001), and facets (1 = p < .01, 2 = p 
< .01, 3 = p < .001 and 4 = p < .001) 
were significantly associated with 
treatment non-completion.  After 
controlling for offence related and 
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clinical variables the PCL-R 
(p=.003) and Factor 1 (p= .011) were 
predictive of treatment non-
completion, whereas Factor 2 and 
facets scores were not significantly 
predictive.  
 
Langevin 
(2006) 
778 male sexual 
offenders 
Full sample PCL-R 
assessed with 9.2% (n 
=71) having a PCLR ≥ 
30 
Hospital (community). 
Variety of sex offender 
treatment units. Treatment 
duration not reported.   
 
Not reported Significantly higher PCL-R scores 
for those who did not engage in 
treatment (p > 0.01) and non-
completers (p < .001).   
 
Ogloff et al., 
(1990) 
80 male offenders Within the full sample 
PCL-R assessed; 21 had 
a high PCL-R score (≥ 
27),  47 a moderate PCL-
R score (18-26) and  12 
low PCL-R score ( 17)  
TC (8 months) Not reported High PCL-R group remained in 
treatment for significantly (p <.01) 
shorter periods of time (103 days) in 
comparison to the moderate (207 
days) and low (241) PCL-R groups.  
 
 
Olver (2003) 113 male sexual 
offenders PCL-R 
assessed (full sample 
321) 
Within the full sample 
28 were assessed as 
having a PCL-R ≥ 25  
Clearwater programme: 
high-intensity CBT 
inpatient sex offender 
treatment (8 months) 
27% psychopathic offenders 
(PCL-R ≥ 25) 
Higher proportion of non-completers 
met the PCL-R criteria (PCL-R ≥ 25) 
for psychopathy than completers (p 
<.01). PCL-R total, factor and facets 
were not significantly related to 
length of time spent in treatment 
(p>.05). 
 
PCL-R total (p <.01) and Factor 1 
(p<.05) and Factor 2 (p <.05) scores 
were significantly predictive of 
treatment non-completion.  
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Olver & Wong 
(2009) 
156 male sexual 
offenders  
Full sample PCL-R 
assessed with 45 having 
a score ≥ 25.  
Clearwater programme: 
high-intensity CBT 
inpatient sex offender 
treatment (8 months) 
27% psychopathic offenders 
(PCL-R ≥ 25) 
Psychopathy designation and 
dimensional PCL-R total were 
significant predictors of treatment 
non-completion (p < .01).  
 
With a mean follow-up period of 9.9 
years, Psychopathic offenders who 
did not complete treatment showed 
the highest prevalence of 
reconviction with a significant group 
difference with respect to violent 
recidivism (p < .05) but not to sexual 
recidivism (p > .05).  
 
Olver & Wong 
(2011) 
154 male sexual 
offenders 
 
 
Full sample PCL-R 
assessed. PCL-R ≥ 25 
was used as a diagnostic 
cut-off for psychopathy 
(n not reported).   
Clearwater programme: 
high-intensity CBT 
inpatient sex offender 
treatment (8 months) 
15% with a mean PCL-R score of 
24.0 (SD 7.6) compared to 85% 
(SD 7.2) with a mean PCL-R 
score of 19.7 
Treatment non-completers had 
significantly higher mean PCL-R (p 
<.01), Factor 1 (p <.01), and Factor 2 
((p < .05)   scores in comparison to 
completers.  
 
PCL-R (p<.01) and VRS-SO 
dynamic risk factors (p<.05) were 
significantly related to treatment 
non-completion. PCL-R factors 
(p<.05) made significant 
independent contribution to 
predicting dropout, whilst dynamic 
risk factors did not (p>.05). 
Univariate correlations showed each 
facet was significant predictor of 
dropout, but only affective facet 
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(p<.01) made significant 
independent contribution.  
 
Sewall & 
Olver (2018) 
302 male sexual 
offenders  
283 PCL-R assessed.  
PCL-R cut off ≥ 25 (n= 
87) 
Clearwater programme: 
high-intensity CBT 
inpatient sex offender 
treatment (8 months) 
29.9% high-psychopathic 
offenders (PCL-R ≥ 25) 
compared to 6% non-
psychopathic 
 
 
High-psychopathy men had 
significantly higher rates of 
treatment non-completion in 
comparison to low-psychopathy men 
(p-value not reported).  
 
PCL-R facets were positively 
correlated with treatment non-
completion (p < .01). In logistic 
regression analysis only lifestyle 
facet uniquely predicted treatment 
non-completion (p < .01).  
 
The study observed no group 
differences (psychopathy and 
treatment status) in rates of sexual 
and violent recidivism (p >.05).  
 
Shine & 
Hobson 
(2000) 
104 PCL-R assessed Full sample PCL-R 
assessed with 26% (n= 
25) of the sample having 
a PCL-R ≥ 30  
TC (18 months) Not reported PCL-R total (p <.01) and Factor 1 (p 
<.01) scores were significantly 
associated with a failure to progress 
from AU onto a therapy wing. Trend 
but non-significant association 
between PCL-R total and treatment 
non-completion (p= .07).  
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Among the studies that met the inclusion criteria, four stemmed from one sample of 
sexual offenders who had completed the same treatment programme (Olver, 2003; Olver & 
Wong, 2009; Olver & Wong, 2011; Sewall & Olver, 2018) and two studies used overlapping 
samples from a medium-security psychiatric hospital (Daffern, Duggan, Huband & Thomas, 
2008; Daffern et al., 2013). Whilst limiting with regard to a systematic review, the studies were 
based on distinct research aims and thus evaluated different outcomes. Therefore, it was 
considered that each study provided valuable evidence, and each study was retained within the 
review.  
 
Psychopathy and treatment non-completion  
Of the 13 included studies, seven reported treatment-specific attrition rates for the sub-
group of psychopathic offenders (PCL-R total score ≥ 25) within the sample, these are reported 
in Table 1. The reported non-completion rates ranged from 30% (Sewall & Olver, 2018) to 56.9% 
(Jeandarme et al., 2017), with the overall median non-completion rate being 46%.  Due to shared 
samples amongst four of these studies (Olver, 2003; Olver & Wong, 2009, 2011; Sewall & Olver 
2018), the attrition rate from the most recent study with an extended sample was used as collective 
attrition rate of these studies.  
 
Of the included studies, only one was based on a prison sample (high-security). This 
study found an attrition rate of 45% (Bennett, 2015) within a sample of 92 male offenders, for 
which the mean PCL-R score varied marginally between treatment non-completers (mean PCL-
R = 30) and completers (mean PCL-R =29.5). The remaining studies were derived from medium- 
and high-security hospital samples, with a median attrition rate of 47% reported. Due to a limited 
variation in treatment setting and treatment modalities across these studies, a meaningful 
comparison of attrition rates was not possible.  
 
Six studies reported that psychopathic offenders are significantly more likely to drop out 
of treatment (Dickie, 2003; Hildebrand & de Ruiter, 2012; Jeandarme et al., 2017; Langevin, 
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2006; Olver, 2003; Olver & Wong, 2009; 2011), and one further study observed a trend but not 
a significant difference between PCL-R score levels and treatment non-completion (Shine & 
Hobson, 2000). Opposing outcomes were reported in studies that explored the relationship 
between psychopathy and time spent in treatment. In Ogloff, Wong & Greenwood’s (1990) study 
higher PCL-R scores were significantly related to shorter periods of time spent in treatment (TC). 
Within the study sample, 26% (n =21) had a PCL-R score of 27 or greater with a mean treatment 
length of 103 days, which was significantly shorter than for those with moderate (207 days) and 
low (241 days) levels of psychopathy. In contrast, Olver (2003) and Dickie (2003) observed no 
significant relationship within their respective samples.  
 
Psychopathy construct as a predictive factor of treatment non-completion 
Whilst the above findings illustrate differences in non-completion rates as a function of 
psychopathy, this section examines the predictive relationship of the construct of psychopathy 
with treatment attrition.  In the majority of studies, the authors used univariate statistics to identify 
correlates, although some made use of multivariate techniques such as logistic regression to 
identify the predictive nature of the psychopathy construct.  A consentient finding across the 
studies was a significant relationship between the PCL-R total, factors and facets with treatment 
non-completion for psychopathic offenders (e.g. Ogloff et al., 1990; Olver & Wong, 2009; 2011; 
Sewall & Olver, 2018), nevertheless the predictive significance of the PCL-R construct (factor 
and facets) yielded less consistent findings.  
 
Four of the included studies were based on a sample of sexual offenders who had received 
treatment services from the Clearwater Sex Offender Treatment Programme, a cognitive-
behavioural, offence-focused intervention. The earliest study (Olver, 2003) comprised a sample 
of 113 offenders, and observed univariate significant correlations between the PCL-R total and 
component (factor and facet) scores with treatment non-completion. Furthermore, PCL-R total 
and factor scores were found to be significantly predictive of treatment non-completion. With the 
same sample, Olver and Wong (2009) observed psychopathy designation and dimensional PCL-
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R total scores as being significant predictors of treatment non-completion. Based on a marginally 
larger sample (n=154), Olver and Wong (2011) found that each PCL-R factor made significant 
contributions to predicting treatment attrition, albeit neither factor was found to be uniquely 
predictive. Furthermore, whilst each facet was significantly predictive of drop-out in univariate 
correlations, only PCL-R Facet 2 (affective) showed a significant unique contribution following 
the completion of a logistic regression. Sewall and Olver (2018) examined the association 
between the PCL-R facets with a larger availability sample (n =302).  All four PCL-R facets had 
significant positive correlation with binary treatment non-completion, however, developing on 
Olver and Wong’s (2011) findings, a logistic regression analysis found that the lifestyle facet was 
the only predictive variable for treatment non-completion.  
 
A further study by Jeandarme et al., (2017) replicated significant associations between 
PCL-R total, factor and facet scores with treatment non-completion in patients (n=221) from 
medium-security hospitals, however, only the PCL-R total and Factor 1 were predictive 
components of treatment non-completion. In contrast to the aforementioned pattern of results, 
Bennett (2015) found the PCL-R total not to be predictive of treatment non-completion, with 
narcissistic personality disorder diagnosis being the only predictive variable within the prison-
based sample (n=92) of high-risk psychopathic offenders.   
 
Psychopathy, treatment non-completers and outcome (risk and recidivism) 
Extending upon the aforementioned findings, this section examines empirical evidence 
concerning the relationships between psychopathy, treatment non-completion and outcome, more 
specifically risk and recidivism. Of the included studies, four examined these relationships; only 
one considered the effect on risk (Olver & Wong, 2011). This study found PLC-R scores to 
correlate with the Violence Risk Scale – Sexual Offence version or VRS-SO (Wong et al., 2003) 
dynamic factors. Furthermore, the treatment responsivity factor of the risk scale was found to 
significantly correlate with the PCL-R Factor 1 and the interpersonal and emotional facets, whilst 
the VRS-SO Criminality factor was strongly correlated with PCL-R Factor 2. Whilst exploring 
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the relative contributions of sex offender risk and psychopathy, it was found that each PCL-R 
factor made a significant contribution to predicting treatment non-completion, while dynamic and 
static risk did not.  
 
The remaining three studies explored the relationship between psychopathy, treatment 
non-completion and recidivism.  Based on a sample of 28 patients discharged from a psychiatric 
unit that implemented a therapeutic approach (underpinned by CBT) to treatment, Daffern et al., 
(2013) reported treatment non-completion and PLC-R Factor 1 as being significant predictors of 
reoffending. The PCL-R Factor 1 variable had a significant odd ratio of 2.27, suggesting that a 
one unit increase in PCL-R Factor 1 score doubled the odds of reoffending. Likewise, treatment 
completion status was a significant predictor with long odds of .013 (inversed), suggesting that 
participants were more likely to be reconvicted if they did not complete treatment.  The PCL-R 
Factor 2 scores were found to be almost significant within the logistic regression.  
 
Olver and Wong (2009) compared recidivism rates of four groups; non-psychopathic 
completers (n=98), non-psychopathic dropouts (n=11), psychopathic completers (n=33) and 
psychopathic dropouts (n=12). With a follow-up period of 9.9 years (ranging from 2.1 to 18 
years), fifty-one (32.7%) offenders were either charged or convicted of a sexual offence, and 85 
(54.5%) of a violent offence.  The study observed that the psychopathic dropout group held the 
highest prevalence of reconviction (50% reconvicted of a sexual offence and 91.7% reconvicted 
of a violent offence) with a significant group difference with respect to violent recidivism, but 
not for sexual recidivism. 
  
With a similar comparative study design, Sewall and Olver (2018) examined associations 
between psychopathy and treatment completion with recidivism (sexual and violent) with a mean 
follow-up period of 17.9 years. Four groups were compared via indicator contrasts; low PCL-R 
completers (n=197), low PCL-R non-completers (n=12), high PCL-R completers (n=61) and high 
PCL-R non-completers (n=26). A statistically insignificant difference in rates of sexual 
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recidivism as a function of psychopathy and treatment completion status was observed, a finding 
that was consistent with and without controlling for baseline risk as measured by the VRS-SO 
and Sex Offender Risk Appraisal Guide or SORAG (Quinsey, Harris, Rice & Cormier, 1998). 
With regard to violent recidivism, low-psychopathy completers and non-completers each had 
lower rates of violent recidivism, in comparison to the high-psychopathy non-completers. After 
controlling for risk, only the low psychopathy-completer group had significantly lower rates of 
violent recidivism than the high psychopathy non-completers, albeit the difference was not 
significant.  
 
 
Discussion 
The main aim of this systematic review was to synthesise existing literature on treatment 
for psychopathic offenders to strengthen understanding of treatment non-completion for this 
high-risk, high-treatment-need offender population. In total, 13 studies met the criteria for 
inclusion, of which, concerningly, only seven studies reported attrition rates for their sample of 
psychopathic offenders (four of these studies were based on a shared sample).  Though there was 
some variation in attrition rates, the overall median attrition rate was 46%, comparatively higher 
than the offender non-completion rates reported in a previous meta-analysis review of offenders 
(Olver et al., 2011) and in a systematic review of psychotherapy for personality disordered clients 
(McMurran et al., 2010). However, it is comparable to the dropout rate of 47% identified in a 
meta-analysis of psychotherapy generally (Wierzbicki & Pekarik, 1993).  
 
Based on the available attrition rates, psychopathic offenders do not appear to be more 
significantly prone to non-completion than other client groups. However, due to the limited 
number of included studies that reported attrition rates for psychopathic offenders, a warranted 
level of caution must be applied to any conclusions. Furthermore, irrespective of comparisons 
with other offender and client groups, the rate of non-completion for psychopathic offenders can 
be considered to be substantial, certainly in the studies that observed higher attrition rates 
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(Bennett, 2015; Dickie, 2003; Jeandarme et al., 2017). This does suggest the potential for wider 
adverse consequences on service cost-efficiency, therapist morale, and on other clients in group 
treatment modalities (McMurran, Huband & Overton, 2010). The variations in reported attrition 
rates for psychopathic offenders from 30% (Sewall & Olver, 2018) to 56.9% (Jeandarme et al., 
2017) is also notable, and may be related to the provision and clinical utility of treatment services. 
More specifically, studies that observed lower attrition rates may provide treatment services with 
enhanced strategies for attending to responsivity variables, which may help keep psychopathic 
offenders in treatment. Whilst a plausible hypothesis, in the interpretation of these findings it is 
prudent not to negate other factors, notably the evident attrition variations across studies that may 
be underpinned by the heterogeneity of the psychopathic offenders, variable PCL-R cut-off scores 
applied across studies, and variations in the definition and applied assessment of treatment non-
completion.  
 
In further considering the attrition rates, it is important to give attention to the variability 
between samples (psychopathic and non-psychopathic, or different levels of psychopathy).  
Sewall and Olver (2018) observed a 29.9% attrition rate for their high psychopathy sample 
compared to 6% for the low psychopathy sample. Whilst a notable difference, the attrition rates 
presented are relatively low and compare favourably to dropout rates from sex offender treatment 
reported in the literature which ranged upward from 30% or 40% (e.g. Browne et al., 1998; 
Craisatti & Beech, 2001). Furthermore, the reported completion rate (70%) of highly-
psychopathic offenders within Sewall and Olver’s (2018) study, suggests that the clinically 
expected high attrition rates for this high-risk, high-need group of psychopathic offenders are not 
inevitable. This encouraging finding is overshadowed by studies reporting significantly higher 
attrition rates. For example, Jeandarme et al., (2017) reported a non-completion rate for their 
sample of psychopathic offenders of 56% (PCL-R ≥ 25), which was significantly higher than that 
for non-psychopathic offenders (17.4%). 
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The three studies that explored psychopathy and time spent in treatment presented 
opposing findings. Ogloff et al., (1990) observed that higher PCL-R scores were significantly 
related to shorter periods of time in treatment (TC). In contrast, Olver (2003) and Dickie (2003) 
observed no significant relationship among samples from sex offender treatment, suggesting that 
PCL-R scores are not inversely related to length of time spent in treatment, giving some support 
to the view that psychopathic offenders are not necessarily doomed to leave treatment early. The 
variability in findings may be caused by a range of factors, including the treatment model and 
approach (TC approach to treatment versus sex offender treatment) and thus the level of 
responsiveness of psychopathic offenders. Indeed, Ogloff et al., (1990) acknowledge that the TC 
model applied within their study may have been overly intrusive (constructive confrontation of 
psychopath’s attitudes and behaviour by fellow peers and staff) thus contributing to their early 
termination of treatment. This tentative conclusion warrants further examination to explore 
specific reasons for treatment non-completion by psychopathic offenders and thereby enhance 
clinicians’ ability to retain psychopathic offenders in treatment.    
 
Psychopathy as predictive factor of treatment non-completion 
A mostly consistent finding across the studies was a significant association between 
psychopathy and treatment non-completion (e.g. Jeandarme et al., 2017; Olver & Wong, 2011; 
Sewall & Olver, 2018), providing tentative evidence of a central relationship between PCL-R 
scores and treatment attrition. Daffern et al., (2008) presented opposing findings, whereby PCL-
R total and Factor 1 and 2 scores showed no significant associations with treatment completion 
status. In interpreting these findings, it is important to consider the apparent limitations of the 
study, notably that the findings may be a consequence of a small and under-represented sub-
sample of psychopathic offenders, potentially reducing the strength and clinical applicability of 
findings to psychopathic offenders.    
 
In relation to the predictive significance of the psychopathy construct, the included 
studies present inconclusive findings. Three of the studies explicitly explored the predictive 
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relationship between the PCL-R total and treatment non-completion, with two studies (Jeandarme 
et al., 2017; Olver & Wong, 2009) observing a significant predictive relationship between PCL-
R total and attrition. Nevertheless, one prison-based study included within this review yielded a 
contrasting finding (Bennett, 2015). This finding may suggest a variation that highlights the 
primacy of psychopathy to treatment non-completion within treatment settings (prison-based 
versus hospital setting samples), a finding that warrants further empirical exploration. However, 
it is more probable that the opposing finding may best be explained by the evaluated sample’s 
psychopathy levels being too uniform across treatment non-completers (mean PCL-R score = 30) 
and completers (mean PCL-R score = 29.5) to allow for meaningful differences to be detected, 
rather than by concluding that psychopathy is unrelated to treatment non-completion.   
 
Whilst not diminishing the clinical bearing of the PCL-R and its relevance to treatment 
non-completion, it is important to acknowledge that the PCL-R total score represents a broad 
range of challenging personality disorder traits.  Furthermore, it is pertinent that the PCL-R is a 
multifaceted as opposed to a unitary construct (Hicks & Patrick, 2006). It is reasonable to infer 
that evaluating the PCL-R total score as a global representation of the construct of psychopathy 
provides restricted insight into the relationship between psychopathy and treatment non-
completion. Thus, it is plausible that the separate components (factors and facets) of the PCL-R 
can reveal more about differences in behaviour. It is notable that across the included studies there 
is evidence in support of PCL-R factors being important contributors to treatment non-
completion, with each factor (Factor 1 e.g. lack of remorse, callousness/lack of empathy, shallow 
affect, pathological lying and manipulative behaviour, and Factor 2 e.g. impulsivity, 
irresponsibility, proneness to boredom, poor behavioural controls) retaining strong relationships 
with programme attrition (Jeandarme et al., 2017; Olver, 2003; Olver & Wong, 2011). This 
provides support for the argument that treatment for psychopathic offenders should focus on PCL-
R factors and their respective traits. More specifically, treatment should be attentive to the 
criminogenic traits of Factor 2, while also carefully accounting for PCL-R Factor 1 
characteristics, to keep offenders in treatment (Wong & Olver, 2015). This is in line with the 
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RNR model (Andrews et al., 1990) that acknowledges psychopathy as a specific responsivity 
factor.  
 
In relation to the PCL-R facets, the affective facet (e.g. shallow affect, callousness/lack 
of empathy and failure to accept responsibility) of Factor 1 has garnered a level of support as 
being a strong, unique predictor of treatment drop-out in comparison to the remaining facets 
(Olver, 2003; Olver & Wong, 2011). However, the aforementioned studies were based on a 
shared sample, thus the observed similar outcomes across these studies is unsurprising. This 
emphasises the paucity of research on the relevance of psychopathy to treatment non-completion. 
Nevertheless, the predictive relevance of the affective facet makes clinical sense, as it reflects the 
relationship between the core features of psychopathy that have been associated with difficulties 
with treatment engagement. Indeed, features of psychopathy such as lack of emotion and 
empathy, callousness and aloof mannerisms, have been advocated as responsivity issues that may 
impede upon the development of meaningful affective relationships with therapists (Won & Hare, 
2005). In addition, the affective and empathy deficits, which are core to this facet, may relate to 
a lack of emotion-based motivation to change and may hinder engagement with emotion-based 
components of treatment, restricting the development of insight, or the capacity or willingness to 
internalise the value of treatment. This may, in turn, contribute to a perception of disengagement 
by treatment providers and/or the client maintaining a level of internal resistance that results in 
their disengagement or removal from treatment (Olver & Wong, 2011; Thornton & Blud, 2007; 
Wong & Hare, 2005).  
 
In addition to the aforementioned, Sewall and Olver (2018) found that the PCL-R 
lifestyle facet (e.g. proneness to boredom, lack of long-term goals, impulsivity and 
irresponsibility) was the only factor to bear a significant predictive association with treatment 
non-completion, again a finding that is unique to this study and that has not been replicated. This 
distinct finding may be related to the increased sample size used within this study in comparison 
to that of Olver and Wong’s (2011), which observed the lifestyle facet not to be a predictive factor 
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of dropout. The finding may suggest that the lifestyle facet also has responsivity implications. 
For example, Sewall and Olver (2018) suggest that the poor therapeutic work ethic that is 
associated with this facet can contribute to the decline in attendance and engagement in treatment.  
Further, it is clinically important to acknowledge that the lifestyle facet may manifest in 
treatment-interfering behaviour, particularly deficits in sustaining engagement and following 
through with treatment goals. This maybe demonstrated during treatment by behaviours such as 
boredom, failing to complete homework, missing treatment sessions, and an increased likelihood 
of treatment withdrawal (Thornton & Blud, 2007).  
 
In contrast to the aforementioned, Jeandarme et al., (2017) found that only the PCL-R 
total and Factor 1, but none of the facets, were predictive of treatment non-completion. Whilst 
not seeking to diminish the value of these findings, it is important to acknowledge in the 
interpretation of the outcomes that the authors report a low PCL-R assessment inter-rate 
reliability, thus questioning the reliability of the PCL-R assessment outcomes and the impact this 
may have had on the outcome.  
 
There is a clear gap in the literature on the relationship between psychopathy and 
treatment non-completion, a notable observation given the developed view amongst researchers 
and clinicians relating psychopathic offenders with exceptionally high attrition rates. The 
evidence, whilst contradictory, does suggest a relationship between the construct of psychopathy 
and treatment non-completion. The evidence therefore reiterates the clinical importance of 
treatment being designed and delivered to meet the unique individual needs of psychopathic 
offenders, so as to enhance their on-going engagement (Andrews & Bonta, 2003; 2010). Whilst 
it would also yield important clinical insight into the relationship between psychopathy and 
treatment completion, further empirical exploration is needed to support clinical practice.   
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Psychopathy, treatment non-completers and outcome (risk and recidivism) 
In an exploration of psychopathy, sex offender risk and treatment non-completion, Olver 
and Wong (2011) concluded that the construct of psychopathy is a better predictor of treatment 
completion than dynamic risk need (higher risk for sexual offending per se). Whilst an important 
clinical finding, it is a conclusion with fairly weak support due to a lack of replicated findings 
and the current ambiguous findings relating to the predictive relevance of the psychopathy 
construct to treatment non-completion.  
 
With regard to recidivism, there is evidence in support of treatment non-completion 
increasing the risk of violent recidivism for psychopathic offenders (Daffern et al., 2013; Olver 
& Wong, 2009). This finding is consistent with evidence previously reported for non-
psychopathic offenders (Day et al., 2010; McMurran & Theodosi, 2007). However, Sewall & 
Olver (2018) presented opposing findings (using an extended sample from Olver & Wong, 2009), 
showing no significant differences between high-psychopathic completers and non-completers 
with regard to recidivism rates (including violent recidivism). The authors suggest that the 
expanded sample and extended follow-up period from the previous evaluation (Olver & Wong, 
2009) may have resulted in this finding.  
 
In addition, both Olver and Wong (2009) and Sewall & Olver (2018) found that the 
treatment completion status of high-psychopathic offenders did not differentiate post-treatment 
sexual recidivism rates. Overall, the findings may imply that treatment completion status has a 
limited impact on recidivism, and more specifically, that completing treatment does not guarantee 
meaningful risk change for highly-psychopathic offenders. However, whilst a possible 
hypothesis, further findings presented by Olver and Wong (2009) and Sewall & Olver (2018) cast 
a level of doubt over this conclusion. Both studies establish that by omitting treatment completion 
status, risk change becomes a unique predictor of both sexual and violent recidivism. Olver and 
Wong (2009) observed that psychopathic offenders who demonstrated positive risk change 
(irrespective of treatment completion status) as a result of treatment were less likely to be 
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involved in both sexual and violent recidivism. In addition, Sewall and Olver (2018) reported that 
high-psychopathic and low-psychopathic offenders did not significantly differ in risk change 
scores, indicating that psychopathic offenders did not necessarily benefit less from treatment.  
 
To further interpret the aforementioned findings, it is important to consider the 
shortcomings of treatment completion status as meaningful predictor of recidivism. Notably, 
applying such an approach in isolation inevitably infers at some level that all treatment completers 
benefit equally with regard to risk reduction, and to some extent that treatment non-completers 
gain restricted benefit, a concept that is not clinically supported. Thus it is prudent to suggest that 
treatment completion status in isolation is a fallacious method and a weak proxy of risk of 
recidivism, raising a level of doubt over the reliability exploring this relationship. Clinically, it 
appears reasonable to suggest that risk change as a result of treatment (irrespective of treatment 
completion status) has more value in terms of appraising the risk of recidivism. Thus, whilst there 
may be some value in future research exploring psychopathy, treatment completion status and 
recidivism, such research is unlikely to yield robust and meaningful insight. It would perhaps be 
more useful therefore, for enhancing clinical understanding and practice, to focus future research 
efforts on exploring a wider range of factors that may contribute to treatment non-completion for 
psychopaths.  
 
Critique of reviewed studies 
As identified in the quality assessment, there are limitations in the studies reported that need 
to be considered whilst interpreting the results. All included studies were conducted on relatively 
small samples of psychopathic offenders meeting the diagnostic cut-off, with a reported range 
between 21 (Ogloff et al., 1990) and 87 (Sewall & Olver, 2018). This suggests that the analysis 
in the included studies may not have been adequately powered, reducing confidence in the results. 
In addition, the majority of studies did not provide sufficient data for the calculation of effect 
sizes, and so the clinical significance of the findings is unclear.  These limitations may in part 
explain some of the contradictory findings observed across the studies, although the variations 
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could equally be related to the heterogeneity of the psychopathic offenders, or the location and 
type of treatment.   
 
It was notable that some studies did not offer a clear definition for their applied assessment 
of treatment non-completion (Jeandarme et al., 2017; Langevin, 2006; Ogloff et al., 1990; Shine 
& Hobson, 2000) and that within the remaining studies the operational definition applied was 
variable, ranging from not completing all sessions or not completing the full duration of treatment 
to premature withdrawal or termination from treatment. Furthermore, non-completion was 
persistently recorded in a singular manner (e.g. client-initiated versus programme-initiated) with 
limited exploration of different reasons for treatment attrition. The lack of a consistent definition 
across studies and the fact that a wider range of contributory factors to treatment non-completion 
was not explored affects the robustness of findings and restricts the potential for further clinical 
insight. This limitation in particular has been identified in previous reviews regarding treatment 
attrition, and thus is reflective of a fundamental limitation of the treatment efficacy literature as 
a whole (Larochelle et al., 2011; McMurran et al., 2010; Olver et al., 2011). 
 
A proportion of the studies included in the review did not report attrition rates for their sub-
group of psychopathic offenders. Whilst, in part, this may relate to the integral aims of the study, 
for instance an exploration of treatment length rather than an explicit exploration of treatment 
non-completion, the omission of attrition rates (Daffern et al., 2008; 2013; Hildebrand & de 
Ruiter, 2012; Langevin, 2006; Shine & Hobson, 2006) may imply a source of bias and may 
suggest that attrition rates for psychopathic offenders are more variable than have been reported.  
 
The applied PCL-R cut-off score for diagnoses of psychopathy or classification as having a 
‘high’ level of psychopathic traits varied across the studies, ranging between 22 to 27 (e.g. 
Hildebrand  & de Ruiter, 2012; Ogloff et al., 1990) and 30 (Jeandarme et al., 2017; Langevin, 
2006; Shine & Hobson, 2000). Furthermore, while Daffern et al., (2008; 2013) reported a sample 
PCL-R mean score of 18 with a score range of 6 to 30 across both studies (and thus it could be 
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implied that a sample will have met the PCL-R diagnostic cut-off) the exact number of 
psychopathic offenders is not reported. In addition, several of the studies either do not report the 
applied PCL-R assessment procedure or completed file-based PCL-R assessment. Whilst there is 
a lack of research in which standard assessment (semi-structured and file-based assessment) and 
file reviews are directly compared, researchers have found that a file-based PCL-R cut-off score 
of 25 provides an optimal predictor of a standard PCL-R score of 30 (Hare, 2003). Nevertheless, 
considerable caution may need to be taken when basing PCL-R ratings on file information alone 
as there is a potential to lose important information relating to the client’s interpersonal ‘style’, 
thus possibly contributing to lower PCL-R scores (Guay et al., 2007; Serin, 1992). Thus, it is 
plausible that the variation in the completion of the PCL-R assessments and applied PCL-R cut-
offs may have contributed to imprecise (under- or over-scored) diagnoses of psychopathy or 
assessments of psychopathic traits, potentially contributing to the mixed findings.  
 
It is also worth noting that some of the included studies did not specify who carried out 
the PCL-R assessment or just stated that it was conducted by an independent reviewer (Dickie, 
2003; Langevin, 2006; Ogloff et al., 1990). Other studies explicitly reported varying 
professionals, for example forensic psychiatrists, researchers and assessors with master’s or 
medical degrees. For the reliability of completed PCL-R assessments it is important that 
professionals are adequately trained (Hare, 2003). The omission of details pertaining to the PCL-
R and IRR procedures within some of the reviewed papers does raise concerns about the clinical 
accuracy of the PCL-R assessments completed.  
 
Although concealing participants’ assessment outcomes was unnecessary in the studies 
as results of the designs employed, blinding treatment providers to PCL-R assessment scores 
could have improved study quality by reducing another potential source of bias. Only one study 
(Ogloff et al., 1990) blinded treatment providers to the PCL-R score whilst also ensuring that 
researchers did not participate in admission or discharge decisions. Furthermore, the collective 
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studies relating to the Clearwater sex offender treatment programme evaluation (Olver, 2003; 
Olver & Wong, 2009; 2011; Sewall & Olver, 2018) reported that PCL-R assessors (primary 
researchers) were blind to recidivism status.   
Finally, a bias towards male offenders is apparent in the studies, with only one study 
including a sample of female offenders, albeit a small one (n=3) (Jeandarme et al., 2017).  This 
is reflective of the disparity in gender amongst offenders (Prison Reform Trust, 2017) and indeed 
is in line with paucity of empirical studies relating to female psychopathy and offenders. 
Nevertheless, it is important to highlight that findings from research that has predominantly 
focused on male offenders cannot be generalised to female offenders, thus associations between 
psychopathy and treatment non-completion cannot be assumed. On the basis that female detention 
rates are increasing (Prison Reform Trust, 2017), ensuring that sufficient clinical understanding 
exists regarding treatment efficacy and retention is vital in preventing recidivism. This 
emphasises the urgent need for further research focusing on female populations. 
 
Limitations of the review 
It must be acknowledged that a critical feature of any systematic review is the 
completeness and representativeness of the studies that are captured (Lipsey & Wilson, 2001). 
Whilst extensive efforts were made to include as many appropriate studies (published and 
unpublished) as possible through the search strategy to reduce the potential of research bias 
(Hopwell, McDonald, Clarke & Egger, 2008), some limitations must be acknowledged. The 
search was limited to English language papers, and additional studies that could have garnered 
further evidence to aid interpretations may have been missed. Furthermore, despite sourcing 
attempts, relatively few studies came from unpublished ‘grey’ literature, and thus it is possible 
that they are underrepresented. In addition, whilst attempts were made to contact authors for 
clarity and missing information, this was not consistently received and due to time limits further 
attempts to source needed evidence were not possible.  
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After data collection and analysis of the included studies, it was highlighted by a 
professional with clinical and research experience within the field that the search terms ‘parolee’ 
and ‘criminal’ may have been appropriate additions to the search strategy that may have yielded 
further key papers. A search of relevant journals using the additional search terms produced no 
further papers. Any future review of this type should give consideration to various terms used to 
describe offenders and the types of studies that each term might identify.  
 
As the overarching aim of the current review was to explore PCL psychopathy in the 
context of treatment non-completion, empirical studies that did not employ the PCL-R tool as 
their clinical assessment of psychopathy were excluded. Whilst this method provided a level of 
control over possible extraneous variables that may have impacted upon outcome, it is important 
to acknowledge the limitations imposed by this exclusion criterion. Notably, excluding studies 
on this basis inevitably restricted the number of empirical studies and thus limited evidence that 
could have been included within the review. Replicating this systematic review, but including 
other empirically supported psychopathy assessments, may be of benefit to further clinical 
understanding into the relationship between psychopathy, treatment non-completion and 
outcome.    
 
Practical implications and recommendations for future research 
The review makes a unique contribution by synthesising existing literature on treatment 
non-completion among psychopathic offenders. The scarcity of studies in this area and the largely 
inconclusive findings presented herein, have restricted the development of definite interpretations 
and thus few practice implications can be defined robustly.   
 
The limited number of studies reporting non-completion rates for psychopathic offenders 
prevented a comparative evaluation of treatment modalities and settings from being made. It also 
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limited the possibility of developing concrete conclusions regarding the prevalence of treatment 
attrition among psychopathic offenders. The relatively high number of studies included within 
this review that did not report attrition rates is of notable concern and may suggest that attrition 
amongst psychopathic offenders is more variable than is understood. Nevertheless, based on the 
available evidence, it is prudent to acknowledge that whilst psychopathic offenders do appear to 
be more prone to treatment non-completion compared to other offender and client groups, the 
tendency is not significantly higher and is, to some extent, comparable. On this basis, it is arguable 
that psychopathic offenders can be effectively managed and retained in treatment that is designed 
to accommodate their responsivity needs. Clinicians should therefore avoid undue pessimism 
when forming expectations about treatment adherence by members of this group.   
 
There is evidence in support of psychopathy being a contributing factor to treatment non-
completion. Whilst research has explored the construct of psychopathy in relation to attrition, the 
findings remain inconclusive. There is, however, clinical utility in the pattern of findings 
presented, for example, as regards the need for treatment to be attentive to PCL-R traits (Wong 
& Olver, 2015) in keeping with the RNR model (Andrews & Bonta, 2003; 2010; Andrews et al., 
1990) that acknowledges psychopathy as a specific responsivity factor. Taking into account that 
psychopathic offenders are now clinically accepted as a heterogeneous group of offenders, an 
exploration of the relationship between PCL-R traits and treatment non-completion could yield 
more meaningful insight.  
 
In light of the paucity of studies in this area and the somewhat inconclusive evidence, it 
is imprudent to draw inferences on the relationship between psychopathy, treatment completion 
and recidivism. Whilst two studies (Daffern et al., 2013; Olver & Wong, 2009) presented 
evidence of treatment non-completion being related to greater risk on release for violent 
recidivism (in comparison to psychopathic offenders who completed treatment), this finding was 
not replicated (Sewall & Olver, 2017). Furthermore, it is evident that treatment completion status 
is unrelated to sexual recidivism for psychopathic offenders (Olver & Wong, 2009; Sewall & 
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Olver, 2017). Whilst this may imply that highly-psychopathic offenders completing treatment did 
not significantly lower their risk of sexual recidivism compared to those who failed to 
successfully complete treatment, it is important to explore the robustness of treatment completion 
status as a measure of treatment effectiveness. Indeed, it is evident that risk change is a valuable 
indicator of recidivism for psychopathic offenders (Olver & Wong, 2009; Sewall & Olver, 2017). 
This observation emphasises the clinical value of individually assessing risk, rather than simply 
concluding that treatment non-completion is an isolated factor that increases risk for psychopathic 
offenders. 
 
The lack of literature and conclusive findings in this area highlights the clinical 
importance of further robust treatment outcome studies for this high-risk, high-need offender 
population.  Whilst it has already been previously reported (McMurran et al., 2010; Olver et al., 
2011), it is worth reiterating that treatment outcome studies should incorporate details pertaining 
to the programme, as well as completion and attrition rates, while exploring a wider range of 
factors that could interact with the treatment-dropout continuum. There is an evident need for this 
field to evolve, and for a more comprehensive approach to be taken to the study of factors that 
affect the completion status of this unique offender population. These factors should include not 
only traits associated with psychopathy, but also external factors and client views about their 
treatment. Others have suggested (McMurran et al., 2010), and we concur, that further research 
is needed that incorporates the examination of additional variables and treatment responses, 
individual analysis to ascertain engagement throughout the course of treatment (Blatt, Besser & 
Ford, 2007; Vermote et al., 2009) and study of the effects of the therapeutic climate (Howells et 
al., 2009). Such needed clinical insight could provide meaningful evidence to aid understanding 
of the treatment engagement process and other factors related to treatment non-completion, 
support programme development and assist with retaining this high-risk, high-need and high-
responsivity offenders in treatment.  Furthermore, due to the evident paucity of published studies 
relating to custodial settings, and female psychopathic offenders, further research into these areas 
would help strengthen clinical insight.   
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This review makes a unique contribution to the clinical understanding of treatment 
attrition among psychopathic offenders. Synthesising the available evidence has helped identify 
ambiguities in understanding as well as important clinical issues pertaining to the treatment of 
psychopathic offenders. Evidence in this area is limited and future research efforts need to be 
directed carefully so that they employ suitable methodologies, have wider research aims and 
provide further transparency to avoid potential research bias.  Further research of this sort could 
have implications for front-line practice, and could provide further clinical insight to support the 
design and delivery of treatments in ways that could maximise retention among this high-risk, 
high-treatment-need group of offenders.   
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Chapter Three: The Effectiveness of the Chromis Programme for High-risk 
Psychopathic Offenders 
Abstract 
 
There remains a level of uncertainty over whether treatment attempts reduce risk for psychopathic 
offenders, which is concerning given the high-risk nature of this population. This study 
investigated the effectiveness of a violence treatment programme (Chromis), implemented within 
a high-security personality disorder treatment service. A high attrition rate (44%) was evident 
within the availability sample of 120 offenders who had engaged in treatment, with PCL-R total 
(and factor) scores not being significantly associated with treatment non-completion.  Self-
reported measures administered at five set points across treatment were employed to evaluate 
changes in self-reported anger, impulsivity, problem solving, locus of control and maladaptive 
schemas within a sample of moderate- (n = 20) and high- (n = 21) scoring psychopathic offenders 
as measured by the PCL-R (treatment completers sample) (n = 41). Group- and individual-level 
analysis showed treatment gains across the evaluated outcomes, however, this was not moderated 
by psychopathy level (moderate or high). Repeated-measures analysis revealed significant 
improvement in anger, impulse control, problem solving and locus of control after treatment, with 
significant change attributed to the Cognitive Skills component of the Chromis programme. 
Significant improvements in eight maladaptive schemas were attributed to treatment in its 
entirety. Individual-level analysis showed a large sample falling within the reliable change 
category. Unreliable change was the least common across the studies’ outcomes. The study 
findings add to the research around treatability of psychopathic offenders, and contrary to clinical 
lore, demonstrate that certain aspects of treatment can deliver a positive outcome with respect to 
risk-related treatment need areas for psychopathic offenders at moderate and high PCL-R levels. 
Limitations and implications for practice are discussed.  
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Introduction 
There has been a long-standing debate over whether treatment attempts reduce risk for 
psychopathic offenders. Indeed, reviews of treatment effectiveness for this unique group of 
offenders have offered rather discrepant interpretations (D’Silva et al., 2004; Harris & Rice, 2006; 
Reidy et al., 2013; Salekin, 2002; Salekin et al., 2010) but consistently present a view that the 
effectiveness of treatment for psychopathic offenders has received limited rigorous study. Whilst 
more recent empirical studies remain hindered by inherent methodological weaknesses, in light 
of significant advances in designing psychopathy treatment (e.g., Wong & Hare, 2005), positive 
outcomes with regard to addressing risk among psychopathic offenders have been observed (e.g., 
Olver et al., 2013; Olver & Wong, 2009; Tock et al., 2018; Wong & Gordon, 2006; Wong et al., 
2012). However, there is still a need to strengthen empirical outcomes to enhance clinical 
understanding of the psychological process of treatment (McGuire, 2008), and the effect of 
treatment on attributes directly associated with violent behaviour, namely dynamic risk factors 
(Dodge & Pettit, 2003). 
 
When considering studies on the effectiveness of treatment, it is important to 
acknowledge the clinical complexity of treating this unique offender population (Hemphill & 
Hart, 2002; Ogloff et al., 1990). Indeed, empirical studies have reported high rates of attrition 
related to this high-risk group of offenders (DeSorcy et al., 2016; Hobson et al., 2000; Ogloff et 
al., 1990), with the systematic review within this thesis (Johnson, Heym & Hamilton, 2019) 
reporting a median non-completion rate of 46% for psychopathic offenders and exploratory 
evidence in support of an association between psychopathy and treatment non-completion. 
Despite this understanding, there is still a need to further understand the relationship between 
psychopathy and treatment non-completion in order to enhance treatment engagement and 
effectiveness.  
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Risk-related treatment needs for psychopathic offenders and treatment effectiveness 
Empirical evidence has substantiated an association between psychopathy and aggression 
(Flight & Forth, 2007; Reidy, Zeichner, Miller & Martinez, 2007), and has demonstrated 
psychopathic offenders’ propensity for instrumental and impulsive, reactive violence caused by 
complex motivational patterns within their personalities (Blair, 2010; Harenski & Kiehl, 2010; 
Walsh, Swogger & Kosson, 2009; Woodworth & Porter, 2002) and a confluence of dynamic risk 
factors, including congenital emotion dysfunction, ineffective coping, impulsivity, antisocial 
beliefs and problems relating to locus of control (Blair, 2006; Douglas, Yeomans & Boer, 2005; 
Hart & Dempster, 1997; Herba et al., 2007; Simourd & Hoge, 2000; Wong & Gordon, 2006). 
Furthermore, whilst empirical research into the prevalence of maladaptive schemas in 
psychopathic offenders is somewhat scant, there is a developing theoretical understanding that 
antisocial and psychopathic offenders commonly make use of schema modes that involve over-
compensatory coping styles, contributing to their aggressive and antisocial behaviour (Ball & 
Cecero, 2001; Bernstein, Arntz & de Vos, 2007; Tremblay & Dozois, 2009).  
 
Thus, there is a confluence of dynamic risk factors that reflect core deficits of 
psychopaths and are identified empirically as factors that contribute to psychopaths’ violent 
offending and recidivism. It is theorised that dynamic risk factors, or ‘treatment need areas’ as 
they are commonly referred to within the literature, can be changed, resulting in a decrease in 
recidivism (Bonta, Law & Hanson, 1998; Howells, 2004; Monahan & Appelbaum, 2000; Olver 
et al., 2013; Wilson, Desmarais, Nicholls, Hart & Brink, 2013). There may, therefore, be support 
for the accepted clinical understanding that effective treatment to reduce recidivism requires 
targeting appropriate risk-related treatment need areas in offenders (Andrews & Bonta, 2003; 
2010). When considering this, it is also pertinent to consider evidence that supports treatment for 
psychopathic offenders focusing on modifying underlying treatment need areas, such as antisocial 
attitudes, cognition, behaviour and aspects of lifestyle related to the Factor 2 features of the PCL-
R (Olver et al., 2013; Wong & Hare, 2005).   
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Empirical studies that have evaluated change in risk-related treatment need areas of 
psychopathic offenders have had inconclusive outcomes; however, there is prominent evidence 
demonstrating that psychopathic offenders are amenable to treatment across an array of risk-
relevant attributes, including anger and emotion control, impulsivity, problem solving and 
maladaptive schemas (Bowes & Johnson, 2016; Chakhssi et al., 2014; Chakhssi et al.,, 2010; 
Mullan et al.; 2017; Tew et al., 2012; Van den Broek et al., 2011; Young et al., 20138).  
Nevertheless, there is also opposing evidence (Doyle et al., 2015; Draycott et al., 2012; 
Hildebrand and de Ruiter, 2012) that raises doubt regarding the effectiveness of treatment in 
addressing risk-related treatment need areas for this high-risk group of offenders. 
 
It has also been evidenced within wider empirical studies that high-scoring psychopathic 
offenders make less treatment progress or improvement compared to non-psychopathic and 
moderately scoring psychopathic offenders (Hughes et al., 1997; Ogloff et al., 1990; Olver, Lewis 
and Wong, 2013). Nevertheless, there are some contrasting findings (Bowes & Johnson, 2016; 
Chakhssi et al., 2010; Hildebrand & de Ruiter, 2012; Tock et al., 2018) where PCL-R score level 
did not moderate the effect of treatment. In this regard, it is pertinent to acknowledge the current 
clinical understanding that psychopathic offenders are not a homogeneous group of offenders 
(Brinkley et al., 2004): this population differs greatly in terms of presentation, needs and 
difficulties (Bebbington et al., 2017; Hart & Hare, 1989, Hildebrand & de Ruiter, 2004; Hilege, 
Das & de Ruiter, 2010). On this basis, it is difficult to conceive of psychopathic offenders as a 
single treatment group, giving strength to the notion that individuals with different combinations 
of classifying traits and behavioural features may benefit from varying treatment approaches 
(Thornton & Bliud, 2007) or respond differently to treatment (Chakhssi et al., 2010; Looman, 
Abracen, Serin & Marquis, 2005). Therefore, it appears important to highlight that group-level 
analysis of psychopaths’ response to treatment is of little clinical interest and does not reflect the 
differential development of individuals during treatment. There is a need for more individual-
                                                 
8 Referenced studies have been discussed in detail in Chapter 1. 
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focused analyses to investigate patterns of change and possible differential outcomes within 
samples of psychopathic offenders.  
 
In overview, whilst there is now a developing evidence base in support of the 
effectiveness of treatment for psychopathic offenders, the literature on treating psychopaths is 
still unable to supply firm conclusions about the efficacy of treatment due to the paucity of 
methodologically sound empirical research and the presence of contradictory evidence. Thus, it 
is important to understand the treatment of psychopathic offenders and replicate findings in order 
to strengthen conclusions and to support clinical practice. The present study aimed to contribute 
further empirical evidence by evaluating the effectiveness of a purposefully designed treatment 
programme (Chromis programme delivered at the Westgate Personality Disorder Treatment 
Service (PDTS)) in the United Kingdom for addressing violence-related risk for psychopathic 
offenders.   
 
 
The Westgate PDTS and the Chromis programme 
The Westgate PDTS is part of the Offender Personality Disorder Pathway (Joseph & 
Benefield, 2012), and provides a therapeutic environment facilitated by a multi-disciplinary team. 
Treatment is supported by a structured and varied regime delivered within an ethos based on the 
‘Good Lives Model’ (Ward & Brown, 2004), and on ‘Conditions of Success’ and ‘Strategy of 
Choices’. The PDTS treatment framework is based on the Risk Need Responsivity model 
(Andrews & Bonta, 2003; 2010), incorporating multimodal skills-based, cognitive behavioural 
methods. Criteria for admission to the PDTS, include motivation and commitment to engage, and 
offenders: 
• posing a high risk of re-offending;  
• having been diagnosed with complex personality disorder (which can include 
psychopathy); and  
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• having a functional link between their personality disorder diagnoses and their 
offending.  
 
The service delivers a range of treatment and services, of which the Chromis programme is 
one part. The Chromis programme draws on best practice in addressing offending behaviour; 
including the ‘what works’ literature (McGuire, 1995), the ‘good lives’ approach (Ward & 
Brown, 2004), and risk, need and responsivity principles (Andrews & Bonta, 2003; 2010). The 
programme aims to reduce violent tendencies in high-risk offenders whose level or combination 
of psychopathic traits disrupts their ability to engage in standard, prison-based treatment. The 
Chromis programme combines the identification, reduction and management of risk to others 
with an emphasis on developing new, fulfilling ways of living prosocially. The programme was 
accredited by the Correctional Services Accreditation Panel (now known as the Correctional 
Services Accreditation and Advice Panel) in 2005.   
 
The Chromis programme consists of three phases of treatment, each with integral treatment 
aims: Motivation and Engagement (ME), Cognitive Skills (CS) and Enabling Change (EC).  
 
The ME component consists of 11 treatment sessions delivered over a period of 
approximately five weeks. It aims to support the engagement of prisoners in Chromis treatment 
and in the wider treatment services of the Westgate unit. The component is delivered on an 
individual basis to motivate offenders to choose to constructively engage in treatment, reinforce 
self-choice and self-responsibility, enable offenders to understand their own strengths and needs, 
enhance constructive, open and respectful involvement and introduce the ‘good life’ approach.  
 
The CS component is delivered over a period of approximately nine months and comprises 
three phases of treatment that promote creative thinking, problem solving and handling conflict. 
The overarching aims of this phase of treatment are to support offenders in developing their 
thought processes, developing risk-management strategies to manage interpersonal conflict, and 
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developing and attaining personally meaningful goals without the use of aggression. The creative 
thinking phase (27 treatment sessions) introduces participants to skills for making sense of and 
solving problems, attaining goals and limiting boredom. The problem-solving phase (25 
treatment sessions) aims to develop critical reasoning and problem definition and resolution. The 
handling conflict phase (42 treatment sessions) explores ways of making sense of, avoiding and 
resolving interpersonal conflict.  Overall, the CS component aims to address treatment needs 
related to anger, impulse control, problem solving and locus of control.  
 
The EC component is the final component of the Chromis programme. This component is 
delivered over approximately five months and aims to support prisoners to develop more adaptive 
core beliefs so as to reduce maladaptive behaviours and to enhance underdeveloped, more 
functional behavioural strategies. The component is delivered in three phases. Phase one 
(delivered individually over 15–20 sessions) identifies unhelpful thinking patterns and core 
beliefs held by the offender via a case formulation approach. This formulation informs phase two 
of the EC component (delivered in a group setting over 45 treatment sessions) where behavioural 
experiments are designed and implemented to test the validity of unhelpful beliefs as well as 
newly constructed beliefs. Phase three (delivered over six treatment sessions) aims to prepare the 
offender for progression by consolidating learnt skills and encouraging ongoing risk 
management.   
 
The Chromis programme is delivered responsively based on individual need and progress, 
with gaps between components to allow for consolidation of learning or for offenders to engage 
with other services delivered by the PDTS unit. The programme is delivered across an offender’s 
engagement with the PDTS with the final component of Chromis (Enabling Change) being the 
offender’s final phase of treatment. The average length of time offenders spend in the PDTS unit 
(assessment and treatment) is variable, with an average completion time of approximately six 
years.    
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 The Chromis programme was developed alongside other aspects of the Westgate PDTS, 
ensuring they were complimented within the finalised treatment framework, and whilst the 
Chromis programme from its commencement in 2004 till 2017 has remained unchanged9, the 
Westgate PDTS has encountered a number of changes to its service delivery. Whilst the clinical 
influence of these changes to the delivery of the Chromis programme are uncertain, they are 
worthy of consideration (Bennett, 2015). Following the introduction of the Offender PD Pathway 
(Joseph & Benefield, 2012) part of the Westgate Unit was re-rolled into a category A 
Psychologically informed Planned Environment (PIPE) in 2012, thus, reducing the Westgate’s 
Service’s capacity from 80 to 65. In addition, a change in admission criteria10 at this time 
contributed to a varied population within the unit (Bennett, 2015).  In order to accommodate the 
complex needs of the population, the Westgate PDTS have developed and delivered other 
treatment programmes, albeit with varied treatment aims than the Chromis programme. It is also 
pertinent that given the recession influence on government funding cuts within the Prison Service 
in England and Wales, a number of changes have impacted upon staff structure and levels at the 
Westgate PDTS. Whilst the impact of these changes have not been evaluated, it is reasonable to 
suggest that reduced staffing within the unit may have had a negative influence on the therapeutic 
regime of the unit.  
 
To date, there have been few evaluations of the Chromis programme (Tew et al., 2012; Tew, 
Bennett & Dixon, 2015). The most prominent was a multiple case study (five offenders) that 
observed significant improvements in all five subjects’ experiences of anger as measured by the 
Novaco Anger Scales and Provocation Inventory (NAS-PI) (Novaco, 1999). Across all cases, 
clinicians observed a reduction in physical incidents, with the exception of one offender who had 
a peak in physical aggression mid-treatment. Verbal aggression reduced in general, but four of 
                                                 
9 The Chromis programme is a manualised offence focused intervention that encourages for consistency in delivery by a variety of 
professionals. Whilst treatment delivery is clinically audited, consistency of treatment delivery cannot be guaranteed owing to 
potential variations that could influence treatment effectiveness and outcome.   
10 The admission criteria changed from having a PCL-R score of above 30 and one personality disorder diagnoses to the presence of 
a complex personality disorder evidenced by either a PCL-R score of 30 and above; a PCL-R score of between 25 and 29 combined 
with at least one personality disorder other than anti-social personality disorder; or two or more personality disorder diagnoses.   
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the offenders displayed significantly more acts of verbal aggression than expected during 
treatment, and all five offenders performed more acts after leaving the PDTS. Whilst 
acknowledging the valuable insight from the study’s findings, it is crucial to recognise that the 
evidence presented provides a narrow analysis based on a small, selective sample.  Thus, at best, 
the study’s findings can only provide cautious optimism for the effectiveness of Chromis, and 
further research is warranted to strengthen clinical insight and to inform ongoing delivery and 
development of this specialist intervention.  
 
 
The present study  
The present study examined treatment need changes in a sample of male psychopathic 
offenders who had engaged with PDTS in a high-security prison (Westgate Unit, HMP 
Frankland), and who, during this engagement, had completed violence intervention (Chromis) for 
high-risk, high-need adult male psychopathic offenders. To enhance the empirical evidence 
presented in the current systematic review of this thesis, the first aim of this study was to explore 
the differences and associations between psychopathy and treatment completion status within the 
sample.  
 
With regard to the evaluation of treatment need change, the present study utilised a large 
psychometric data set generated as part of the clinical research strategy at the Westgate PDTS. 
This data had been collated primarily to assess changes in treatment needs within the Chromis 
programme. The research approach took into account that in the clinical application of 
psychometric scales, there are ethical considerations regarding the selection of psychometric 
tests, their reliability and validity, and their use within offender treatment. The psychometric 
properties of the majority of the applied scales that formed the psychometric battery used by the 
Westgate PDTS had not been evaluated in the context of psychopathic offenders within the wider 
literature. Thus it could not be assumed that the measures would allow for a valid assessment of 
treatment need (Beggs, 2010; Fanniff & Becker, 2006). Therefore, the second aim of this study 
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was to evaluate the psychometric properties of the battery of scales employed by the PDTS to 
ascertain whether they were reliable and valid, and thus able to provide meaningful evidence of 
treatment change in core areas of treatment need.   
The third and overarching aim of the present study was to then utilise available data to 
investigate the clinical effectiveness of the Chromis programme as a whole and of the two main 
treatment components (relating to Cognitive Skills and Enabling Change) in reducing aggression 
and treatment need areas, specifically experiences of anger, problem solving, anger, impulsivity, 
locus of control and maladaptive schemas. These variables, whilst not exhaustive, cover a broad 
range of factors which are generally considered relevant to violent reoffending in psychopathic 
offenders (Ball & Cecero, 2001; Blair, 2006; Bernstein et al., 2007; Douglas et al, 2005; Hart & 
Dempster, 1997; Herba et al., 2007; Simourd & Hoge, 2000; Wong & Gordon, 2006; Tremblay 
& Dozois, 2009), and which, at least in theory, are apt to change. This study evaluated direct 
clinical change through pre- and post-treatment psychometric assessment at group level and 
individual level, utilising the reliable change index (RCI) (Jacobson & Traux, 1991) to investigate 
differential outcomes within the group of psychopaths. A subsidiary aim was to examine 
differences in treatment effects as a function of psychopathy trait levels (moderate and high) to 
ascertain whether treatment change differs between the psychopathy groups.  
 
Based on the available evidence, the following hypotheses have been proposed:  
 
Hypothesis 1:  Treatment non-completers will have significantly higher PCL-R total 
and factor scores in comparison to treatment completers.   
 
Hypothesis 2: Following treatment (pre- to post- treatment), offenders will show 
significant improvements in the evaluated treatment need areas of problem solving, anger, 
impulsivity, locus of control and maladaptive schemas.  
 
 80 
Hypothesis 3: Since offenders’ responses to treatment are variable, it is hypothesised 
that regardless of group-level changes, a proportion of participants would achieve reliable 
change in the evaluated treatment need areas.  
 
Hypothesis 4: Whilst existing evidence is contradictory, it is hypothesised that 
treatment need change (pre- to post- treatment) will be moderated by psychopathy trait levels 
(moderate and high) at both the group and individual level.  
 
 
Method 
 
Design 
This study was a retrospective secondary data analysis study, utilising a within-subject 
repeated-measures design to evaluate short-term measures of clinical change. Multiple 
psychometric assessment stages (five set time points) across the treatment period allowed for the 
examination of clinical change in relation to individual treatment components (Cognitive Skills 
and Enabling Change) and the full Chromis intervention. The primary independent variable was 
the time of administration of the psychometrics [(1) baseline (pre- Motivation and Engagement 
component), (2) pre- and (3) post- Cognitive Skills component and (4) pre- and (5) post- Enabling 
Change component]. The second independent variable was the level of psychopathy (moderate 
or high) as measured by the PCL-R.  The dependent variables were participants’ scores on 
individual psychometric tools.  
 
Sample 
The availability sample consisted of 120 incarcerated adult male offenders who met the 
criteria for prison-based, high-security personality disorder services and engaged with the 
Chromis programme between 2004 and 2017. The availability sample constituted almost all of 
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the population11 of the Westgate unit whereby clinical and psychometric data was available. The 
full sample is representative of treatment completers (n = 43), treatment non-completers (n = 53) 
and current treatment engagers (n = 24). The demographic and offence characteristics of the full 
sample are summarised in Table 1. Cell size discrepancies within the tables are the result of 
missing data.  
 
The average age of the full sample on admission to the specialist treatment unit was 36.7 
years (SD = 9.08) and, based on the available data, a higher proportion of the sample were white 
in ethnicity. Most participants had been convicted with a life sentence and had an index offence 
of physical violence (murder/manslaughter or violence). The average PCL-R total score for the 
full sample was high (mean = 29; Factor 1 mean score = 10; Factor 2 mean score = 13), which is 
not surprising given all participants had met the criteria for a personality disorder treatment 
service. The prevalence of personality disorder in the sample was large, with 93% of the 
participants receiving at least one Axis II diagnosis. Eight participants were diagnosed with no 
personality disorders but had met the criteria for the treatment service based on psychopathy level. 
The most frequently diagnosed personality disorder was antisocial, with most personality disorder 
diagnoses being within the Cluster B disorders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
11 The term population is used, as a synonym of Universe that is reflective of a complete set of elements (persons) that possess the 
same common characteristics defined by the sampling criteria, which for the purpose of the present study was defined by the Westgate 
PDTS. It is important to accept that the full population may not have been included within study, owing to missing data.  
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Table 1  
 
Full sample, treatment completer sample by psychopathy group (moderate and high12) and treatment 
non-completer sample: demographic information, offence characteristics, PCL-R mean scores and Axis 
II diagnoses 
 
 Full sample  
n=120 
Treatment completers  
n = 41* 
Treatment non-completers  
n = 53 
  Moderate PCL-R 
n =20 
High PCL-R 
n=21 
 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age 36.7 (9.08) 33.5 (7.1) 37.4 (7.5) 36.1 (9.3) 
Pre-convictions 30.9 (32.80) 30.7 (34.5) 30.4 (42) 34.9 (32.7) 
Custodial sentences 6.6 (6.4) 5.47 (5.7) 5 (6.5) 8.1 (7) 
Sentence type Number (%) Number (%) Number (%) Number (%) 
Life 87 (72) 15 (75) 18 (85) 31 (58) 
IPP* 25 (20) 3 (14) 3 (14) 14 (26) 
Determinate  7 (5) 2(10) 0 (0) 6 (11) 
Index Offence type Number (%) Number (%) Number (%) Number (%) 
Murder/Manslaughter 36 (35.3) 4 (20) 9 (42) 15 (28) 
Violent 39 (38.2) 6 (30) 4 (19) 24 (45) 
Sexual 26 (25.5) 6 (30) 6 (28) 10 (18.9) 
Ethnicity* Number (%) Number (%) Number (%) Number (%) 
White 104 (67) 17 (85) 17 (80) 50 (94) 
Black 6 (3) 2 (10) 1 (4.7) 1 (1.9) 
Not stated/missing 45 (29) 1 (5) 3 (14.2) 2 (3) 
Psychopathy Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
PCL-R total 29.3 (5.0) 25.7 (3.1) 32.1 (2.5) 29.7 (5) 
Factor 1  10.9 (3.1) 8.8 (1.8) 12.3 (2.2) 11.3 (3) 
Factor 2 13.9 (2.8) 13.8 (2.1) 14.5 (1.9) 14.3 (2) 
Axis II disorder Number (%) Number (%) Number (%) Number (%) 
Antisocial 98 (81) 18 (90) 19 (90.4) 39 (73) 
Borderline 66 (55) 14 (70) 13 (61.9) 23 (43) 
Narcissistic 30 (25) 0 (0) 6 (28.5) 15 (28) 
Histrionic 12 (10.0) 2 (10) 2 (9.5) 5 (9) 
Paranoid 38 (31) 10 (50) 4 (19) 16 (30) 
Schizoid 15 (12) 2 (10) 4 (19) 6 (11) 
Schizotypal  6 (5) 2 (10) 0 (0) 3 (5) 
Obsessive compulsive 5 (4) 0 (0) 0 (0) 3 (5) 
Avoidant 22 (18) 7 (35) 2 (9.5) 4 (7) 
Dependent  2 (1) 0 (0) 0 (0) 1 (1) 
* Full sample consists of treatment completers, non-completers and current treatment engagers; Imprisonment for Public Protection 
(IPP); minority-ethnic participants have been defined as ‘black’ using the term in its political sense to apply to non-Caucasians who 
are either Black African, Black Caribbean, Black Other or from the Asian subcontinent; Within the availability sample, 43 prisoners 
had completed the Chromis programme in its entirety, albeit PCL-R data was only available for 41 prisoners and thus 41 prisoners 
made up the completers sample for this study.   
                                                 
12 As a means of further understanding the treatment completer sample, differences in demographic and clinical variables between 
the psychopathy groups (moderate and high) were tested (using independent sample t-tests and contingency tables with Pearson’s chi-
square test or Fisher’s Exact test, when appropriate), however, as this was not an aim of the study, the findings will be summarised 
here. Differences between the moderate and high psychopathy groups in PCL-R and Factor (1 and 2) mean scores were significant at 
p < 0.01.  With regard to personality disorder diagnoses, no significant group differences were prevalent, other than for narcissistic 
(p < 0.05) and paranoid personality disorders (p < 0.05). There were no statistically significant differences in demographic, sentence 
type or offence characteristics between the psychopathy groups at p < 0.05.  
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Within the availability sample, 43 prisoners had completed the Chromis programme in its 
entirety, albeit PCL-R data was only available for 41 prisoners (treatment completers’ sample 
mean PCL-R = 29 (SD= 4.28)).  In accordance with the analytical strategy, individuals in the 
treatment completer sample were placed into either a ‘moderate’ (n = 20; PCL-R score of 29 or 
below) or a ‘high’ psychopathy group (n = 21; PCL-R score of 30 or above), depending on their 
total PCL-R score, cut-offs advocated by previous research13 (Coid & Ullrich, 2010; Hare, 2003). 
The respective PCL-R mean scores, personality disorder diagnoses, demographic and offence 
specific characteristics for each psychopathy group (presented in Table 1) follow a similar pattern 
to the full sample.   
 
Within the remaining availability sample, a total of 53 prisoners (44.1%) had either left 
and not returned to treatment or had been deselected from treatment by the treatment service at 
various stages14. The treatment non-completers’ PCL-R mean scores, personality disorder 
diagnoses, demographic and offence-specific characteristics are presented in Table 1. The 
attrition rates for each treatment stage are presented in Figure 1.  Clinical and assessment data 
was also available for 24 prisoners who were mid-treatment, this cohort was omitted from the 
study analysis, leaving an overall studied sample of 96. 
 
 
 
Figure 1: Standardised administration stages of the psychometric battery in relation to the treatment 
delivery of Chromis15  
                                                 
13 The extracted PCL-R score data showed that whilst the full PCL-R, including Factor 1 and Factor 2 scores had been recorded, the 
four facet scores of the PCL-R had not been documented in the majority of incidences, meaning that it was not possible to record 
PCL-R facet scores as planned. 
14 Details pertaining to the sample of non-completers and the reason for deselection were not made available, however, this 
information was not relevant to the integral aims of the present study. 
15 Stage 1: n = 96 reflects the full available sample (N = 120) minus those currently engaged in treatment (N = 24). 
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Measures 
The Psychopathy Checklist—Revised (PCL-R) (Hare, 2003) is a clinical rating scale 
designed to assess psychopathy in forensic populations. The PCL-R consists of 20 items, each 
rated 0 to 2 (0 = does not apply, 1 = applies to some extent, 2 = definitely applies). The PCL-R 
yields a dimensional total score between 0 and 40 indicating the degree to which the individual 
matches the prototypical psychopath, with previous research advocating a cut-off score of 30 or 
more on the total scale for a diagnosis of psychopathy (Coid & Ullrich, 2010; Hare, 2003). The 
PCL-R has been extensively studied and significantly predicts general and violent recidivism 
(Leistico et al., 2008), and is the most widely used clinical assessment tool for assessing 
psychopathy.  Hare, Clark, Grann & Thornton (2000) found PCL-R scores to be highly reliable 
when used with trained and experienced raters. 
 
The International Personality Disorder Examination (IPDE) (Loranger et al., 1994) is a 
semi-structured clinical interview developed to assess personality disorders in a manner 
compatible with the ICD and DSM classification systems16.   Scoring of the 93 items is undertaken 
using a three-point rating (0 = absent or within normal range, 1 = present to an accentuated degree, 
2 = pathological or meets criterion) and the final algorithmic integration of the items permits 
personality disorder diagnostic classification. Satisfactory psychometric properties have been 
previously reported (Loranger et al., 1994; Loranger, Janca & Sartorius, 1997). Indices of inter-
rater reliability reported elsewhere have been acceptable (Ullrich & Marneros, 2004). 
 
The Social Problem-Solving Inventory—Revised (SPSI-R) (D’Zurilla et al., 2002) is a 52-
item measure that requires respondents to self-report and assesses the ability of respondents to 
resolve problems in everyday life. It comprises five empirically supported subscales: positive 
problem orientation (PPO): five items, negative problem orientation (NPO): 10 items, rational 
problem solving (RPS): 20 items, impulsivity/ carelessness style (ICS): 10 items and avoidance 
                                                 
16 As part of PDTS clinical practice during the research timeframe, DSM criteria were used to assess personality disorder diagnoses.   
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style (ICS): 10 items).  The inventory is scored using a five-point Likert scale (0 = Not at all true 
of me to 4 = Extremely true of me). With a sample of sexual offenders, the scale has been shown 
to have very high internal consistency (α = .86), and good test–retest reliability (r (30) = .94) 
(Wakeling, 2007). In addition, positive treatment-related change was found on all scales of the 
SPSI-R except for the PPO subscale after three months of problem-solving therapy with 
personality disordered offenders (McMurran, Egan, Blair & Richardson, 2001).  
 
The Barratt Impulsiveness Scale (BIS-II) (Barratt, 1994) provides an assessment of 
Motor, Cognitive and Non-Planning Impulsiveness. The scale comprises 30 items rated on a four-
point Likert scale (1 = ‘rarely/never applies to me’ to 4 = ‘almost always or always applies to 
me’). The higher the aggregate score for all items, the higher the level of impulsiveness. The 
psychometric properties of the BIS have been extensively researched and scores on the instrument 
have been shown to be related to aggressive behaviour (Grisso et al., 2000; Wang & Diamond, 
1999). The internal consistency of the scale has been found to be acceptable, with Cronbach’s α 
of .80 as the total score for both forensic and in-patient populations (Carrillo-de-la-Pena, Otero 
& Romero, 1993; Patton et al., 1995). The scale has also been found to hold good test–retest 
reliability (Spearman’s Rho = 0.83; Stanford et al., 2009).  
 
The Novaco Anger Scale and Provocation Inventory (NAS-PI) (Novaco, 1994) consists 
of 85 items grouped into two sections. The NAS focuses on experiences of anger and contains 60 
items with four subscales: cognitive, arousal, behavioural and anger regulation. The PI contains 
25 items and focuses on the kind of situation that leads to anger in five content areas: disrespectful 
treatment, unfairness, frustration, annoying traits of others and irritations, to produce a single total 
PI score.  The item responses range from 1 = Never True to 3 = Always true for NAS items to 1 
= Not at all Angry to 4 = Very Angry for PI items. Examinations of the psychometric properties 
of this scale have demonstrated test–retest correlations ranging from .78 to .91, and internal 
consistency coefficients for the NAS in excess of .95, and of .88 for the PI with an adult criminal 
sample (Mills et al, 1998). The NAS-PI has been used extensively with individuals in high-
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security forensic psychiatric care in the United Kingdom who have a history of violence (Renwick 
et al, 1997; Novaco & Renwick, 1998). Others have reported on reliability and validity data for 
the NAS (Mills, Kroner & Forth, 1998, Novaco,1994), and Cunningham (2011) looked at this 
specifically within the DSPD population, concluding that the scale had adequate test–retest 
reliability and internal consistency (i.e. coefficients of 0.80 or higher).  
 
The Adapted Locus of Control (LoC) is an 18-item scale that assesses the extent to which 
a participant believes what happens to him is determined by external factors or whether he has 
control over his experiences. Huntley, Palmer & Wakeling (2012) reported that the scale was 
adapted by the Prison Service Interventions and Substance Misuse Group from a scale devised 
by Levenson (1974).  The scale is scored on a five-point Likert scale (0 = strongly disagree to 4 
= strongly agree), with a higher score (> 40) indicating someone who attributes his experience to 
internal factors and with lower scores indicating a tendency to blame external factors. Within a 
sample of sexual offenders, the adapted measure has been shown to have very high internal 
consistency (α = .81), and the test–retest reliability of the scale was very good (r = .71, p < .001) 
(Huntley, Palmer & Wakeling, 2012). 
 
The Young Schema Questionnaire—Short Form (YSQ–SF) (Young & Brown, 1999) 
assesses the severity of the early maladaptive schemas (EMS) that fall within the following five 
domains: disconnection and rejection, impaired autonomy and performance, impaired limits, 
other-directedness and over-vigilance, and inhibition. The scale comprises 75 items that are rated 
on a six-point Likert scale (1 = completely untrue of me to 6 = describes me perfectly). For all 
subscales and domains, a higher score reflects a more maladaptive and pervasive core belief. The 
original Young Schema Questionnaire-Long Form (YSQ-LF) possessed adequate internal 
consistency and test–retest reliability as assessed within clinical samples (Lee, Taylor & Dunn, 
1999; Schmidt, Joiner, Young & Telch, 1995). Since its initial development the questionnaire 
was revised a number of times and a short form has been designed (YSQ-SF) (Young, 1999). The 
YSQ-SF and YSQ-LF are seen as broadly comparable (Waller, Meyer & Ohanian, 2001) and the 
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initial 15-factor structure of the YSQ-SF has been confirmed in clinical samples (Hoffart et al., 
2005; Welburn, Corstine & Dagg, 2002). Furthermore, studies have demonstrated acceptable to 
very good internal consistency (α > .70) for both the overall YSQ-SF and its subscales (Waller et 
al, 2001; Welburn et al., 2002).  
 
Procedure  
In line with the treatment service’s clinical practice, the clinical assessments PCL-R 
(Hare, 2003) and IPDE (Loranger, 1999) were completed upon the participant’s admission to the 
treatment unit. The clinical assessments were administered by a team of trained clinical staff 
(including trainee psychologists and therapists) led by a forensic psychologist practitioner whose 
role was to provide clinical oversight and supervision of the assessment process. The clinical 
assessments were based on interview and available file information.    
 
A trained and qualified member of the treatment team administered the psychometric 
scales to participants individually, and support was available for those with literacy difficulties. 
All measures were administered in a battery in counterbalanced order to account for fatigue and 
boredom and to minimise bias. The psychometric battery was administered at five set time points 
during the Chromis treatment process.  The first administration was prior to any exposure to 
treatment and the motivation and engagement component (stage 1: baseline). Stage 2 
administration was before the Cognitive Skills component (pre-CS), with stage 3 being six 
months after the completion of this component (post-CS). Stage 4 administration was before the 
Enabling Change component (pre-EC), and stage 5 was six months after completion of the post-
Chromis treatment component (post-EC). The standardised administration stages of the 
psychometric battery in relation to the treatment delivery of Chromis is presented in Figure 1.17  
 
 
                                                 
17 The administration of the psychometric battery ended in 2017.    
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Ethical considerations 
Ethical approval was granted from both Nottingham Trent University and Her Majesty’s 
Prison and Probation Service (HMPPS).  Upon admission to the PDTS and prior to treatment, a 
qualified member of the treatment team sought the informed consent of the prisoners for use of 
their anonymised data, including demographic and clinical assessment data used to evaluate the 
effectiveness of the assessment, treatment and complementary regimes offered as part of the 
treatment service. All participants within the availability sample provided their informed consent. 
Additional consent for the purpose of this retrospective secondary data analysis study was 
therefore not sought—this was approved by both ethics-approving organisations. 
 
The research data was held in line with the Data Protection Act 2018. The database 
created for this research, from the original databases held at HMP Frankland, Westgate unit, was 
both confidential and anonymous. No identifiable information was included within the database, 
ensuring that no information on the research database could be traced to any individual.  
 
Data analysis plan 
Data analysis was carried out in four stages: (i) exploration of the PCL-R total and factor 
score differences and associations with treatment attrition (binary outcome), (ii) data cleaning 
and initial psychometric validation of the scales and their properties for this sample, (iii) a series 
of 2x5 repeated-measures Multivariate Analyses of Variance (MANOVAs) to assess clinical 
change across time points for each scale; and (iv) calculation of the RCI to examine individual 
change for each scale.   
 
(i) PCL-R total and factor score differences and associations with treatment attrition: 
Differences in PCL-R total and factor scores between treatment non-completers and completers 
were examined using independent sample t-tests.  In addition, the relationship between PCL-R 
total and factor scores and treatment completion status (binary outcome) were examined using 
Pearson r correlations and point-biserial correlations for dichotomous variables.  
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(ii) Data cleaning and psychometric scale properties: In order to ensure meaningful scale 
scores, respective psychometric manual procedures regarding missing data were followed, 
including using median scale values when appropriate or omitting participants’ data if it met the 
missing data cut-off as recommended by each psychometric manual. An examination of the 
distribution of data for each scale and component subscales was conducted using Shapiro-Wilk 
test of properties of normality. An analysis for identifying outliers greater than three standard 
deviations from the group mean was performed for each scale (and subscale) following 
Tabachnick and Fidell (1989).  
 
Utilising the full sample baseline data, internal scale consistencies were evaluated using 
item-total correlations. Cronbach’s alphas and component subscales and, when appropriate, intra-
scale, correlations were computed. Common guidelines for interpreting Cronbach’s alpha suggest 
that an alpha of at least 0.8 is an average benchmark for widely used measures (Lance, Butts & 
Michels, 2006), whereas Field (2000) suggests that alphas over 0.6 reflect a measure that is 
internally consistent. To examine the convergent validity of each scale, zero-order correlations 
were conducted between each psychometric scale (and subscale) score.  
 
(iii) Clinical change at group level: A series of 2x5 repeated-measures MANOVAs were 
conducted using psychopathy group (moderate and high PCL-R score) as the between-subjects 
factor and the repeated assessment of each psychometric scale (time points 1 to 5) as the within-
subjects factor. Post-hoc analyses were conducted when appropriate, using a Bonferroni 
adjustment.  
 
(iv) Clinical change at individual level: Pre- and post- treatment group scores provide no 
information about how an individual fared in treatment. Similarly, statistical significance tests 
offer little with regard to clinical interest.  Thus, to examine individual change, the RCI was 
calculated for each individual on all of the psychometric measures. The RCI addresses whether 
participants’ change during treatment exceeds the change that would be expected based on 
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measurement error alone. The RCI controls for the degree of difference in pre- to post- test scores 
as a result of measurement unreliability. Because there was no control group, the RCI was 
calculated using the Standard Deviation (SD) of the pre-treatment group in the calculation, as 
suggested by Jacobson and Traux (1991). The RCI is defined by Jacobson & Traux (1991, p. 14) 
as: 
 
 
Jacobson and Traux (1991) suggest that RCIs larger than 1.96 would be unlikely to occur 
(p < .05) without actual change (with a 95% confidence level). It is noteworthy that the RCI has 
been criticised in the past for being based on individual’s obtained pre-test score, which has an 
inherent measurement error and may therefore not be a ‘true’ pre-test score (Christensen & 
Mendoza, 1986). Whilst an adjustment has been recommended to provide a more stringent 
formula for the RCI, this was not adopted for this study as the original RCI formula was deemed 
stringent enough. The use of the original RCI formula has been recommended in previous 
research with similar populations (Chakhssi et al., 2010). In this study, participants with a 
negative reliable change (RCI < -1.96) were labelled as ‘reliably deteriorated’, participants within 
the band of no reliable change (-1.96   RCI  1.96) were labelled as showing ‘uncertain 
change’, and participants with a positive reliable change (RCI > 1.96) were labelled as ‘reliably 
improved’. Differences in reliable change categories (deterioration and uncertain change versus 
improvement) between psychopathy groups were tested using Pearson’s chi-square test or 
Fisher’s Exact test, as appropriate. 
 
Because multiple analyses were conducted, consideration was given to reducing the 
significance level to .01 in order to reduce the chance of Type I errors. It was acknowledged, 
however, that such an over-correction would have increased the likelihood of Type II errors. 
Therefore, a significance level of .05 was used for all statistical tests and for the conducted 
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MANOVAs, the statistical effect size was reported for the within-subject factor statistical 
analysis.  In addition, it is worth noting that due to the small sample size and the increased 
likelihood that individual differences could significantly impact results, the more idiographic 
approach of individual analysis (RCI) was used, an approach recommended in previous research 
(Oddie & Davies, 2009).  
 
 
Results 
 
(i) PCL-R total and factor score differences and associations with treatment attrition 
The demographic attributes, offence characteristics, PCL-R mean scores and Axis II 
disorder diagnoses for treatment non-completers and completers are presented in Table 1.  There 
were no statistically significant differences between treatment completers and non-completers in 
terms of PCL-R and factor (1 and 2) mean scores (total: p = .43, Factor 1: p = .28, Factor 2: p = 
.81). Furthermore, PCL-R total (p = .43), Factor 1 (p = .29) and Factor 2 (p = .81) and treatment 
completion status (binary outcome) were not significantly associated.  
 
(ii) Data cleaning and psychometric scale properties 
Data cleaning 
For the SPSI-R, three extreme outliers were omitted. Preliminary analysis using Shapiro-
Wilk tests identified that the SPSI-R subscales for both psychopathy groups for each 
psychometric assessment stage were normally distributed, other than those for assessment stage 
5 of the SPSI-R NPO subscale, high psychopathy group (p < .01). The distribution of data for 
assessment stage 5 of the SPSI-R NPO subscale as measured by skewness and kurtosis followed 
the distribution pattern of the other subscales and were within an acceptable range, suggesting 
that normality assumptions could be supported (Field, 2009). 
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One extreme outlier was identified in assessment stage 3 of the BIS total scale— this 
outlier was omitted from the full analysis.  BIS total scale scores for psychopathy groups other 
than the stage 5 high psychopathy group (p < 0.05) and each psychometric assessment stage were 
normally distributed. In addition, the subscales at each assessment stage and for psychopathy 
groups were normally distributed, other than those for assessment stage 5 on the BIS subscale 
cognitive index (high psychopathy group p <0.05) and the non-planning index (moderate 
psychopathy p <0.05). The non-normally distributed scales followed the distribution pattern 
(skewness and kurtosis) of the other subscales and were within the acceptable range.  
 
There were no extreme outliers identified for the NAS-PI and LoC, and for all conditions 
(psychopathy group and assessment stage), the data was normally distributed.  For the YSQ-SF, 
three extreme outliers were omitted. With regard to the YSQ-SF data, approximately a third of 
the scales for each psychopathy group did not meet the properties of normality. As such, a non-
parametric Spearman rank-order correlation was conducted for intra- and inter-scale correlations. 
It was nonetheless considered appropriate to continue to explore the subscales using a MANOVA 
as it is proclaimed that the F test is robust enough to withstand deviations from normality 
(Lindman, 1974). In addition, as only 37% of the subscales across both conditions (assessment 
stage and psychopathy group) were abnormally distributed, this small number should not detract 
from the overall MANOVA outcome.  
 
Psychometric scale properties 
Social Problem-Solving Inventory Revised (SPSI-R): Item-to-total correlations were 
examined on all 52 SPSI-R items. Six items had correlations less than .20, the remainder being 
between .20 and .57.  The internal consistency for each of the SPSI-R subscales ranged from 
acceptable (positive problem orientation = .77) to excellent (rational problem solving = .96). The 
intra-scale correlations were statistically significant with correlations ranging between -.35 and 
.83; showing diverse range, with no emerging pattern. The relevant descriptive statistics and intra-
scale correlations for the SPSI R, BIS, NAS-PI and LoC are shown in Table 2. With regard to 
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convergent validity, SPSI-R subscales are consistently moderately to highly correlated with 
measures of impulsivity (BIS) and LoC. The correlations are in the expected direction, with 
impulsivity correlating significantly positively with the two positive problem-solving styles, PPO 
and RPS, and significantly negatively with the dysfunctional problem-solving dimensions NPO, 
ICS and AS.  The opposite patterns emerged for LoC, as expected.  
 
The Barratt Impulsivity Scale (BIS): Item-to-total correlations on all 30 BIS items 
indicated that three items had correlations of less than .20, with the remainder being between .24 
and .75. The BIS full scale showed excellent internal consistency (=.91), with Cronbach’s alphas 
for each of the subscales ranging from questionable (Non-Planning Impulsiveness = .67) to good 
(Motor Impulsiveness = .89). The intra-scale correlations are statistically significant with 
correlations ranging from .72 to .93.  Each subscale correlated best with the BIS total. The 
relationship between the BIS with the SPSI-R, LoC and NAS-PI demonstrated consistent 
concurrent validity, with moderate to high correlations across scale totals and subscales in the 
expected direction.  
 
The Novaco Anger Scale and Provocation Inventory (NAS-PI): The 85 NAS-PI items 
had item-to-total correlations of between .24 and .79.  The internal consistency alphas for each 
of the NAS-PI subscales ranged from good (cognitive = .89) to excellent (arousal = .93). The full 
scale NAS had excellent overall internal consistency (.93), as did the full scale PI (.96). The intra-
scale correlations of the four subscales ranged from -.62 to .87, and the correlation between the 
NAS scale total and PI scale total was .77.  The NAS-PI statistically significantly correlated with 
the SPSI-R, BIS and each component subscale. The NAS-PI and component subscales are 
consistently moderately to highly correlated with the LoC measure, with associations in the 
expected direction.  
 
Locus of control (LoC): Item-to-total correlations were examined on all 18 LoC scale 
items. Two items had correlations of less than .20, the remainder had correlations ranging from 
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.21 to .65.  The internal consistency of the locus of control scale was examined and had a 
Cronbach’s alpha of .82, indicating high internal consistency. Removing item 15 resulted in the 
alpha increasing from .82 to .84. Item 15 ‘I understand why my problems vary so much from one 
occasion to another’ fits with the construct of the scale, and due to a marginal increase in the 
alpha score after removing this item, it was decided that the item would remain, thus ensuring 
that the analysis was conducted on the full scale. The relationship between the LoC with SPSI-R, 
BIS and NAS-PI demonstrates consistent concurrent validity, with moderate to high correlations 
across scale totals and subscales in the expected direction.  
 
Young Schema Questionnaire—Short Form (YSQ-SF): Two of the YSQ-SF items have 
an item-to-correlation of less than .20. The remaining items ranged between .29 and .77. Internal 
consistency alphas for each of the YSQ-SF subscales ranged from acceptable (unrelenting 
standards = .77) to excellent (abandonment = .96). A non-parametric Spearman’s rank-order 
correlation was conducted for intra- (presented in Table 3) and inter-scale correlations (presented 
in Table 4). The intra-correlations of the subscales ranged from .10 to .73, with each subscale 
correlating statistically significant, other than emotion deprivation and mistrust/abuse with 
enmeshment, and self-sacrifice with entitlement. Inter-scale correlations that are similar in 
construct to the YSQ-SF demonstrate convergent validity. The SPSI-R subscales (other than PPO 
and RPO) are consistently significantly associated with each of the YSQ-SF subscales, in the 
desired direction.  The NAS-PI (and subscales) were associated with each subscale within the 
disconnection and rejection domain and the impaired limits domain, and the subscale for emotion 
inhibition. BIS (and subscales) statistically correlated with the YSQ-SF subscales insufficient 
self-control and emotional inhibition.  
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Table 2 
Alpha coefficients, scale-subscale correlations and convergent validity between SPSI-R, BIS, NAS-PI and LoC 
 PPO NPO RPS ICS AS BIS MI CI NPI NAS PI COG ARO BEH AR LoC 
α .77 .93 .96 .94 .89 .91 .84 .81 .67 .93 .96 .89 .93 .93 .86 .82 
SPSI-R - - - - - - - - - - - - - - - - 
PPO - - - - - - - - - - - - - - - - 
NPO -.42** - - - - - - - - - - - - - - - 
RPS .78** -.35** - - - - - - - - - - - - - - 
ICS -.38** .83** -.51** - - - - - - - - - - - - - 
AS -.46** .82** -.38** .77** - - - - - - - - - - - - 
BIS -.51** .70** -.65** .82** .64** - - - - - - - - - - - 
MI -.37** .64** -.49** .74** .54** .90** - - - - - - - - - - 
CI -.55** .68** -.62** .77** .64** .93** .77** - - - - - - - - - 
NPI -.46** .54** -.63** .66** .54** .83** .58** .72** - - - - - - - - 
NAS -.27** .51** -.37** .55** .45** .60** .61** .57** .39** - - - - - - - 
PI -.30** .50** -.29** .51** .46** .51** .44** .52** .40** .77** - - - - - - 
Cog -.29** .47** -.35** .53** .42** .58** .56** .55** .42** .92** .77** - - - - - 
Aro -.39** .62** -.41** .63** .53** .60** .64** .61** .48** .94** .80** .87** - - - - 
Beh -.27** .45** -.42** .53** .40** .59** .59** .56** .40** .92** .69** .81** .86** - - - 
AR -.48** -.49** -.64** -.58** -.43** -.62** -.51** -.60** -.56** .53** -.55** -.62** -.66** -.66** - - 
LoC .54** -.59** .33** -.55** -.64** -.61** -.51** -.63** -.50** -.48** -.49** -.46** -.54** -.41** -.42** - 
Notes: ** p <.01; * p < .05 level. Social Problem-Solving Inventory Revised (SPSI-R): Positive Problem Orientation (PPO), Negative Problem Orientation (NPO), Rational Problem 
Solving (RPS), Impulsivity/Carelessness Style (ICS), Avoidance Style (AS); Barratt Impulsiveness Scale (BIS): Motor Impulsiveness (MI), Cognitive Impulsiveness (CI), Non-
Planning Impulsiveness (NPI); Novaco Anger Scale and Provocation Inventory (NAS-PI): Cognitive (Cog), Arousal (Aro), Behavioural (Beh), Anger Regulation (AR); Locus of 
Control (LoC) 
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Table 3 
YSQ-SF subscale alpha coefficients and subscale correlations 
 ED Aba Mis SI Def Fa De Vu Enm Sub SS EI US Ent IS 
α .93 .94 .92 .93 .92 .88 .81 .80 .89 .83 .80 .89 .77 .86 .88 
Disconnection and rejection                 
Emotional deprivation (ED) - - - . - - - - - - - - - - - 
Abandonment (Aba) .33** - - - - - - - - - - - - - - 
Mistrust (Mis) .52** .57** - - - - - - - - - - - - - 
Social isolation (SI) .53** .58** .66** - - - - - - - - - - -  
Defectiveness (Def) .49** .58** .56** .62** - - - - - - - - - - - 
Impaired autonomy and performance                
Failure (Fa) .40** .55** .50** .57* .58** - - - - - - - - - - 
Dependence (De) .40** .61** .39** .53** .58** .70** - - - - - - - - - 
Vulnerability (Vu) .42** .64** .59** .64** .52** .60** .61** - - - - - - - - 
Enmeshment (Enm) .15 .44** .18 .32** .34** .46** .51** .48** - - - - - - - 
Other-directedness and inhibition                
Subjugation (Sub) .45** .57** .43** .56** .67** .58** .69** .60** .53** - - - - - - 
Self-Sacrifice (SS)  .19** .36** .21* .21* .28** .31** .32** .38** .35** .39** - - - - - 
Over-vigilance and inhibition                
Emotional inhibition (EI) .53** .43** .64** .73** .64** .57** .49** .58** .28** .56** .28** - - - - 
Unrelenting standards (US) .27** .40** .21* .381** .26** .36** .34** .38** .20* .21* .25** .26** - - - 
Impaired limits                 
Entitlement (Ent) .40** .27** .39** .55** .44** .48** .39** .59** .32** .48** .10 .52** .43** - - 
Insufficient self-control (IS) .46** .46** .56** .60** .62** .71** .61** .58** .35** .58** .30** .66** .41** .68** - 
     Note: ** = p <.01; * = p < 0.05 level. 
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Table 4 
Convergent validity correlations between YSQ-SF, SPSI-R, BIS, NAS-PI and LoC 
Domain Disconnection/Rejection Impaired Autonomy Other-directedness Over-vigilance Impaired limits 
Subscale ED Aba Mis SI Def Fa De Vu Enm Sub SS EI US Ent IS 
SPSI-R                
PPO -.23* -.29** .37** -.18 -.25** .37** .30** -.31** -.21* .25* .06 -.16 0.03 -.16 -.38** 
NPO .32** .54** .38** .41** .55** .64** .61** .52** .37** .60** .24** .39** .28** .41** .67** 
RPS -24* -.12 -.24** -.12 -.11 -.31** -.24** -.13 -.11 -.11 -.11 0.13 -0.11 -.27 -.40** 
ICS .33** .40** .42** .38** .45** .59** .48** .39** .29** .44** .19* .40** .28** .46** .69** 
AS .37** .52** .45** .38** .63** .63** .56** .51** .41** .54** .24** .43** .27** .35** .64** 
BIS .31** .41** .47** .47** .36** .55** .49** .37** .24** .37** .86** .38** .21* .44** .70** 
MI .26** 37** .48** .48** .35** .46** .43** .36** .14 .38** .13 .32** .24* .44** .67** 
CI .26** 24** .42** .42** .30** .58** .47** .33** .27** .28** .07 .33** .20* .39** .64** 
NPI .29** 24** .33** .33** .36** .39** .40** .30** .28** .34** .02 .38** .03 .31** .54** 
NAS .37** .38** .62** .46** .42** .41** .35** .37** .10 .36** .19* .48** .15 .53** .58** 
PI .32** .44** .60** .44** .44** .35** .26** .31** .09 .29** .22** .43** .16 .41** .52** 
Cog 43** .39** .66** 54** .44** .41** .34** .44** .07 .36** .16 .52** .19* .56** .58** 
Aro 40** .44** .66** .49** 45** .48** .43** .40** .15 .37** .18 .49** .19* .49** .60** 
Beh 31** .22* .45** .34** .31** .33** .25** .21** .02 .25** .09 .35** .09 .51** .53** 
AR -.28** -.23** -.37** -.36** -.32** -.38 -.35** -.22** -.04 -.19* -.05 -.34** -.08 -.41** .45** 
LoC -.29** -.45** -.46** -.40** -.54** -.59** -.51** -.49** -.42** -.48** -.21** -.40** -.14 -.39** -.58** 
Notes: ** = p <.01; * = p < .05 level. Social Problem-Solving Inventory Revised (SPSI-R): Positive Problem Orientation (PPO), Negative Problem Orientation (NPO), Rational 
Problem Solving (RPS), Impulsivity/Carelessness Style (ICS), Avoidance Style (AS); Barratt Impulsiveness Scale (BIS): Motor Impulsiveness (MI), Cognitive Impulsiveness 
(CI), Non-Planning Impulsiveness (NPI); Novaco Anger Scale and Provocation Inventory (NAS-PI): Cognitive (Cog), Arousal (Aro), Behavioural (Beh), Anger Regulation 
(AR); Locus of Control (LoC) 
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(iii and iv) Change during treatment at group and individual level (treatment completers 
only)  
The results of the repeated-measures MANOVAs for each psychometric scale and 
subscale found no statistically significant main effect on the psychopathy group nor any 
interaction between treatment and psychopathy group (p < .05). As psychopathy group was not 
found to moderate the effect of the treatment across the psychometric scores, the more prominent 
results will be reported; the effect of treatment for the full treatment completers sample. For the 
MANOVAs that did not meet sphericity assumptions, the degrees of freedom were corrected 
using the Greenhouse-Geisser correction.  
 
The results of each repeated-measures MANOVA (mean change between the assessment 
stages18 and the results of individual change using the RCI for the full treatment completer 
sample) conducted are presented in Table 5. The means and standard deviations at the five 
assessment time points and the RCI categories for each psychometric scale are presented for the 
moderate and high psychopathy groups within the appendix (6 and 7).   
 
Social Problem-Solving Inventory—Revised (SPSI–R): There was a statistically 
significant main effect of treatment for each of the SPSI-R subscales: positive problem orientation 
(PPO:  F(2.736, 82.078) = 12.829, p <.01), negative problem orientation (NPO: F(2.533, 68.380) 
= 13.808, p<.01), rational problem solving (RPS: F(2.354, 70.627) = 19.560, p <.01), impulsivity 
and carelessness style (ICS: F(2.048, 61.439) = 17.315, p <.01) and avoidance style (AS: F(2.329, 
69.860) = 11.325, p <.01). The SPSI-R subscale scores pre- (stage 1) to post- treatment (stage 5) 
changed in the desired direction. Post-hoc analysis using Bonferroni pairwise comparisons 
indicated that for the SPSI-R subscales PPO, NPO, RPS and ICS, there are statistically significant 
differences in the desired direction between assessment stages 2 and 3, and between pre- (stage 
1) and post-treatment (stage 5).  
                                                 
18 (1) baseline (pre-Motivation Engagement component), (2) pre and (3) post Cognitive Skills component and (4) pre and (5) post 
Enabling Change component). 
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Table 5 presents the results for individual change using the RCI, including the number and 
percentage of the sample who reliably deteriorated, showed uncertain change or reliably 
improved for the SPSI-R and component subscales. A higher proportion of the sample fell within 
the reliable improvement category for the RPS and AS subscales, with the uncertain change 
category holding the highest prevalence for the PPO and NPO subscales. The reliable 
deterioration category consistently held the lowest frequency across the subscales.  
 
Differences in reliable change categories (deterioration and uncertain change versus 
improvement) in moderate and high PCL-R groups were tested using the chi-square test for 
association (or Fisher’s Exact test, as appropriate) in the 2x2 contingency table. The chi-square 
test was not statistically significant for each of the subscales; PPO (p = .07), NPO (p = .63), RPS 
(p = .35), ICS (p = .75) and AS (p = .16). Similarly, for the remaining psychometric scales and 
component subscales, there was a consistent pattern of non-statistically-significant differences 
between the reliable change categories and psychopathy groups (Chi-square outcomes are 
presented in appendix 7).  
 
Barratt Impulsiveness Scale (BIS): The results of the MANOVA (presented in Table 5) 
indicate statistically significant treatment effects for the total BIS scores (F(2.899, 81.177) = 
24.474, p <.01), and for each of the subscales; MI (F(2.741, 76.749) = 23.347, p <.01), CI 
(F(2.934, 82.169) = 16.760, p <.01), NPI (F(4,112) = 17.183, p <.01). The scale and subscale 
scores changed in the desired direction pre- to post- treatment (decrease). For the total BIS, MI 
and CI there are statistically significant differences between assessment stages 2 and 3, and 
between pre- (stage 1) and post-treatment (stage 5). Similarly, there was a significant difference 
pre- (stage 1) and post- treatment (stage 5) for the NPI, and between assessment stages 4 and 5.  
 
As presented in Table 5, none of the participants fell within the reliable deterioration 
category for the BIS total or subscales. A higher proportion of participants fell within the reliable 
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improvement category for the BIS total and NPI subscale, with the uncertain change category 
holding the highest prevalence for the MI and CI subscales.  
 
Table 5 
Mean change between assessment stages and percentage of reliable change for study outcome measures 
  Mean change Treatment 
effect sig. 
ηp 2 
 
Reliable 
deterioration 
Uncertain 
change 
Reliable 
improvement 
 n S2–S3 S4–S5 S1–S5   n % n % n % 
SPSI-R             
PPO 32 3.5** 1.5 4.2** .00 .29 1 2.9 21 65.6 10 31.2 
NPO 32 - 5.5** -0.4 -7.6** .00 .26 1 3.1 17 53.1 14 43.7 
RPS 32 16.4** 6.8 22.6** .00 .39 3 9.3 6 18.7 23 71.8 
ICS  32 - 7.9** - 0.3 -10** .00 .36 2 6.2 15 46.8 15 46.8 
AS 32 - 3.3 - 0.2 - 5.6** .00 .27 4 12.5 9 28.1 19 59.3 
BIS  30 - 9** - 4.7 - 19.4** .00 .46 0 0 8 25.8 23 74.2 
MI 30 - 4** - 0.5 - 7** .00 .45 0 0 16 51.6 15 48.4 
CI 30 - 2.5* - 1.1 - 5.7** .00 .37 0 0 19 61.3 12 38.7 
NPI 30 - 2.4 - 3.1* - 6.8** .00 .38 0 0 11 35.5 20 64.5 
NAS  34 -7.7* -6.1 16.3** .00 .27 2 5.8 17 50.0 15 44.2 
PI  34 -7.1** -2 -12.9** .00 .21 3 8.8 15 44.1 16 47.1 
Cog 34 -3.23* -2.53 -6.8** .00 .28 1 2.9 18 52.9 15 44.1 
Aro 34 -3.41* -2.67 -7.4** .00 .28 0 0 20 58.8 14 41.1 
Beh 34 -3.06 -1.5 -7** .00 .29 0 0 19 55.8 15 44.2 
AR 34 2.2 -.02 4.2** .00 .22 0 0 24 70.6 10 29.4 
LoC 36 9.7** 0.7 8.5** .00 .41 1 2.8 20 55.5 15 41.7 
YSQ-SF             
ED 34 .5 .5 1.5 .56 .02 4 11.8 22 64.7 8 23.5 
Aba 34 -.8 -2.6 -2.5* .04 .08 5 14.7 19 55.9 10 29.4 
Mis 34 -2.4 -1.2 -4.9** .00 .18 0 0 21 61.8 13 38.2 
SI 34 -2.7 -2.3* -4.4** .00 .17 0 0 20 58.8 14 41.2 
Def 34 -.7 -1.8 -3.6** .02 .08 1 2.9 25 73.5 8 23.5 
Fa 34 -1.3 -1 -2.7* .04 .08 1 2.9 25 73.5 8 23.5 
De 34 -2.3 -3** -3.7** .00 .16 0 0 27 79.4 7 20.6 
Vu 34 -1.1 -1.3 -.9 .24 .04 2 5.9 29 85.3 3 8.8 
Enm 34 -.6 .2 .3 .57 .01 5 14.7 26 76.5 3 8.8 
Sub 34 -.9 -1.5 -2 .06 .06 0 0 28 82.4 6 17.6 
SS 34 1.4 1 2.2 .03 .08 6 17.6 27 79.4 1 2.9 
EI 34 -2.2 -1.3 -3* .02 .38 0 0 26 76.5 8 23.5 
US 34 1.4 .3 .8 .47 .02 2 5.9 30 88.2 2 5.9 
Ent 34 -1.1 -.6 -1 .33 .03 0 0 30 88.2 4 11.8 
IS 34 -2.9 -1.3 -3.6** .00 .13 0 0 27 79.4 7 20.6 
Note: ** = p <.01; * = p < .05 level 
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Novaco Anger Scale and Provocation Inventory (NAS-PI): With regard to the conducted 
MANOVA, there are statistically significant differences in the NAS total scores (F(2.772, 88.714) 
= 12.066, p <.01) and PI total scores (F(2.924, 87.711) = 8.257, p <.01) pre- to post- treatment, 
with scores changing in the desired direction (decrease). There are statistically significant 
differences pre- to post- treatment (decrease), for the following NAS-PI subscales: cognitive (F(4, 
128) = 12.641, p <.01), behavioural (F(2.901, 92.823) = 13.539, p <.01) and anger (F(2.372, 
75.912) = 9.494, p <.01).  Similarly, a significant difference was found on the arousal subscale 
(F(2.746, 871) = 12.644, p <.01), with scores increasing pre to post-treatment (desired direction). 
For the NAS total, PI total and each subscale there were statistically significant differences pre- 
(stage 1) and post- (stage 5) treatment (p < .01).  Between assessment stage 2 and 3, there were 
significant differences within the Cog (p < .05) and Aro (p <.05) subscales and within the NAS 
total (p <.05) and PI total (p <.01) for the full smaple. There were no significant differences 
between assessment stages 4 and 5 for the total and subscales. There was no significant main 
effect of psychopathy group or interaction between treatment and psychopathy group for any of 
these analyses.  
 
With regard to the RCI categories for the NAS-PI, other than for the AR subscale 
whereby a higher proportion of the sample fell within the uncertain change category, for the NAS 
and PI total and remaining component subscales the sample fell comparably between the 
uncertain change and reliable change categories.  
 
Locus of Control (LoC): The LoC total score improved during treatment for both 
moderate and high psychopathy groups (main effect of treatment F(2.837, 96.442) = 23.787, p < 
.01) with a significant increase in scale scores pre- (stage 1) to post- treatment (stage 5) treatment 
(p < .01), and between stages 2 and 3 (p < .01). As shown in Table 5, whilst a higher proportion 
of the sample fell within the uncertain change category for the LoC scale total, the difference was 
marginal with a slightly smaller proportion of the sample falling within the reliable change 
category for this scale.  
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Young Schema Questionnaire—Short Form (YSQ-SF): There was a statistically 
significant main effect of treatment for eight of the subscales, including  abandonment: F(2.9, 
93.7) = 2.8, p < .05, mistrust: F(2.9, 95.4) = 7.1, p < .01, social isolation: F(2.5, 80.3) = 6.7, p < 
.01, defectiveness: F(3.3, 107.8) = 3.1, p < .05, failure: F(2.6, 85.9) = 2.7,  p < .05; dependence: 
F(3.2, 104.2) = 6.5, p < .01, entitlement  F(2.5, 80.3) = 6.7, p < .01  and insufficient self-control 
F(3.3, 107.8) = 3.1, p < .05. For these scales, a statistically significant difference was observed 
between assessment stage 1 and 5, with scale scores decreasing as expected.  In addition, for 
subscales social isolation (p <.01) and dependence (p < .05), statistically significant differences 
between stages 4 and 5 were observed.   
 
The RCI analysis for the YSQ-SF illustrates that the unreliable change category holds 
the lowest prevalence across the subscales. Whilst a higher proportion of the treatment completers 
consistently fall within the uncertain change category, there was a variable proportion (between 
8.8 and 41.2% across subscales) within the reliable change category.   
 
 
Discussion 
 
Treatment evaluation studies for psychopathic offenders have largely relied on dynamic 
risk assessment total change and recidivism as indicators of programme effectiveness. This is 
important, but underestimates the clinical change process and, therefore, restricts clinical 
understanding of the change in underlying psychological processes as a result of treatment for 
this unique high-risk group of offenders.  This study sought to evaluate the effectiveness of the 
Chromis programme, an intervention designed to address the risk of violence for psychopathic 
offenders. A crucial preceding aim was to evaluate the psychometric properties of the scales used 
for this study for psychopathic offenders. Moderate support exists for their reliability and 
construct validity, justifying the clinical application of these psychometric scales to psychopathic 
offenders. The study evaluated empirically supported treatment need areas that have been 
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associated with aggression for psychopathic offenders. The findings provide evidence of positive 
improvements within treatment need areas that have received limited prior evaluation in the 
context of psychopathic offenders. The study provides valuable evidence to demonstrate the 
clinical effectiveness of the Chromis programme and perhaps of the wider therapeutic 
environment of the PDTS.19  The individual-level analysis explored individual change, providing 
further support for the notion that individual variability within psychopaths is masked in group-
level analyses.  The patterns of individual change within the sample of psychopathic offenders 
were mostly consistent across the outcomes, with a proportion demonstrating reliable change. 
The findings collectively demonstrate that psychopathic offenders are treatable, and strengthen 
the evidence base for reducing the uncertainty within the field of psychology on this point. 
 
PCL-R total and factor score differences and associations with treatment attrition 
The overall attrition rate of 41% for the smaple of this study is high, albeit comparable 
to a median non-completion rate of 46% observed within the systematic review in this thesis that 
appraised existing empirical studies to explicitly explore the relationship between psychopathy 
and treatment non-completion (Johnson et al., 2019). Nonetheless, the rate of non-completion can 
be considered substantial and not only reflects the unique challenges of working therapeutically 
with this high-risk group of offenders but suggests the potential for wider adverse consequences 
on service cost-efficiency, therapist morale and in-group treatment, and other clients (McMurran 
et al., 2010). 
 
The observed non-significant difference in PCL-R total and factor scores between 
treatment non-completers and completers is in contrast to previous findings (Dickie, 2003; 
Hildebrand & de Ruiter, 2012; Jeandarme et al., 2017; Langevin, 2006; Olver, 2003; Olver & 
Wong, 2009; 2011) whereby PCL-R scores were found to be significantly higher within each of 
                                                 
19 It is important to remember that individuals did not just take part in Chromis while on Westgate, and so findings may, in part, reflect 
the impact of the Westgate regime. Given that Westgate works using the same core principles and model of change as Chromis, it can 
be hypothesised that the study’s results provide positive evidence of the impact of working in this way with offenders with high levels 
of psychopathic traits. 
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the studies’ treatment non-completer cohorts. Furthermore, the non-significant association 
between PCL-R total and factor scores with treatment completion status is also dissimilar to 
previous findings that have demonstrated strong relationships between psychopathy and attrition 
(e.g., Jeandarme et al., 2017; Olver, 2003; Olver & Wong, 2011; Sewall & Olver, 2018).  
 
The present study’s findings are unsurprising taking into account previous findings where 
PCL-R total score was not found to be predictive of treatment non-completion within the same 
sample used in this study (Bennett, 2015). Whilst the present study extends these findings by 
exploring the relevance of PCL-R factors (not explored within Bennet’s 2015 study), it is 
pertinent that despite a modest sample size of 94 (41 treatment completers and 53 treatment non-
completers), the limited variance within the PCL-R total scores (treatment completers’ mean 
PCL-R = 29 (SD = 4.2) and non-completers’ mean PCL-R = 29.7 (SD=5)) may have influenced 
the finding of non-significance. More specifically, the sample was too uniform on the PCL-R 
measure to allow for a difference to be detected between treatment non-completers and 
completers. Therefore, a conclusion based on the study’s findings with regard to the association 
between psychopathy and treatment non-completion cannot be reliably defined.  
 
Psychometric evaluation 
The results provide moderate support for the theoretically derived measures: SPSI-R, 
BIS, NAS-PI, adopted LoC and YSQ-SF scales with a population of psychopathic offenders.  The 
scales and component subscales showed acceptable reliability in terms of their alpha coefficients 
and intra-scale correlations. The analysis demonstrated that each measure total had good or 
excellent internal consistency, with a similar pattern of results observed for each of the component 
subscales (other than the BIS subscale NPI where questionable internal consistency was 
observed). These reliabilities are comparable to those generated with varying forensic samples 
for the SPSI-R (Wakeling, 2007), BIS (Carrillo-de-la-Pena, Otero & Romero, 1993; Patton et al., 
1995), NAS-PI (Cunningham (2011)), adapted LoC (Huntley, Palmer & Wakeling, 2012) and 
YSQ-SF (Waller et al., 2001; Welburn et al., 2002). The intra-scale correlation analysis of each 
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psychometric scale demonstrated a pattern of statistically significant relationships, with moderate 
and high relationships observed across the measures, with the exception of the YSQ-SF where a 
pattern of weak correlations was observed within the subscales self-sacrifice and unrelenting 
standards.  
 
The data supported the convergent validity of each of the outcome measures showing 
expected associations between the measures of social problem solving, anger, locus of control 
and impulsivity.  These measures were also found to be associated with maladaptive schemas that 
are similar in construct. These findings extend upon previous research that has found similar 
relationships between these constructs with varying forensic populations (e.g. D’Zurilla & Nezu, 
1990; Fives et al., 2011; Huntley et al., 2012; Wakeling, 2007).  
 
The strongest associations were between impulsivity and experiences of anger, indicating 
that increased impulse control was significantly associated with improved management of anger, 
which supports the theoretical perspective that behavioural approach sensitivity is positively 
related to personality traits of anger (Barratt, 1991; Harmon-Jones & Siglman, 2001). A 
significant positive correlation was found between impulsivity and locus of control, which 
theoretically, are similar in construct (Fisher, Beech & Browne, 1998; Mazur, Wolchik & 
Sandler, 1992). More specifically, impulsive behaviour is determined by immediate extrinsic 
motivators. Thus, individuals who have poor impulse control are likely to perceive their 
behaviour as being determined by external environmental forces, which is congruent with an 
external locus of control (Fisher et al., 1998; Mazur et al., 1992). 
 
It was also found that locus of control and social problem solving had high convergent 
validity demonstrating that a more internal locus of control is linked to more effective problem 
solving. These results provide support for the suggestion that there is overlap between these 
cognitive constructs (D’Zurilla & Nezu, 1990; Huntley et al., 2012; Judge et al., 2002), although 
it is not known theoretically why and how these constructs are linked or whether a ‘higher order’ 
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construct may underpin the associations (Judge et al., 2002). Further research would benefit from 
conceptualising and further exploring the links between these constructs within psychopathic 
offenders.   
 
The findings with regard to the YSQ-SF were consistent with social-cognitive theories 
of aggression and the theory of Early Maladaptive Schemas (EMS) asserted by Young et al., 
(2003), in that the EMS domains disconnection and rejection and impaired limits were related to 
various indicators of anger within the NAS-PI. Disconnection and rejection is often characterised 
by fear of abuse and abandonment, which can result in feelings of anger as a maladaptive coping 
strategy (Young et al., 2003). Furthermore, the impaired limits domain is in part characterised by 
impulsivity, an empirically supported factor related to anger (Stuart & Holtzworth-Munroe, 
2005). These findings extend upon previous research that observed similar results with varying 
offender samples (Kachadourian et al., 2013; Shorey, Elmquist, Anderson & Stuart, 2015; 
Tremblay & Dozois, 2009). Furthermore, problem solving was also associated with the schemas 
(other than positive problem orientation and rational problem orientation), demonstrating that a 
higher presence of maladaptive schemas is linked to the adoption of dysfunctional coping 
(Bernstein, Arntz & de Vos, 2007; Young, Klosko & Weishaar, 2003). The finding that the 
schemas ‘insufficient self-control’ and ‘emotion inhibition’ were significantly related to 
impulsivity is cogent given the similarities in construct (Chakhssi et al., 2012).  
 
However, convergent validity was not consistently demonstrated with the YSQ-SF.  The 
subscale self-sacrifice (measuring a desire to meet other’s needs) was unrelated to the BIS and 
NAS-PI subscales, unrelenting standards (measuring a need to meet high standards of behaviour) 
with NAS-PI totals and two subscales (behaviour and anger regulation), and LoC, enmeshment 
(excessive emotional involvement and closeness with a significant other) and NAS-PI total and 
subscales. Whilst this may suggest problems with the YSQ-SF’s convergent validity, on closer 
inspection, it appears that the scales are measuring characteristics that may not be directly related 
to the assessed schemas and thus a non-significant association would be expected. This is not 
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consistent across all subscales, for example, an association between unrelenting standards 
(measuring a need to meet high standards of behaviour) and locus of control would be expected. 
More specifically, a need to meet high standards are reflective of behaviour that is determined by 
taking responsibility and acceptance, which are congruent with an internal locus of control.  
Further exploration of the convergent validity of the YSQ-SF scale is desirable, with a possible a 
benefit of exploring the association between the scale and PCL-R traits.  
  
Overall, taken together there is moderate support for the reliability and construct validity 
for the psychometric scales. Whilst the evidence is less consistent for the YSQ-SF and there is a 
need for further examination of the psychiatric properties of this scale, there seems to be 
encouraging evidence to support the clinical application of the evaluated assessment measures to 
psychopathic offenders to provide a meaningful assessment of treatment need.   
  
Treatment change at group level 
The study findings revealed that treatment was generally effective at mitigating anger 
and the related treatment need areas for psychopathic offenders. The finding that psychopathy 
level did not moderate the effect of treatment across psychometric scores may contrast with some 
previous findings (Hughes et al., 1997, Ogloff et al., 1990; Olver et al., 2013) but is consistent 
with studies that have observed that psychopathy trait level has a limited impact on treatment 
gain (Chakhssi et al., 2010; Hildebrand & de Ruiter, 2012; Mullan et al., 2017).  
 
In interpreting these findings, it is crucial to concede that the observed significant 
difference in PCL-R scores between the high and moderate PCL-R groups may not be an accurate 
outcome when taking into account standard errors of measurement for the PCL-R, namely, + or 
– 2 (Hare, 2003). Thus, given the limited variation in PCL-R scores across the treatment 
completer sample, it is probable that when standard error of measurement is considered, a 
proportion of the sample would overlap with the other PCL-R group, thus rendering the PCL-R 
grouping used within this study as fallacious.  Therefore, whilst it may be a plausible conclusion 
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that treatment effect is not moderated by psychopathy score level (providing support to previous 
research that has reached similar conclusions) it is prudent to accept in the interpretation of the 
present study’s findings that the variation in PCL-R scores between the moderate and high 
psychopathy groups may have been insufficient to meaningfully evaluate a group effect.  
 
The repeated-measures analysis suggests that psychopaths are responsive to treatment 
with a pattern of significant change across the measures in the expected direction. It was found 
that treatment impacted positively on social problem solving, with a positive impact on the varied 
modalities, including problem-solving styles and positive/negative orientations. These findings 
extend upon limited existing empirical findings, whereby treatment (Reasoning and 
Rehabilitation programme) has been found to have a positive effect on social problem solving in 
psychopathic and mentally disordered offenders (Clarke et al., 2010; Cullen, et al., 2011; Young 
et al., 2013). A consistent finding across these studies is that treatment did not lead to a significant 
change in all problem solving modalities, specifically negative and maladaptive orientations. 
Thus, the present study’s findings suggest that treatment can have an impact upon the varied 
modalities of problem solving for psychopathic offenders, with Chromis treatment having a 
positive impact on both positive and negative problem solving orientations.  Based on a 
theoretical perspective, it is suggested that the Chromis programme helps develop a cognitive and 
emotional approach to problem solving as a means of addressing coping deficits and enhancing 
self-efficacy (McMurran, 2008). Furthermore, it is pertinent to acknowledge empirical findings 
that suggest a reduction in maladaptive coping strategies in offenders can reduce psychological 
and behavioural difficulties, and support a reduction in offending because of improved self-
control (D’Zurilla, 1986, 1990; D’Zurilla & Maydeu-Olivares, 1995; Gottfredson & Hirschi, 
1990; Heppner & Hillerbrand, 1991).  
 
The present study found that the arousal and behavioural domains of anger, alongside 
motor, cognitive and behavioural impulse control significantly improved because of treatment. 
Thus, the positive changes in impulse control, coercion and anger regulation could be seen as 
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positive indicators of Chromis’ potential for reducing violence (Howells, 2004).  These findings 
are consistent with a sample of personality disordered offenders, including a small sample of 
psychopathic offenders (Doyle et al., 2016) and extends upon an earlier evaluation of the Chromis 
programme (Tew et al., 2012), whereby five offenders demonstrated improvements in self-
reported anger (as measured by the NAS-PI). Thus, the present study’s findings are prominent 
and demonstrate that the core treatment need areas that are strongly related with the antisocial 
features of psychopathy (Blair, 2010; Hare, 1991) are amenable to change. Whilst the study did 
not evaluate psychopathy trait change, and thus a behavioural outcome cannot be concluded, the 
findings are promising.  Furthermore, these are important findings given that these measures 
(Gordon & Egan, 2009) have been shown to predict recidivism (Monahan et al., 2001; Novaco, 
2011). 
   
The adapted LoC measure was sensitive to treatment change, with significant 
improvement observed. To the best of our knowledge, no earlier study has examined the effect 
of treatment in addressing deficits in locus of control within psychopathic offenders, a somewhat 
surprising observation, taking into account empirical findings that suggest locus of control as an 
important factor affecting treatment outcome for offenders, with greater levels of external locus 
of control impeding upon taking responsibility and treatment engagement (Dekel, Bebenishty & 
Amram, 2004; Fisher et al., 1998; Page & Scalora, 2004). In view of blame externalisation being 
a relatable feature of psychopathy, it is encouraging that there was a significant shift in treatment 
within the sample to a more internal locus of control. This provides evidence to suggest that 
psychopathic offenders are able to modify their passive thinking and displacement of 
responsibility to feel more empowered to take responsibility for events and outcomes.  These 
findings also provide support for the use of the LoC measure in clinical work to assess the changes 
in locus of control orientation following treatment. 
 
With regard to clinical change in maladaptive schemas, it was found that eight out of 15 
YSQ-SF maladaptive schemas improved significantly across treatment. In contrast to the schemas 
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social isolation and dependence, for which statistically significant differences pre- to post- 
Enabling Change were observed, the remaining six schemas demonstrated significant 
improvement over the whole treatment programme, rather than specific components of Chromis 
(no statistically significant differences pre- to post- Cognitive Skills or Enabling Change). This 
may suggest that the treatment modality in itself (the Chromis programme in its entirety) 
contributed to the clinical improvements in maladaptive schemas. The Chromis programme 
focuses on the deepest levels of cognition as a means of addressing treatment need (Young et al., 
2003) and whilst a treatment aim of the Enabling Change component is to address maladaptive 
schemas, it is pertinent that neither Chromis nor its subsequent components provide an integrative 
model of treatment that has been empirically supported to address maladaptive schemas directly 
(Young et al., 2003). In other words, the Chromis programme does not include a treatment model 
such as schema-focused therapy that has been found to be effective with complex offenders 
(Chakhssi et al, 2014; Young et al., 2003).    
 
Chromis may have had a positive effect in terms of addressing some of the evaluated 
schemas, however, wider factors operating within the group setting or wider treatment services 
may have had an additive effect to treatment at a group-process level (Simpson et al., 2010). For 
instance, the unique social component and treatment ethos facilitated by the treatment service 
may have directly challenged or provided a process of normalising or de-shaming schemas, thus 
supporting a process of change outside of the treatment context (Farrell, Shaw & Webber, 2009; 
Simpson et al., 2010). This is a plausible hypothesis, nevertheless it provides restricted insight 
into the variation of clinical change across the evaluated maladaptive schemas. Whilst definite 
conclusions cannot be drawn, the study’s results provide evidence to suggest that psychopathic 
offenders are able to make changes to some maladaptive schemas that were previously thought 
to be impervious to change (Ball, 2007; Young et al., 2003). The study therefore extends previous 
findings that such changes were not observed (Doyle et al., 2016). 
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Whilst statistically significant improvement as an effect of overall treatment was 
observed in the evaluated treatment need areas, given the pattern of results, it is apparent that 
significant change within the treatment need areas of anger, impulse control, problem solving, 
and locus of control can be attributed to the Cognitive Skills component. Taking into 
consideration that an integral aim of the Cognitive Skills component is to address the 
aforementioned treatment need areas, this is an encouraging finding relating to the component’s 
effectiveness. Furthermore, it provides support to current theoretical understanding that 
psychopathic offenders can benefit from appropriately targeted and designed interventions (Olver 
& Wong, 2009; Reid et al., 2013). Indeed, the Cognitive Skills component and Chromis utilise a 
cognitive behavioural approach treatment designed to address criminogenic needs (treatment 
needs) while providing treatment that is individualised and structured and responsive to the 
personality traits of offenders (Andrews & Bonta, 2003; 2010; Andrews et al., 2011). 
 
The pattern of results relating to the Enabling Change component, more specifically a 
pattern of non-significant change across the aforementioned outcomes, could suggest that this 
component does not focus sufficiently on addressing the evaluated treatment need areas for 
psychopathic offenders. Whilst a plausible hypothesis given the present study’s findings, it is 
prudent to acknowledge that the results are surprising considering the treatment modality of the 
Enabling Change component and the empirical evidence in support of a formulation-based 
cognitive behavioural approach to treatment when working with violent and forensic populations 
(McGuire, 1995; Wong & Gordon, 2006). When interpreting these findings, it is crucial to 
acknowledge that the Enabling Change component of treatment could have helped maintain 
treatment gain or indeed alternative treatment gain that has otherwise not been evaluated within 
this study. An alternative hypothesis could be that following the completion of the Cognitive 
Skills component, no further gain for the specific treatment need areas is possible for this unique 
offender population, that is to say that the Cognitive Skills component provides a sufficient 
intensity of treatment. Whilst a tentative conclusion worthy of further exploration, it is necessary 
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to acknowledge Olver and Wong’s (2013) view that unsuccessful treatment programmes for 
psychopathic offenders are those that ‘over-treat’, that is, those that provide a higher intensity or 
dosage of treatment than those that have demonstrated more positive outcomes. This is an 
argument deeply rooted in the risk, need and responsivity principles of effective treatment models 
(RNR) (Andrews & Bonta, 2003; 2010; Andrews et al., 2011).  
 
Treatment change at the individual level 
Although group-based change analyses are relevant and provide evidence of the overall 
efficacy of a programme achieving its objectives, individual-level results highlight how analyses 
of reliable and clinically significant change may offer useful information regarding individual 
offenders’ progress in treatment. In line with the group analysis, there were no statistically 
significant differences between psychopathy groups (moderate and high psychopathy) in the 
reliable change categories (deterioration and uncertain change versus improvement). In contrast 
to clinical lore, treatment in this study did not make psychopaths worse, a finding that is in line 
with previous outcomes (Chakhssi et al., 2010).  A substantial percentage of the sample 
demonstrated statistically reliable reductions in their experienced anger and related treatment 
need areas: social problem solving, impulsivity and locus of control. More specifically, 
approximately two-thirds of psychopaths showed reliable change in their impulsive behaviour 
and rational problem solving, with a further pattern of results demonstrating over one third of the 
sample indicating reliable change across varying scales.  In line with the group analysis for the 
YSQ-SF, a more varied pattern of results was observed, and whilst the uncertain change category 
was consistently the most prevalent across the subscales, over one third of psychopaths 
demonstrated reliable change in the evaluated schemas of mistrust and social isolation.   
 
For a small group within the sample, across the psychometric scales the outcomes 
deteriorated. This may suggest that psychological treatments for a small sample of psychopathic 
offenders, may cause harm.  Whilst further exploration into this specific sample is warranted, 
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based on previous findings it is conceivable that the sample included heighted interpersonal and 
affective facet scores, which have been related to reduced engagement and treatment gains 
(Hobson et al., 2000). The present study found no significant association between reliable change 
categories (deterioration and uncertain change versus improvement) and PCL-R groups and thus 
creates a level of uncertainty regarding the influence of interpersonal and affective traits in 
relation to clinical change. Further exploration with regard to the relevance of facet scores would 
be advantageous.  It is also plausible that for those who deteriorated, under- or over- reported on 
the psychometric scales at baseline, and for cases where rapport with clinicians developed or 
insight increased, participants’ post-psychometric scores gave a more accurate representation of 
their problems, which resulted in an increase (or decrease) in scores. To differentiate the various 
reasons for score deterioration, further evaluation is needed to verify findings such as behavioural 
evaluation of dynamic risk and treatment need.  
 
Overall, the findings demonstrate that within a group of psychopaths, treatment 
responsiveness varies and underlines the notion that individual variability within psychopaths is 
underestimated in group-level analyses. Further evaluation studies using this method, alongside 
an exploration of the personality pathology of those able to make reliable change versus those 
who deteriorated or remain unchanged is needed to strengthen clinical insight.  
 
Methodological limitations and clinical implications 
The findings of the current study must be considered in light of potential limitations. 
Firstly, the small sample size, which was restricted by the available data set, raises a level of 
concern regarding the robustness of the study’s findings. However other than for the YSQ-SF 
scale where a pattern of low to high effect sizes was observed, the remaining scales showed good 
effect sizes within the main analysis of this study (repeated-measures MANOVA). Furthermore, 
the completion of the individual analysis, which confirmed and enhanced the findings of the 
group analysis, to some extent reduces concerns regarding the reliability of findings, however it 
is important to acknowledge that the small sample size limited statistical strength and therefore 
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potentially obscured significant differences. It is therefore crucial that the presented findings are 
interpreted with caution.  
 
It is also critical to acknowledge the underlying challenges of conducting treatment 
efficacy studies with this unique offender population, most notably the restriction on using 
rigorous methodology. The gold standard for the evaluation of offending behaviour programmes 
is considered to be randomised control trials (RCT) or quasi-experimental designs (Harper & 
Chitty, 2005) with long-term evaluations of recidivism. Owing to ethical and operational 
constraints, the present investigation is not a controlled study of treatment efficacy, and this is an 
inherent methodological limitation of forensic outcome studies. This methodological limitation 
indicates that the observed clinical change within the study’s outcomes could be due to natural 
changes in the participants over time or to test practice effects, rather than to effect of treatment 
(Nunes, Babchishin & Cortoni, 2011). To some extent the incorporation of individual-level 
analysis ameliorated this concern as the RCI allows for control over the possibility that observed 
changes are due to measurement error. Nevertheless, extraneous factors influencing change 
cannot be fully discounted.  It is also pertinent to acknowledge that the Chromis programme is 
implemented within a wider treatment unit, therefore the observed positive treatment change may 
be considered reflective of the impact of the Westgate regime as a whole. Given that Westgate 
works to the same core principles and model of change as Chromis, this is positive evidence of 
the impact of work with offenders with high levels of psychopathic traits in this way. 
 
Another limitation of the current study is that the measurement of treatment outcomes 
was solely based on responses to self-reported measures. This assessment approach is subjective 
and may be biased by the effects of social desirability (Ones, Viswesvaran & Reiss, 1996), which 
given the nature of traits associated with psychopathy, could be heightened. In addition, factors 
influencing psychometric scores, including motivation, concentration or mental state, mean that 
there are difficulties in assessing change through self-reported measures (Gudjonsson & Haward, 
1998). Also, it should be acknowledged that a positive change in psychometric score post-
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treatment may be reflective of increased insight, rather than a fundamental change in the 
dimension observed. Whilst the study findings in part emulate those of Tew et al., (2012), for 
more reliable accounts of treatment change, future research should harness more robust 
evaluation methods and corroborate treatment effects observed through self-reporting with more 
objective and subjective measures of change, including behavioural analysis.  Furthermore, the 
range of measures used within this study is limited to an evaluation of cognitive domains with no 
assessment of change with regard to the full spectrum of personality psychopathological issues.  
To this end, we do not know to what extent inferences based on clinical change within cognitive 
domains correspond to changes in underlying personality constructs such as trait impulsivity.   
 
Finally, the present study provides short-term evaluation of change in psychological 
outcomes, therefore maintenance of treatment gain in the longer term remains unknown. This 
concern is heightened within the population of interest as skill retention diminishes more for high-
scoring psychopathic offenders (Blud et al., 2003). Research with longer evaluation periods 
should be conducted to observe any possible attenuation of programme effect across time. Other 
outcomes such as recidivism should also be measured to provide evidence of long-term treatment 
effectiveness (behavioural change), and to explore the mediating effects of psychological risk 
factors on recidivism as a result of treatment.  With this, it is important to highlight that due to 
the limited number of men who have progressed from the Westgate PDTS unit into the 
community, it is not possible to examine reoffending as a behavioural outcome at this juncture. 
 
Although these limitations do apply, and further research is needed, it is encouraging that 
this study has found positive improvements in treatment areas because of the Chromis 
programme. This provides exploratory evidence to suggest that the Chromis programme is a 
valuable treatment component within the PDTS treatment framework. Nevertheless, it may prove 
beneficial for programme developers to review the treatment modalities and treatment targets in 
light of the study’s findings or reconsider the intensity and length of treatment provided. 
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The findings of the study provide important evidence in relation to the treatment 
responsiveness of psychopathic offenders.  The group-level evaluation provided evidence of 
positive improvements across the studied outcomes, thus providing insight into psychopathic 
offenders’ abilities to make clinical change across treatment need factors related to aggression. 
The individual-level analysis provided valuable information about the variability of change, 
whilst providing meaningful clinical evidence in support of treatment effectiveness. Taken 
together, the study findings and as well as those of some previous studies (Chakhssi et al., 2010; 
Olver et al., 2013; Looman et al., 2005; Olver & Wong, 2009; Skeem et al., 2002), suggest that 
psychopathic offenders are treatable, and strengthen the evidence base to diminish the harboured 
uncertainty within this field. These important advances in our understanding are positive and used 
constructively, could enhance clinical practice. Whilst psychopaths do show higher rates of 
recidivism than other forensic populations (Olver & Wong, 2006; Salekin, 2008; Serin & Amos, 
1995), this does not imply that they are untreatable. Rather, it accentuates the importance of 
understanding the heterogenous population and the psychological processes for addressing the 
treatment needs of this unique population of offenders. Such research is critical in evaluating 
treatment programmes and the variables that contribute to processes underpinning offender 
change. In addition, further efforts in understanding psychopathic offenders in terms of their 
functional differences are crucial to aid clinical decision making and treatment efforts. There is a 
clinical importance to being able to identify those able to benefit from forensic treatment, and 
those who deteriorate or remain unchanged. 
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Chapter Four: Discussion and Conclusion 
 
The first chapter of this thesis established context by providing a review of the relevant 
literature relating to the characterisation, assessment and treatment of psychopathic offenders. 
Evidence supporting the psychometric properties of the PCL-R (Hare, 1991; 2003) was set out 
(e.g. Harris et al., 2013; Ismail & Looman, 2016; Kiehl & Hoffman, 2011), alongside evidence 
that casts some doubt on the clinical accuracy of the tool (e.g. Jeandarme et al., 2017; Murrie et 
al., 2012).  In addition to considering the value of PCL-R assessment within clinical practice, the 
review appropriately acknowledged ongoing debates regarding the structure and nature of the 
PCL’s conceptualisation of psychopathy. The most significant of these concerned the variability 
between individuals with high levels of psychopathic traits as measured by the PCL-R, which 
emphasised the heterogeneity of this unique offender population (Brinkley et al., 2004).  
 
In considering the empirical and clinical understanding of treatments for psychopathic 
offenders, evidence highlighting the unique challenges of working therapeutically with 
psychopathic offenders and the wider impact this poses was examined together with empirical 
evidence that postulated that psychopathy is related to treatment attrition. The review of the 
literature on the effectiveness of treatment for psychopathic offenders included a critical analysis 
of empirical studies. The analysis showed that whilst more recent studies have employed variable 
methods to evaluate treatment effectiveness and have provided more positive outcomes, the 
robustness of these studies remains limited by methodological weaknesses that diminish the 
strength of findings. The analysis showed that existing literature on the treatment of psychopathy 
provides an inadequate basis for drawing firm conclusions, a result that emphasises the 
importance of further empirical study for advancing clinical understanding.   
 
After the review of the available empirical evidence, the following overarching research 
questions were posed as the basis for this thesis:   
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• To what extent is the construct of psychopathy associated with treatment non-
completion, and how does this relate to risk? 
• To what extent is the Chromis programme effective in producing significant and 
reliable changes in treatment need areas related to violence for individual 
psychopathic offenders?    
This chapter summarises the research described in the thesis and the most salient findings 
relating to the overarching research questions. It also explores the results of the systematic review 
on treatment non-completion among psychopathic offenders (Chapter 2) and the empirical study 
on the effectiveness of the Chromis programme (Chapter 3), with emphasis on advances in 
clinical understanding and on practice implications. Whilst the limitations relating to each study 
have been highlighted in the respective chapters, this section will note the limitations that should 
be kept in mind when considering each overarching research question.   
 
 
Treatment attrition – Summary of findings, implications and limitations 
The systematic review addressed the first research question:  
 
• To what extent is the construct of psychopathy associated with treatment non-
completion, and how does this relate to risk? 
The limited existing empirical evidence suggested an association between psychopathy and 
treatment attrition (DeSorcy et al., 2016; Hobson et al., 2000; Ogloff et al., 1990; Olver et al., 
2011); however, to date, no review had been conducted specifically to explore this postulated 
association. Thus, as an important clinical objective, the systematic review (Chapter 2) 
synthesised the existing literature on psychotherapeutic treatment attrition among psychopathic 
offenders to enhance the clinical understanding of the association between psychopathy, 
treatment completion and outcome.    
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The review makes a unique contribution to the clinical understanding of treatment attrition 
among psychopathic offenders, and identifies and discusses a number of important clinical 
considerations for the treatment of psychopathic offenders as well as areas for future research. 
Furthermore, the review highlighted inconsistencies in findings across the included studies and 
important gaps in clinical understanding with regard to treatment for this unique group of 
offenders. It was argued that given the heterogeneity of psychopathic offenders, the variety of 
treatments offered, differences between the services that offer treatment and the methodological 
weaknesses of existing studies, the level of inconsistent findings observed was to some extent 
expected. Nevertheless, the findings reflected important gaps in clinical knowledge, emphasising 
the need for further robust empirical exploration.  
  
It is prudent to accept that due to the paucity of studies and the largely inconclusive findings 
across the included studies, the development of definite conclusions was not possible. On the 
basis of available evidence, it was argued that treatment attrition rates for psychopathic offenders 
are not fundamentally higher than those of other offenders and client groups. Whilst it is pertinent 
to acknowledge that psychopathic offenders are a challenging group to engage in treatment, 
clinicians should not be unduly pessimistic about the treatment adherence of offenders with 
heightened levels of psychopathic traits. It is imperative, however, that treatment for psychopathic 
offenders is purposefully designed and delivered in a manner that responds to the specific and 
unique needs of this group of offenders (Andrews & Bonta, 2003; 2010). 
 
The review identified evidence supporting an association between psychopathy (PCL-R total 
score) and treatment non-completion, which in turn does oppose the aforementioned tentative 
conclusion that attrition rates amongst psychopathic offenders are not fundamentally higher than 
those of other offenders. In further consideration of these findings, it is important to acknowledge 
that the PCL-R total score provides a global representation of the construct of psychopathy, and 
thus provides limited insight into the relationship between psychopathy and treatment non-
completion. Conversely, existing studies that explored more profoundly the construct of 
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psychopathy, in particular the PCL-R facets, with attrition, inconclusive findings were observed, 
raising a level of doubt over the true association between psychopathy and treatment non-
completion. Thus, whilst an association between psychopathy (PCL-R total) and attrition can be 
concluded as based on existing evidence, this should be considered to be a fallacious outcome. 
This emphasises the importance of clinicians to not perceive a high PCL-R total score as a likely 
contributor to treatment non-completion but to work responsively with psychopathic traits within 
treatment to enhance engagement and completion (Andrews & Bonta, 2003; 2010). It is also 
important for clinicians to take into account the heterogenous nature of psychopathic offenders 
and the significance of this to treatment outcome. It was concluded that more individualised 
analysis should be conducted of the relevance of PCL-R traits in relation to treatment engagement 
and attrition to further enhance clinical understanding and to enhance treatment approaches.   
 
Previous literature has reported the potential for treatment non-completion to be related to an 
increased risk of reoffending (McMurran & Theodosi, 2007). The current review sought to 
determine whether this applied to psychopathic offenders, given that psychopathic offenders are 
reportedly five times more likely than non-psychopathic offenders to recidivate violently (Olver 
& Wong, 2006; Salekin, 2008; Serin & Amos, 1995), and given that this already elevated risk is 
likely to increase with treatment non-completion. Two of the included studies partially supported 
the relationship between treatment non-completion and greater risk on release for violent 
recidivism in comparison to psychopathic offenders who completed treatment (Daffern et al., 
2013; Olver & Wong, 2009). However, this finding was not replicated by Sewall and Olver 
(2017) and did not prove to apply to sexual recidivism (Olver & Wong, 2009; Sewall & Olver, 
2017).  The scarcity of evidence on this point meant that definite conclusions regarding the 
relationship between treatment non-completion and risk could not be drawn. Nevertheless, the 
clinical limitations of treatment completion status as an indicator of recidivism were discussed. 
Evidence in support of using psychopathy, risk and treatment change to assess the risk of 
recidivism was discussed and deemed preferable to using treatment completion status in isolation 
to form clinical judgements on risk issues.  
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The critical appraisal of the included studies highlighted shared methodological 
weaknesses that affect the quality of the studies’ outcomes and the interpretations of those 
outcomes.  An important issue was the definition of non-completion, which varied across the 
included studies. In addition, treatment non-completion outcome was persistently recorded in a 
singular manner (i.e. client initiated versus programme initiated), and a variety of reasons for 
non-completion was left unexplored. This hinders clinical understanding into wider factors 
related to treatment non-completion for individuals with heightened levels of psychopathic traits 
and may have contributed to the negative perception that treatment non-completion for 
psychopathic offenders is related to their turbulent engagement and presented problematic 
behaviour (Hemphill & Hart, 2002; Ogloff et al., 1990), a flawed inference that negates the 
appreciation of wider motives. It is important to aid clinical practice by considering and 
differentiating between possible reasons for treatment non-completion including those that are 
negative (engagement difficulties, dislike of treatment, difficulties understanding content or a 
lack of motivation to change), positive (engaging in alternative treatment or entering education), 
practical (difficulties in accessing or attending treatment), related to other life events (relationship 
breakdown or bereavement) or related to programme-directed exclusion (poor attendance at 
sessions, rule breaking or disruptive behaviour).  Clearly, a greater appreciation of the specific 
motivations and reasons for treatment non-completion with consistency across studies is needed 
to gain more in-depth insight to support clinical practice. This in turn would enhance treatment 
provision and support treatment engagement and completion.  
 
The systematic review was initially intended to explore the influence of a wider range of 
factors on treatment non-completion among psychopathic offenders, such as service-related 
barriers to treatment completion, client motivation and perceptions (including attitudes and 
beliefs), demographic and offence characteristics and co-morbidities. However, due to the paucity 
of empirical studies exploring these factors (and specifically, treatment non-completion for 
psychopathic offenders), the aim of the current systematic review had to be refined. This reflects 
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the narrow and limited level of research into psychopathic offender attrition, a notable 
observation given empirical studies that have explored a wider range of factors and their influence 
on attrition within other offender and client groups (e.g. McMurran & Theodosi, 2007; Olver et 
al., 2011).  Whilst the sole focus upon relatively stable characteristics such as psychopathic traits 
in relation to treatment non-completion is a valuable strategy that could yield important clinical 
insight, it could contribute to a problematic approach within practice – professionals may seek 
inherent deficits in offenders to explain treatment non-completion rather than appreciating a 
wider range of factors including service and treatment delivery, demographic factors and 
motivation. It is important that professionals avoid creating an attrition profile for offenders, as 
this could shape inappropriate professional expectations and, equally importantly, offenders’ 
chances of being accepted into treatment (Bekyo & Wong, 2005; Olver et al., 2011). Thus, there 
is a need for a more comprehensive approach to determining what has an effect on the treatment 
completion and non-completion status of psychopathic offenders, with specific focus on 
individual factors, treatment and service variables.  
 
A somewhat neglected area of research to date that could yield meaningful insight is an 
exploration of psychopathic offenders’ experiences of treatment engagement and non-
completion. Such investigations may permit a more in-depth evaluation of a wider range of 
factors (e.g. factors relating to service and treatment delivery and therapists) that are likely to 
have a greater influence on treatment retention within this unique offender group. It is anticipated 
that such derived evidence could support the development of more effective approaches and 
strategies to retain psychopathic offenders in treatment, an area of practice that currently holds 
limited empirical support.  
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The effectiveness of Chromis treatment – Summary of findings, implications and 
limitations 
The fundamental purpose of effective treatment is to reduce risk and support future risk 
management to decrease the likelihood of recidivism. Despite longstanding pessimism, more 
recent evidence has established that the effectiveness of treatment can be demonstrated for this 
unique high-risk offender population when appropriately designed treatment programmes are 
implemented. Nevertheless, inherent methodological limitations remain a contentious factor in 
the interpretation of such derived empirical findings. In this context, it is critical to reemphasise 
challenges with conducting treatment efficacy studies with this unique offender population, most 
notably the restriction on using rigorous methodology. Thus, in the absence of a more robust 
methodological approach it is postulated that other methods should be employed to enhance the 
understanding of treatment effectiveness (Friendship, Falshaw & Beech, 2003; Hollin, 2008) 
particularly for those with high levels of psychopathic traits. 
 
The second research question involved exploring treatment responsivity in psychopathy, 
specifically, to what extent the Chromis programme is effective in producing significant and 
reliable changes in treatment need areas related to violence for individual psychopathic offenders.  
The overarching aim of the study (Chapter 3) was to evaluate the effectiveness of the Chromis 
programme, a purposefully designed intervention aimed at reducing violence in high-risk 
offenders whose level or combination of psychopathic traits disrupts their ability to engage in 
standard prison-based treatment.  More specifically, Chromis is delivered following 
contemporary treatment methods based on the best available evidence of what works with 
offenders more generally and with psychopathic offenders – this includes focusing treatment on 
addressing risk whilst delivering treatment that is responsive to the unique personality traits, 
emphasising motivating change, utilising a cognitive-behavioural approach and providing 
treatment that is individualised yet structured (Olver & Wong, 2009; Reidy et al., 2013).   
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In line with the main issues identified in the wider literature, the current review also 
examined whether psychopathy and treatment non-completion are associated.  The observed 
overall attrition rate of 41% for the sample used in this study was comparable to a median non-
completion rate of 46% that was found within the systematic review in this thesis. Nevertheless, 
in contrast, the study observed no significant difference or association between psychopathy and 
treatment non-completion. To some extent these findings were unsurprising taking into account 
previous findings where PCL-R total score was not found to be predictive of treatment non-
completion within the same sample as was used this study (Bennett, 2015). It is important to note 
that the study within this thesis extends these findings by exploring the relevance of the PCL-R 
factors, a topic that was not explored by the Bennett (2015) study. In the study within this thesis, 
a firm conclusion could not be reached due to the limited variance within the PCL-R total scores 
of the treatment non-completer and completer cohorts, so the study’s finding cannot be reliably 
used to demonstrate a different outcome from those presented in the systematic review. 
 
In order to pursue the overarching aim of the study, a secondary clinical data set was 
utilised to investigate the clinical effectiveness of the Chromis programme as a whole and its 
individual stages by examining change in a range of treatment need areas (problem-solving, 
anger, impulsivity, locus of control and maladaptive schemas) related to aggression and violence 
for this distinct group of offenders. Results were presented using two approaches, namely (i) 
group-level analysis to facilitate a comparison with previous literature using this standard 
methodology, and (ii) individual change analysis to investigate differential outcomes within the 
group of psychopaths as means of enhancing the strength of the study’s outcome by taking the 
notion of sample heterogeneity into account.  
 
In line with the clinical understanding that psychopathic offenders are not a homogenous 
group (Brinkley et al., 2004) and the disparity in empirical evidence regarding psychopathy score 
levels and treatment change (e.g. Chakhssi et al., 2010; Hildebrand & de Ruiter, 2012; Olver et 
al., 2013), the group-level evaluation incorporated an examination of treatment change in two 
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psychopathy groups (moderate and high PLC-R score). The study observed that psychopathy 
level did not moderate the effect of treatment, with comparable treatment gains observed across 
both moderate and high PCL-R groups.  Whilst providing valuable insight into the process of 
treatment change, taking into account identified shortcomings relating to the applied PCL-R 
grouping and restricted variation in PCL-R scores across the sample, the findings cannot be 
reliably interoperated and thus concluded.  Nonetheless, the studies’ outcomes demonstrated that 
psychopaths are responsive to treatment with a pattern of significant change across the measures 
in the expected direction. Critical analysis of the targeted treatment needs within each specific 
stage of treatment established that treatment need change in the core areas of anger, impulse 
control, problem solving and locus of control could be attributed to the Cognitive Skills 
component. These are encouraging findings given that this component of Chromis is designed to 
address these treatment need areas.   
 
With regard to clinical change in maladaptive schemas, the pattern of results 
demonstrated significant improvement for eight of the 15 schemas over the whole treatment 
programme, rather than specific components of Chromis. A statistically significant change pre- 
to post- Enabling Change component was observed for two schemas (social isolation and 
dependence). Taking into account that the Enabling Change component is designed to address 
unhelpful thinking patterns and core beliefs associated with schemas, the study’s findings in 
relation to the effectiveness of this component is concerning. Nevertheless, Chromis and its 
components do not provide an integrative model of treatment that has been empirically supported 
as addressing maladaptive schemas directly (Young et al., 2003). In other words, the Chromis 
programme does not include a treatment model such as Schema Focused Therapy that has been 
found to be effective with complex offenders (Chakhssi et al., 2014; Young, 1999; Young et al., 
2003). Thus, whilst Chromis may have had a positive effect in addressing some of the evaluated 
schemas, substantial change should not be expected and thus it appears prudent to acknowledge 
that the observed changes may equally have been a result of a wider range of factors provided by 
the PDTS.   
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The pattern of no significant change in treatment need areas across the evaluated 
outcomes pre- to post- Enabling Change was unforeseen. Whilst it may suggest that this 
component of treatment is not effective in reducing risk related treatment need areas, it is 
important to consider alternative hypotheses for this finding, notably the potential of ‘over-
treatment’, maintenance of treatment gain or addressing treatment need areas that have otherwise 
not been evaluated (Andrews et al, 2011). Thus, it would appear that further exploration is 
warranted to develop a deeper understanding of the overall effectiveness of the Enabling Change 
component of Chromis.  
 
The accompanying individual-level analysis provided valuable information about the 
variability of treatment change across a group of psychopaths, whilst providing further 
meaningful and unique clinical evidence in support of treatment effectiveness. The patterns of 
individual change were mostly consistent across the outcomes, with a prominent proportion 
demonstrating reliable change. Nevertheless, it also pertinent that an equal and at times a higher 
proportion of the sample demonstrated uncertain change across the outcome measures, and for a 
small group, the outcomes deteriorated across the psychometric scales. This may suggest that 
psychological treatments may, for a proportion of psychopathic offenders pose limited effect in 
addressing risk related treatment need areas and for some cause harm. Whilst no firm 
interpretations of these findings could be made, the findings emphasise the clinical importance 
of individual-level analysis in evaluating treatment for this unique group of offenders. It is worth 
exploring the hypothesis that (considering that the heterogeneous nature of those with high levels 
of psychopathic traits is now clinically understood) variations in personality traits, alongside other 
extraneous variables (e.g. level of motivation, sentence type and co-morbid disorders) may 
contribute to differential treatment outcomes (Donahue, McClure & Moon, 2013). It is critical to 
acknowledge that there is a need for research to be more sensitive to individual variability among 
psychopathic offenders in order to truly evaluate the effectiveness of treatment for this unique 
group of offenders.   
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Overall, it is pertinent that the evaluated outcomes of this study have received limited 
prior evaluation and thus this study offers unique evidence of psychopathic offenders’ capabilities 
for change across the measured outcomes. Furthermore, the study’s findings provide a level of 
support for the current theoretical understanding that appropriately targeted and designed 
treatment can facilitate positive change for some psychopathic offenders, with the study 
observing a proportion of sample demonstrating uncertain change and deterioration across the 
measured outcomes within the sample. Furthermore, it is imperative to reiterate that whilst the 
study provides support for the effectiveness of Chromis, treatment change across most of the 
outcome measures was attributed to the Cognitive Skills component, raising a level of doubt over 
the clinical effectiveness of Enabling Change component. On balance, the study’s findings 
provide important evidence to support the continued commissioning of Chromis for this 
population and continued investment in working with individuals with high levels of 
psychopathic traits using the approach taken by the programme.  
 
Taken together, the study findings as well as those of some previous studies (e.g., 
Chakhssi et al., 2010; Olver et al., 2013; Olver & Wong, 2009), suggest that a proportion of 
psychopathic offenders are treatable, and strengthen the evidence base to diminish the remaining 
uncertainty within this field. These important advances in our understanding are positive, and 
used constructively, could enhance clinical practice. Nevertheless, it must be acknowledged that 
the present study’s findings do not have external validity, outside of the specific service in which 
it took place, and therefore the findings cannot be generalised to other services. Furthermore, 
whilst interpreting the results, it needs to be remembered that the Chromis programme is delivered 
in a wider treatment unit, therefore the observed positive treatment change may be considered 
reflective of the impact of the Westgate PDTS regime as a whole, rather of the Chromis 
programme in particular. Nonetheless, given that Westgate works to the same core principles and 
model of change as Chromis, the study provides positive evidence of the impact of this sort of 
work with offenders with high levels of psychopathic traits.  
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The present study has made the best use of currently available data to enhance evidence 
in the evaluation of the Chromis programme, and thus has contributed to the literature about 
treatment for psychopathic offenders. This study has made some efforts to advance the robust 
empirical research and knowledge in this area. There are widely documented criticisms of 
treatment effectiveness studies with this unique group of offenders, such as methodological 
limitations including the lack of an adequate control group, treatment that is not appropriately 
designed to address risk, inept assessment or unclear conceptualisations of psychopathy (e.g. 
D’Silva et al., 2004; Harris and Rice, 2006; Reidy et al., 2013). The empirical study in this thesis 
made use of the PCL-R definition and structure of psychopathy, and the treatment targets and 
treatment model of Chromis are clear and evidence-based. These aspects are clear improvements 
on some previous work investigating the effectiveness of different treatments with this 
population. However, there are still some limitations to acknowledge – specifically, it was not 
possible to include a control group. Identifying control groups appears to be a difficulty for many 
researchers, often owing to ethical, operational and time constraints, however, some have 
conducted small-scale studies with control groups (e.g. Wong & Gordon, 2006; Wong et al., 
2012). Whilst to some extent the incorporation of individual-level analysis within this study 
ameliorates concerns regarding treatment change, without a comparative control group the study 
cannot confidently conclude that the positive outcomes observed were a result of treatment alone. 
Thus, as means of progressing empirical outcomes, future programmes and work should aim to 
identify and collect data with a suitable control group to provide a more detailed and robust 
understanding of the findings.  In light of more recent developments within the United Kingdom 
relating to the Offender Personality Disorder pathway, there may be value in exploring the 
feasibility of the identification and use of appropriate control groups from prisoners within this 
framework.  
 
It is also important to consider the limitations of conducting a treatment evaluation study 
based on treatment need change in isolation. The current approach provides meaningful insight 
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into the process of treatment change and there is existing literature that advocates risk-related 
treatment need change as being linked to a reduction in reoffending risk (Bonta et al., 1998; 
Howells, 2004; Monahan & Appelbaum, 2000; Wilson et al., 2013) and that this is still the case 
for individuals with high levels of psychopathic traits (Olver et al., 2013). Thus, whilst the 
observed treatment need changes observed within this study are positive indicators of Chromis’ 
impact in reducing violence for psychopathic offenders, it could be argued that further formal 
evaluation of Chromis’ impact on recidivism is needed to draw a firm conclusion. In this vein, it 
important to reiterate evidence presented in Chapter 1 that expressed re-offending as a coarse 
indicator of the success of treatment (Hanson, 1997). Thus, a more effective direction for 
treatment effectiveness studies could be a long-term evaluation of treatment need change, 
recidivism and an exploration of associations between these two outcomes.   
 
The current study was limited to the measurement of treatment outcomes based solely on 
responses to self-reporting measures. This assessment approach is subjective and may be biased 
by the effects of social desirability (Ones et al., 1996), which, given the nature of traits associated 
with psychopathy, could be heightened. Furthermore, the range of measures used within this 
study is limited to an evaluation of cognitive domains with no assessment of change with regard 
to the full spectrum of personality psychopathological issues. An important clinical question that 
remains unexplored within the wider literature base is, more specifically, whether treatment has 
an effect on psychopathic traits themselves. Thus, whilst cognitive and behaviour change as a 
result of treatment is now empirically supported for psychopathic offenders, it remains unclear to 
what level the core interpersonal and affective features of the disorder remain intact and how this 
may impact upon future risk. This is a potentially fertile area for future research that will enhance 
the clinical understanding of the treatment change process for psychopathic offenders.   
 
Despite the aforementioned limitations, the outcomes of this empirical study have 
provided encouraging evidence of psychopathic offenders’ capabilities for treatment need 
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change. Alongside previous evaluations (Tew et al., 2012; Tew et al., 2015), there is now 
increasing evidence in support of the treatment and management principles of Chromis.  It is 
important to recognise the need for the ongoing support and management of psychopathic 
offenders following the completion of treatment, or indeed during the process of progression from 
a distinct treatment unit such as the Westgate PDTS to a new prison environment. It would seem 
plausible to suggest that the treatment approach of Chromis is incorporated with the wider 
personality disorder pathway to support progression and continued risk management. This could 
provide increased scope for a more coordinated approach to an individual’s sentence management 
and treatment planning, allowing more of their sentence to be specifically tailored to their needs 
(Olver and Wong, 2009; Reidy et al., 2013).  
 
 
Conclusion 
Collectively, the body of work contained within this thesis has added to the evidence base 
relating to the treatment of psychopathic offenders. The conducted systematic review presented 
an opposing yet tentative conclusion that treatment attrition rates for psychopathic offenders are 
not unduly higher than for other offender groups, though it is pertinent to note that the rate of 
non-completion is substantial, and undoubtedly has adverse consequences. Capricious evidence 
in support of psychopathy as a contributing factor to treatment non-completion was presented, 
with relationships between the PCL-R and drop-out being offered with apparent clinical utility. 
This evidences the unique nature of psychopathy in relation to treatment and emphasises the 
importance of identifying the problematic traits of the disorder as responsivity factors that require 
considered treatment approaches to maintain engagement (Andrews & Bonta, 2003; 2010). Thus, 
the clinical importance of treatment being designed and delivered in a manner that is responsive 
to psychopathic unique needs was accentuated. Empirical studies that explored the relationship 
between psychopathy and treatment non-completion on the one hand, and recidivism on the other, 
produced evidence that was inconclusive, and due to the paucity of evidence, firm conclusions 
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could not be drawn. The use of treatment completion status as an indicator of recidivism in 
isolation was discussed, with the clinical importance of assessing risk change being viewed as a 
more reliable assessment for aiding clinical judgement on the predication of recidivism. Overall, 
the conducted systematic review has provided a unique contribution to the clinical understanding 
of treatment attrition for psychopathic offenders. The synthesis of available evidence has 
identified ambiguities in understanding and identified important clinical considerations for the 
treatment of psychopathic offenders. There remains a clinical need for a more in-depth 
exploration of wider factors to treatment non-completion for this unique, high-risk, high treatment 
need group of offenders – without this understanding it plausible to suggest that treatment 
approaches will remain hindered.  
 
The empirical study in this thesis provided valuable evidence to demonstrate the clinical 
effectiveness of the Chromis programme and perhaps the wider therapeutic environment of the 
PDTS. Both group- and individual-level analysis showed positive outcomes across the evaluated 
treatment need areas. The study findings add valuable evidence to the wider research base relating 
to the treatability of psychopathic offenders and despite clinical lore, the findings demonstrate 
that certain treatment aspects can facilitate a positive outcome for psychopathic offenders.  
 
In consideration of the empirical findings, it is important to acknowledge that it has taken 
considerable time to counter the view that treatment makes all offenders with high levels of 
psychopathic traits worse (Rice et al., 1992). Due to more recent empirical findings, there is now 
an established argument that the nihilism concerning the treatment of psychopathic offenders is 
unhelpful and unfounded. Fortunately, there appears to be a more consistent and constructive 
attitude prevailing in clinical practice that these individuals can be effectively engaged in 
treatment and are capable of change. Whilst an encouraging step forward, it is imperative that 
clinicians and policymakers remain aware of the limitations of the current literature and continue 
to be critically curious about treatment effectiveness for those with high levels of psychopathic 
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traits. It is important that practice does not follow inappropriate routes, as may have been the case 
previously, and thus empirical findings need to be carefully applied to aid the development of 
treatment approaches for this unique offender population. Indeed, treatment providers should 
make use of current empirical evidence and devote attention to the development of interventions 
that take into account the unique motivational strengths and deficits of psychopathic offenders. 
The case is made for the value of considering the nature of an individual’s psychopathic traits in 
order to work meaningfully with those who have high levels of these traits to address their risk 
of re-offending. Similarly, researchers should devote attention to conducting methodologically 
adequate evaluation studies as a means of enhancing clinical understanding, with a greater level 
of transparency with regard to the evaluated treatment and the outcomes. Due to the 
heterogeneous nature of those with high levels of psychopathic traits, the value of conducting 
individualised analysis to ascertain patterns of change among a group of psychopathic offenders 
is strongly advocated to enhance the applicability of research findings to practice.  
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Chapter Five: Individual Learning Plan and Reflective Report 
 
Competence Development Record 
 
Activity Date(s) RDF competence 
developed 
Publications during academic programme:   
• Bennet, A., & Johnson, D. (2017) Co-morbidity of 
personality disorder and clinical syndrome in high-
risk incarcerated offenders. Journal of Forensic 
Practice. 19(3), 207-216 
Published July 2017  
 
A1, A2, A3, D1, 
D2 
 
• Falcus, C., & Johnson, D. (2018) The violent 
accounts of men diagnosed with co -morbid anti - 
social and borderline personality disorders. 
International Journal of Offender Therapy and 
Comparative Criminology, 62 (9), 2817-2830 
Published January 
2018 
 
A1, A2, A3, D1, 
D2 
 
• Mullan, C., Johnson, D., & Tomlinson, J. (2018) 
An exploration of personality disordered 
offenders’ experiences of completing a social skills 
treatment component. Journal of Criminological 
Research Policy and Practice. 4 (3), 174 - 185   
Published 
September 2018 
 
A1, A2, A3, D1, 
D2 
 
Research publications in progress (publications written 
and awaiting full edit prior to submission):  
  
• Bennet, A., & Johnson, D. (In progress). Co-
morbidity between Clinical Disorders and 
Psychopathy within High-Risk Personality 
Disordered Prisoners.  
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
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• Heron, H., Johnson, D., & Bennet, A.  (In 
progress).  Co-occurrence of Psychopathy and 
Mental Health diagnoses within a high-risk group 
of offenders 
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
 
• Howie, T., Johnson, D., & Taylor, A. (In 
progress). Substance Related Offending Behaviour 
Programme (SROBP):  exploring male prisoner’s 
experiences of treatment and application of 
learning. 
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
 
• Howie, T., Johnson, D., & Taylor, A. (In 
progress). Violence Prevention Climate: 
relationship with the exposure to violence and 
aggression and impact on prison staff well-being.  
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
 
• Tock, G., Johnson. D., & Gibson, K. (In progress). 
Prisoners’ experiences of transition from a 
progression PIPE to a mainstream high secure 
prison environment. 
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
 
• Tock, G., Johnson. D., & Gibson, K. (In progress). 
The impact of engagement with a high security 
Personality Disorder Treatment Service on risk of 
violence.  
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
 
• Cartwright, K., & Johnson, D. (In progress) 
Perpetrators experiences of a community domestic 
violence perpetrator programme.  
Planned submission 
2019 
A1, A2, A3, D1, 
D2 
 
• Mullan, C., Johnson, D., & Tomlinson, J. (In 
progress) Evaluation of a social skills treatment 
Planned submission 
2019 
 
A1, A2, A3, D1, 
D2 
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component within a high-secure personality 
disorder treatment service.  
Conference presentations:    
• Research presentation on co-morbidity within 
personality disordered offenders and treatment 
evaluation at the British and Irish Group for the 
Study of Personality Disorder (BIGSPD).  
March 2017 
 
D2, D3 
• Research presentation on the effectiveness of 
Chromis programme for psychopathic offenders 
(thesis study (chapter 3)) at the BPD Division of 
Forensic Psychology conference.  
June 2018 
 
D2, D3 
• Presentation of current research activity and 
findings in relation to clinical practice. Newcastle 
University.  
July 2018 
 
D2, D3 
Research skill and knowledge development:    
• Self-directed learning (self-directed reading, 
research reflections and supervision).   
2017/2018 
 
A1, A2, B2, C1, 
C2, C3, D1 
• Systematic review workshop  March 2017 A1, A2 
• Teesside University research mentor meetings 
 
2017/2018 
 
B2, B3, C1, C2, 
C3, D1, D2, D3 
• HMP Frankland’s research meetings  2017/2018 A1, D1, D2, D3 
• NOMS research meeting April 2017 A1, D1, D2, D3 
• Meeting with Enterprise and Business Engagement 
lead for the School of Social Sciences, Humanities 
and Law at Teesside University.  
May 2018 
 
D1, D3 
• Psychology department research meetings – 
Newcastle University 
June 2018 onwards A1, D1, D2, D3 
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• Research funding and bid process workshop July 2018 C1, C3 
• Professional Doctorate research supervision  2016 – 2018 A1, A2, A3, B2, 
C1, C2, C3, D1 
Teaching and Supervision   
• Module Leader: Undergraduate level 5 
(Theoretical Approaches to Forensic Psychology), 
level 7 (Assessment and Treatment in Forensic 
Practice), level 8 (Advanced Independent work).   
2016/2018 
 
D1, D2, D3 
• Programme Leader: BSc (Hons) Forensic 
Psychology, MSc Forensic Psychology and 
Professional Doctorate in Psychology.  
2016/2018 
 
D1, D2, D3 
• Academic mentor to junior academic staff  2016/2018 D1, D2, D3 
• Research supervisor: UG, PG dissertations and 
thesis, and Trainee Psychologists. 
2016/2018 
 
D1, D2, D3 
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Individualised Learning Plan (summary of progress20) 
 
Vitae 
Domain 
Final 
Phase 
required 
Need identified Action to address need Summary of progress Final 
phase 
rating 
A1 (Knowledge 
base) 
2+ Systematically advance 
knowledge, which is at the 
forefront of professional 
forensic psychology 
practice.  
Strengthen theoretical and 
empirical understanding on 
literature relating to treatment 
for psychopathic offenders. 
Utilise knowledge to aid the 
development and completion 
of thesis research. 
  
At the commencement of the research process, I had a level 
of understanding of literature which was solely related to 
research studies that I had conducted but also due to my 
practice (assessment and treatment of personality disordered 
offenders).  Nevertheless, as my reading progressed, I 
became aware of broader empirical studies but also of 
methodological weakness of past and current research.  I 
utilised this understanding to aid the development of the 
proposed research studies.  The approach employed has 
allowed me to strengthen my awareness of appropriate 
sources of research.  
 
3 
                                                 
20 The summary of progress provides an overview of my competence development as a research practitioner (mapped to the Researcher Development Framework), the next subsection (Reflective Report) provides a 
more detailed account of experiences, competence development and reflections.  
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It is pertinent to acknowledge that the main research study is 
not without limitations, albeit attempts were made to 
strengthen the methodological approach to strive for robust 
findings. This has allowed me to develop a broader 
appreciation of a range of standards and methods, whilst 
encouraging me to justify chosen approaches within 
research. I encountered a number of difficulties, notably 
accessing and collating the research data. Through a 
systematic approach and with persistence the study was 
completed within a timely manner.   
 
Overall, it is my view that the study’s findings contribute to 
the wider field, pose practice implications and strengthen 
current knowledge in hope of enriching the research area.  I 
have developed a thorough understanding of the related topic 
of psychopathy and this has supported my research and 
clinical practice. Despite some self-resistance at the 
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commencement of the programme, I have developed a 
broader range of research skills and knowledge, and through 
in-depth reading have developed a sound justification for my 
research approach. This developed research skills and 
knowledge has supported my supervision of others, as I have 
been able to provide clearer guidance on appropriate 
selection of research design.   
 
A2 (Cognitive 
abilities) 
2+ Display critical 
investigation and 
evaluation of a topic from 
an advanced body of 
literature relevant to 
forensic psychology 
practice.  
Develop skills to critically 
evaluate research. Develop 
research skills in conducting 
systematic reviews.  
 
Whilst the completion of the systematic review was a 
challenging process, with a number of changes to the focus 
and aims of the review, it provided a strong learning 
experience, whereby I strengthened my skills in effectively 
critiquing and synthesising literature.  
 
I now value the importance of systematic reviews in 
synthesising current evidence. I have also learned the 
importance of proficient critical thinking to support the 
3 
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development of independent arguments. Whilst I would not 
consider myself to be proficient in critical thinking, and 
indeed this remains as an on-going area for development, I 
have developed these skills to a point whereby I consider my 
approach to be robust and able to support the development of 
sound and realistic judgements based on evidence available.   
 
I have developed my ability to monitor and evaluate my 
research progress, whilst also striving to formulate and apply 
effective solutions to a range of research problems. Whilst at 
times I have felt defeated during my research progress, I have 
reflected upon my experiences and considered options 
available to ensure that the research project remains relevant 
and meaningful. I am encouraged by my developed skills, 
and this experience has reiterated the importance of research 
planning and considering factors that could impede upon 
successful completion of research projects.  
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A3 (Creativity) 2+ Display an independent 
and original contribution 
to forensic psychology 
knowledge to inform 
professional practice.  
Develop research knowledge 
and skills to support the 
development of a robust and 
defensible study.  Ensure 
arguments are well thought-
out, rigorous and evidence 
based.  
 
At the commencement of thesis write-up, a priority was to 
ensure arguments were supported and proficiently explained. 
I have now developed my skills in writing for publication 
and whilst a positive, it initially posed difficulties for the 
thesis write-up.  I struggled to write in-depth as I was 
concerned that my approach was not adding sufficient 
evidence to the presented arguments. Reviewing other theses 
added to my apprehensions of writing in detail, and in-turn I 
questioned my capabilities. This was discussed during 
supervision and we acknowledged the word count of my 
submission, and subsequent word counts for included 
chapters. This made me realise that I did not have available 
words to write in-depth, and thus my ability to write 
succinctly became a strength of the thesis write-up. I strived 
to ensure presented arguments were well thought out, 
meaningful and evidence based.   
3 
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Throughout the research process, I have strived to consider 
unexplored or areas that lacked consistent findings to ensure 
my research outcomes were meaningful to the field and 
practice. Throughout I have developed an ability to see 
beyond immediate issues and questions to provide depth to 
my research. Whilst a strength it has also raised difficulties, 
notably developing a large research project and to some 
extent unachievable within the restricted word count of the 
Thesis. Thus, it was important for me to identify main 
aspects of the study that remained true to original research 
questions but would also provide the strongest outcomes to 
produce robust arguments.  
 
      
B1 (personal 
qualities) 
2+ Personal reflection on 
developments and lesions 
To make time to reflect on 
research experiences, identify 
Whilst reflecting on my clinical practice is an important skill 
that I have developed over many years, within the earlier 
4 
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learned through the 
completion of research.   
 
 
strengths and weaknesses in 
research skill and knowledge 
and seek ways to improve on 
performance.  
 
 
stages of this programme I realised that my reflective 
approach to research was less developed or at least I was less 
attentive to my research journey and development.  I 
acknowledged that this was driven by a need for me to 
conduct research that was within my skill set and I held 
limited ambition to develop. I have wondered whether this 
has been related to a lack of confidence or a longstanding 
belief that I will never be a true academic. Whilst academic 
working has now taken a greater priority for me, I am 
consistently mindful of the challenges related to successfully 
achieving both elements of my profession (research and 
clinical practice). I will need to find a workable balance, 
although I appreciate that this may be a challenging 
endeavour.   
 
My initial research plans for my Thesis were within my 
current skill set with no scope for development. Focusing 
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attention on the ILP, reflecting on my research practice and 
considering wider aspects of research as identified within the 
Researcher Development Framework, has developed my 
enthusiasm to strengthen my research skills. Through 
supervision my research studies have developed and thus 
through independent learning, my research skills have 
strengthened. I now have a greater passion for research and 
remain keen to inspire others, including those who I 
supervise and researchers. Moving forward with my research 
career I recognise the importance building a range of support 
structures.  Whilst striving for excellence in research, I now 
recognise the importance of reflecting upon my research 
experiences to ensure I am identifying strengths and 
weakness to aid my progression.  
 
B2 (Self-
management) 
2+ Take strategic view of 
project; prioritise, plan 
Develop a research plan to 
maintain commitment for the 
Reflecting on my research practice and engaging in 
discussions with my research supervisors allowed me to 
3 
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and demonstrate forward 
thinking to meet 
deadlines.  
 
proposed research project, to 
ensure I am managing my 
time effectively, to adhere to 
deadlines and demonstrate a 
purposeful and determined 
approach on developing 
excellence in research. 
Review research plan with 
supervisory team.  
 
recognise that my approach to research was initially 
haphazard.  Thus, I identified a need for me to develop a 
more systematic approach to research and ensure I was 
allocating sufficient time.  Developing a research project 
plan for my thesis that included important deadlines, allowed 
me to monitor my progression, prioritise tasks and to ensure 
I was committing sufficient time to the progression of my 
research.  Whilst I made every effort to adhere to the plan, at 
times this was not possible, and deadlines were not met. 
Nevertheless, I continually monitored my progression, and 
this maintained my motivation and commitment. I now 
recognise that I do have some established time management 
skills, however I need to ensure that my achievements are 
realistic and achievable, whilst maintaining a sound work-
life balance.  
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B3 (Professional 
and career 
development) 
1+ Active member of the 
wider professional 
forensic psychology 
community and develop 
links with both 
professional and academic 
communities. 
Engage with a research 
mentoring scheme and 
develop research network to 
assist in establishing research 
trajectory. Build collaborative 
relationships with a range of 
professionals with a focus of 
conducting research.  
 
My career progression has always been a salient focus in 
both elements of my profession (academic and clinical), and 
during the length of this programme I have considered 
applying for promotions and eventually applied and was 
successful in gaining a lecturing post a Newcastle 
University.  In regards to networking, I have become to 
realise the importance of developing networks and to some 
extent I have to date engaged with both research and practice 
related networks with some benefit. Nevertheless, I have not 
utilised them to full effect and I appreciate a need for me to 
establish further networks to enhance my research 
opportunities.  I have set a further objective to engage and 
contribute more actively to developed networks and form 
further external relationships.  
 
3 
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C1 (Professional 
conduct) 
1+ Adhere to ethical and legal 
requirements.  
Maintain understanding of 
ethical and legal 
requirements. Adhere to these 
requirements whilst 
conducting research.  
 
Throughout my practice and research I have adhered to 
Ethical and Legal requirements. I consider myself confident 
in working independently and conducting applied research 
whilst not compromising my integrity or the Code of Ethics 
and Conduct. In addition, through the process of supervising 
others and teaching I have gained extensive experience of 
educating and supporting others in the adherence to these 
principles. Nevertheless, I recognise the importance of 
keeping up to date with research procedures and seek 
guidance when needed.    
 
3 
C2 (Research 
management) 
 
 
 
3+ Exercise personal 
responsibility and 
autonomous decision 
making.  
 
Apply effective project 
management through the 
setting of research goals, 
intermediate milestones and 
prioritisation of activities 
Research management has been an area that I have 
continually needed to develop, specifically allocating 
sufficient time to research activity, developing robust 
research plans and prioritization of activities. I have 
struggled with this, nevertheless upon realising that my 
progress was being hindered by my haphazard approach, I 
3 
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decided to prioritise the completion of my Thesis over my 
clinical work and other research projects. Whilst 
appreciating the impact this may have on my career 
progression, it was important to consider my short 
progression over long term goals. This acceptance allowed 
me to create more time for my thesis and adhere to set goals. 
Whilst initially disappointed I did not meet the original 
submission date, I now recognise that the deadline may have 
been unrealistic.  I appreciate that research management will 
remain a difficulty for me and will be an area of on-going 
development, especially as I work towards larger research 
projects.  Underpinning this is a need for me to develop a 
balance between my academic and clinical work. Whether 
this is possible is another question and something I will need 
to continually monitor as my career progresses.  
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C3 (Finance, 
funding and 
resources) 
 
 
1+ Awareness of funding 
sources and grant 
application procedures.  
Develop awareness of key 
relevant funding sources and 
grant application procedures.  
 
Throughout the academic programme, I have paid limited 
attention to this objective and upon reflection, I believe this 
has related to a lack of confidence and available time.  
 
Since I commenced my academic role and until more 
recently I openly explained to others that I did not perceive 
myself as a “true academic”.  In others words whilst I had an 
agenda to conduct practice related research, I did not 
envisage research as being a priority, as I was mindful that 
being a practitioner was my primary drive. Nevertheless, 
throughout the time on this programme, my views have 
changed and I now have a greater appreciation and a desire 
to conduct research. With this in mind, I have recently spent 
time speaking with colleagues and I have also attended a 
workshop about income and funding opportunities. Through 
these discussions I gained an opportunity to start developing 
an understanding of funding sources, grant application 
1 
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processes, financial management and the significance of 
income generation in regards to my own career progression. 
Whilst an excellent opportunity to develop learning, I 
reflected that my lack of confidence had hindered my 
willingness to source and pursue funding opportunities.  
Whilst a level of self-doubt remains, I am now keen to 
progress with this and with appropriate mentoring I now 
realise that I do have the knowledge, skill and ability to 
source funding for research.  It is imperative that I make 
creative use of available resources and cultivate useful 
connections to support myself through this process.  
      
D1 (Working 
with others) 
 
 
1+ Team working, 
supervising and 
supporting the 
development of others.  
Develop supervisor approach 
to support development and 
autonomy within supervisees. 
Ensure advice provided is 
rationale, well thought out 
Whilst I have gained extensive experience supervising 
research for UG and PG students, and professionals I have 
for a number of years supervised based on what I thought 
was good practice rather than truly thinking about my 
students and trainee psychologists needs and what actually 
3 
 151 
and defensible. Seek feedback 
on own supervisory style. 
was “good practice”.  With this in mind, I decided to develop 
a more theoretical understanding of supervision, focusing on 
various models. This has allowed me to develop a greater 
understanding of the purpose and effective approach to 
supervision, and whilst my style is continually developing, I 
now realise that my approach needs to reflect the needs of 
those I am supervising rather than using a consistent 
approach. I perceive supervision as a means of helping 
students to build confidence and competence as they grow in 
the profession and research, in turn I also get an opportunity 
to know more about my students.  
 
Whilst I have gained experience of leading others both 
within clinical practice and academic settings (Programme 
Leadership) and have strived to coach team members, I 
remain sensitive to their needs and remain transparent in my 
approach. Overall, I have established an independent 
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personal management style and this is an element of my work 
that I am committed too. Nevertheless, within my current 
role  as a Lecturer I unfortunately do not have an opportunity 
to lead others, and whilst valuing this time with less 
responsibility, it is an element of working that I am 
beginning to miss. I have spoken with the Head of 
Department about this and we are in the process of 
considering available options for me to take a greater level 
of leadership within my role and to consider a development 
plan to strengthen my supportive approach to management.  
D2 
(Communication 
and 
dissemination) 
2+ Communication and 
dissemination of research 
findings.  
Present work to professionals 
and engage in the knowledge 
exchange activities. 
 
Continue to produce 
publishable materials and 
disseminate findings.  
During the time on this programme, I have had the 
opportunity to present at two conferences, and whilst a 
challenging learning experience, I am now developing 
confidence in communicating my research findings and 
defending my arguments to professionals. I will 
continuously seek to self-improve and explore opportunities 
3 
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to present my research nationally, and at some point 
internationally.    
 
In order to prioritise my thesis, I made the decision to reduce 
my commitment to other research projects. Whilst not an 
ideal position, I have continued to provide supervision and 
guidance to my research collaborators.  I am now in a 
position whereby I have several papers awaiting my final edit 
and submission for peer review, and this will be progressed 
once my thesis has been submitted.  Whilst in the past I was 
reluctant to publish research due to a perceived lack of 
confidence, I am now keen to work towards actively 
publishing in a variety of outlets and develop my skills to 
become a peer reviewer for publications.  
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D3 
(Engagement 
and impact) 
 
 
1+ Teaching approach to 
support students learning.  
Continually improve own 
approach and develop wider 
repertoire of teaching styles 
and techniques.  
 
Reflecting on my teaching experience I am able to recognise 
my achievements, whilst also acknowledging areas of 
development.  I have gained an extensive array of experience 
of teaching across undergraduate and postgraduate 
programmes. I pride myself on utilising a research focused 
approach to teaching whilst also incorporating examples 
from practice to strengthen the students theoretical 
understanding. My commitment to teaching was recognised 
in 2017, as I was nominated and awarded the title of ‘most 
inspirational lecturer’ at Teesside University, this was an 
excellent achievement. Nevertheless, I strive not to become 
complacent with my teaching and frequently reflect upon my 
practice. Furthermore, I seek support and guidance from 
more experienced academic staff on my teaching approach, 
and enthusiastically implement varying styles and 
techniques. I am consistently mindful that my teaching 
approach is very directive, and I am now striving to 
3 
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encourage for students to become more independent in their 
own learning.  
 
Furthermore, I am continually mindful of a need for research 
to have an impact, and whilst I have presented at two 
conferences and attended numerous research meetings to 
communicate research findings, I continue to minimise the 
potential impact of the research I do conduct. I now release 
that this is related to my confidence rather than competence, 
and it is an area of my work that I need to develop. With this 
I have scheduled to attend a work shop on “publishing your 
research for optimal visibility and maximum citation 
impact” to develop a better understanding on strategies to  
promote and improve opportunities for my published studies 
to be citied and applied to practice.  
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Reflective report 
 
 
Domain A:  Knowledge and Intellectual Abilities 
 
Start of academic programme 
 
Through my research experience I have developed skills in acquiring research literature to assist in 
developing both theoretical and empirical knowledge. I am confident in my abilities to source literature 
to aid the development of a research study, notably to ensure that the proposed aims of a study are 
empirically supported and there is a clinical need for the research outcomes. This is evidenced through 
my research practice, research publication and supervising Forensic Psychologists in Training and level 
7 and 8 students in their academic research projects.  
 
I have learned that critical evaluation of literature is an important skill and I evaluate literature in depth 
to develop a good understanding of the evidence base.  Nevertheless, as I have progressed within this 
academic programme I have come to appreciate that my approach to literature searching is not robust 
and therefore to ensure I am assessing the reliability and relevance of source material I need to develop 
my skills in conducting advanced and systematic literature searches.   
 
Throughout my research activity and practice I have demonstrated my ability to interpret and 
communicate complex information in a meaningful manner. I consider myself to be competent in the 
area of cognitive abilities, notably independent and critical thinking, developing sound and realistic 
judgement based on evidence and formulating solutions to a range of research problems. Nevertheless, 
a pertinent area of development is strengthening my skills in drawing greater meaning to research 
outcomes (theoretical concepts).  
 
I thrive on learning and acquiring new knowledge within my practice, nevertheless it is crucial that I 
acknowledge that other work commitments have infringed on the amount of time that I could commit 
to my research activity. It is imperative that I place a greater importance on my research progression. 
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Whilst able to defend my research in a written format I have to date had limited experience of defending 
research outcomes verbally.  This is related to confidence, albeit I am now actively seeking 
opportunities to present my research outcomes.  
 
Within my academic and supervisory roles, I have gained extensive experience of guiding others on 
the quality and validity of research information and data. However, I have come to realise the 
importance of research impact; at varying levels including, practice, policy development and at 
organizational level. Evaluating research outcomes is an area that I have neglected and as such is an 
aspect of my research practice that I need to give further consideration. It is important for research 
outcomes to have value and to have major contributions to understanding.  
 
Prior to the commencement of this academic programme I had developed a clear research idea with a 
methodology that I considered to be robust. Through considered reflection I acknowledged that the 
proposed idea was driven by practice rather than underpinning the design and aims of the study by 
literature, notably an empirically supported rationale. In addition, through the early stages of 
supervision I acknowledged that I was being rigid to my initial idea, specifically the research design 
and I had to challenge my underpinning thoughts. It is imperative that I am flexible and open minded, 
remain responsive to supervision and see beyond my initial research idea. Challenging my abilities in 
research will aid my competence as a research practitioner. 
 
Current RDF Phase 
A1   Knowledge Base = 1         
A2   Cognitive Abilities = 2  
A3   Creativity = 1 
 
 
Interim Review  Year 1 – April 2017 
 
Current Phase 
A1   Knowledge Base = 2  
A2   Cognitive Abilities = 2  
A3   Creativity = 2  
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Developing a thorough knowledge and understanding of the current evidence within psychopathy 
treatment has been a salient focus during this period. Based on this developed understanding I am 
confident that the proposed study will offer an original and needed contribution to the field. Through 
discussion in supervision and reflection I am now more mindful of the need to ensure that the chosen 
methodology for this study is robust and defensible to ensure the research outcomes are meaningful. At 
this stage I have observed a clear development in my approach to research as in the past I would spend 
limited time developing a comprehensive understanding of surrounding literature and would develop a 
study based on my abilities and competence, rather than being driven on a need to produce a rigorous 
study. This in turn has restricted my development and progression. With this I am now underpinning 
my decisions for the proposed study on research outcomes and impact. In addition, this thorough 
approach is allowing me to consider the relevance of my proposed study within the developing evidence 
base.  
 
In regards to the progression of the proposed study I have developed an overarching aim and have 
developed a robust empirically rationale. Despite adapting the original study design from a mixed 
method to a quantitative study, it has become clear during discussions with my supervisor team that my 
research ideas for this study remain ambitious. Thus I am now considering the aims of the proposed 
study to ensure they are realistic and manageable. This reflects my need to strive for excellence in 
research, to seek and to respond effectively to feedback.  
 
A pertinent learning need during this period was for me to develop my skills to evaluate the reliability 
of current literature. Throughout my research experiences I have learned that critical evaluation of 
literature is an important skill and whilst I have developed a superficial ability to evaluate literature, I 
have come to realise that my approach has not been robust. Attending the systematic workshop has 
been fundamental in developing my skills in conducting advanced research searches and applying 
robust evaluation criteria to reviewed research papers. Whilst in the initial stages of developing my 
aims and criteria for conducting a structured review, I am now reviewing literature in a more critical 
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manner which in turn is assisting me in developing a greater appreciation of the limitations of the 
research within the field. This critical approach of literature is beneficial in developing my insight, but 
I am equally mindful that due to the nature of the proposed study I will not be able to fully address the 
inherent difficulties reflected within past research on Personality Disordered (including psychopathy) 
treatment effectiveness. Nevertheless, this insight has allowed me to develop a more holistic review of 
the proposed study from the onset and I have developed awareness of using appropriate source material 
for research.   
 
 
Annual Review Year 1 – October 2017 
 
Current Phase 
A1   Knowledge Base = 3  
A2   Cognitive Abilities = 2  
A3   Creativity = 2 
 
 
I have spent a considerable amount of time developing a detailed understanding of literature relevant 
to the proposed research area, thus developing an empirically supported rationale for the study.  
Developing this insight was fundamental in the development of the aims and focus of proposed 
structured review and the method of the research study. In addition, whilst not directly related to the 
development of my thesis, during this period I supervised a number of research projects related to 
Personality Disordered Offenders and as such I have developed a more in-depth understanding of 
surrounding literature within this area.  Three of these studies have been written for publication, of 
which two have been accepted and one is currently being reviewed by NOMS for approval prior to 
submitting the paper to a Journal for peer review. As previously reflected, I have for a number of years 
recognised my apprehensions over submitting papers for publication which is largely underpinned by 
my lack of confidence in conducting and reporting research. I have also acknowledged that my 
inaccurate perception of research as being a solitary pursuit is also related to my lack of confidence, 
and as such I have acknowledged a need for me to talk to colleagues about their research experiences 
and reviewer comments. This will hopefully allow me to develop a better understanding of the 
 160 
publication process and hopefully encourage me to see the publication process as being constructive 
rather than a critical evaluation of my research skills.   
 
From the onset I have focused predominately on my research study and utilised supervision to aid the 
development of the research aims and design. Whilst confident that I had developed and was proposing 
a robust research study, I recognised whilst writing the research proposal that I had neglected to 
consider the structured review in depth and my initial aims were not robust. This was discussed during 
supervision and the importance of developing a unique structured review was highlighted. Thus I spent 
time reviewing literature and recently conducted structured reviews relating to treatment effectiveness 
for personality disordered and psychopathic offenders. I identified a number of recently published 
systematic reviews, which concluded that the aim of my initially planned review would yield limited 
benefit. In addition, I was also mindful that published research exploring treatment for personality 
disorder offenders over recent years was limited and thus I was faced with a number of challenges in 
identifying a relevant aim for my structured review.  Discussing this in supervision was fundamental 
in progressing the development of the review and after careful consideration it was agreed that I would 
conduct an up-dated systematic review following a review completed by the Home office in 2003 
(Warren et al., 2003). The overarching aim of critically evaluating literature into the effectiveness of 
treatment for severe or complex personality disordered offenders was decided and a rationale was 
developed.  
 
After spending time developing the aims and design of the systematic review and research study, 
writing the research proposal was relatively straight forward and I was able to justify decisions made 
through reference to literature. Feedback received on the proposal from my supervisors, highlighted 
areas that required further clarity to ensure the rationale and design was clearly presented. As part of 
the research approval process the research proposal was submitted to the NOMS research manager for 
their review. Whilst initial approval was received by NOMS, feedback on the proposal was provided 
to aid the development of the research design.  Receiving independent feedback was useful and it was 
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utilised to aid the development of the research proposal, nevertheless it further reiterated the restrictions 
of utilising secondary data.  The research proposal was submitted to the University on the 09.05.17 and 
I presented the proposed structured review and research study to an independent review on the 02.06.17. 
Feedback received from this process was useful and reiterated the need to remain focused to the 
research aims to ensure the research was realistic and achievable within the time frame. Following 
University approval, a submitted my research proposal to the NOMS research manager (Offender 
Personality Disorder Programme) on the 23.06.17. Feedback received was meaningful and reiterated 
issues already considered by my supervisor and myself.  NOMs research approval was gained on the 
08.08.17 and ethical approval was gained from Nottingham Trent University on the 11.08.17.   
 
Whilst I had attended the SR workshop and found this to be fundamental in my learning, I recognized 
my need to further develop my skills and knowledge in conducting structured literature reviews. I was 
confident that I had a sound understanding of the process, I was conscious that if not all steps were 
followed effectively this may have a detrimental impact on the outcome. Thus I spent time reviewing 
relevant text and published SR articles to develop my competence.  Within the early stages of 
conducting the review I accepted that it was a tedious and lengthy process, something I completely 
underestimated. At the commencement of the review, I was confident that the review aims, and search 
criteria were robust, however after numerous database searches my confidence in my initial review plan 
reduced considerably, more specifically I was overwhelmed by the number of outputs. This raised a 
number of concerns, predominately whether this was a realistic and achievable review for my thesis 
submission. At this point, I spent time considering my research aims and through consultation with my 
supervisor the focus was narrowed. Whilst this provided some relief, I remained apprehensive that I 
was not conducting a comprehensive review, nevertheless it is important to recognize what is realistic 
and achievable.  
 
Whilst I have enjoyed employing a structured approach, there were many times during the database 
searching, review and journal collating that I found myself rushing in order to get it finished and as 
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such adhering to deadlines I had set.  After experiencing feelings of stress and concern that I was not 
on target, I reflected considerably on the process and reminded myself that rushing this work may lead 
me to overlooking something important and thus I continually had to prompt myself to slow down. I 
reminded myself frequently that rigorous and robust results are achieved largely by work that often 
feels tedious and time consuming, whilst deadlines are needed, quality is more important. Now, I am 
placing less pressure on myself to get the review complete by stringent deadlines, and I am appreciating 
the importance of this work.  
 
Interim Review Year 2 – April 2018  
 
Current Phase 
A1   Knowledge Base = 3  
A2   Cognitive Abilities = 2  
A3   Creativity = 2 
 
During the last six months, the main focus of my research has been collating data, developing 
competence in conducting statistical analysis via self-directed learning and supervision. I encountered 
a number of barriers in regards to accessing the data from the organisation which impeded on the studies 
progression.  Whilst initially agreed, although informally, that I would have access to the data 
following, it transpired at this point that due to a change in the organisations data sharing agreement 
procedures for research, that I would need to complete their induction process, specifically 
safeguarding, data protection and security awareness.   
 
Whilst recognising the importance of prioritising the organisations induction session to ensure that my 
research project progressed, due to other work commitments, the earliest induction session that I was 
available to attend was November 2017.  I completed the induction process and was provided access 
to the data.  Nevertheless, at this point I was informed by the organization of additional data sharing 
agreement requirements that had recently been brought to their attention. With this I was sent a form 
to complete and return for national approval, rather than local approval. Again this presented as another 
barrier to my research progression as I was aware from previous research projects of the complexity 
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and time involved with this process, I was left feeling defeated by another presented challenge.  
Through the process of reviewing the requirements of national data sharing agreement, I identified that 
the required data for the study did not fall within the requirements of national agreement, in particular 
that I would be collating individual level and anonymized data from one prison site. I discussed this 
openly with the research lead at HMP Frankland and we sought clarity from the National research 
manager. Through meaningful discussion, it was agreed that national agreement was not needed, and 
thus local data sharing agreement was approved.  The process and experience allowed me to appreciate 
my own time management skills, my ability to engage with change and to respond flexibly to barriers.  
It also reminded me of the need to remain up to date on research approval and agreement procedures, 
rather than relying upon the organisation. This would ensure that a research project can be more 
effectively planned and in turn managed to ensure deadlines are achieved.  
 
The main frustration during the data collation process was that the difficulties in accessing data. I had 
initially been informed that the secondary data had been stored centrally within one database and 
therefore would be easily accessible for research purposes. Nevertheless, it was apparent that was not 
the case with evident gaps within the data. Some of the participants had partial or no data recorded. 
There was no information given as to the nature of the missing data, or an explanation as to why this 
data was not included. Whilst frustrated by this, I decided to take a proactive approach to ensure that 
the study could progress. I sought guidance from colleagues and located primary sources of the data.  
Whilst the data collection process took longer than initially planned, by accessing the primary data 
(completed psychometrics) and entering the data into the database, it provided me with a more in-depth 
understanding of the psychometric tools and scoring. This strengthened my understanding of the 
secondary data that supported me through the process of cleaning the data and analysis.   
 
Due to my commitment, I collated all available data in January 2018. Whilst I had anticipated the 
challenges of cleaning a large data file, I again had underestimated the time it would take to complete 
this task.  Prior to conducting the analysis, I reviewed relevant textbooks to remind myself of the 
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analysis process. Whilst I commenced with the reliability and validity analysis, discussions with my 
supervisor ensured I remained realistic on what I could achieve within the time available for this 
research project. We reviewed my analytical strategy and made justified decisions on what analysis 
would be conducted.  This has been a steep learning process but has been rewarding and enjoyable.  
Seeing the outputs and starting to understand the findings reiterated the benefit of this study.    
 
Through this process, I recognized that whilst secondary data analysis offers methodological benefits, 
notably accessing already available data to generate new knowledge, I became aware of the inherit 
difficulties and challenges. In hindsight, I should have been more prepared and anticipated a level of 
challenge from this process. Nevertheless, through this experience I have developed a greater 
understanding of applied research and recognise the importance of taking a strategic approach to 
research planning, and effectively evaluating and managing potential distractions.   
 
Domain A:  Final Submission 
Vitae 
Domain  Phase required  
A1                     2+ 
A2                     2+ 
A3                     2+ 
Current Phase                                                        
A1   Knowledge Base = 3  
A2   Cognitive Abilities = 3  
A3   Creativity = 3  
 
Final Reflections on Being a Researching Practitioner 
Following the initial challenges of accessing the secondary data and then spending a considerable 
period of time cleaning the large data file, conducting the analysis was an exciting process.  Observing 
and understanding the findings provided a sense of meaning to the research project, eventually the 
clinical relevance of the study was apparent and from the onset I was making theoretical links to support 
the interpretation of the findings.  An unexpected and a challenge to this research project was remaining 
focused on the research aims, as the breadth of data would allow for a broader range of analysis to be 
conducted. I was keen to produce as much output as possible to support clinical understanding and in 
turn the robustness of the findings. However, it was important to remain focused to ensure evidence 
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provided within the thesis was meaningful and explained in sufficient detail rather than a submission 
that was broad and lacked substance. Overall, the process of collating and analysing the data has been 
a valuable learning process that has been challenging yet rewarding. Through this process, I recognized 
that whilst secondary data analysis offers methodological benefits, notably accessing already available 
data to generate new knowledge, I became aware of the inherit difficulties and challenges. In hindsight, 
I should have been more prepared and anticipated a level of challenge from this process. Nevertheless, 
I have learned and now understand that successful secondary data analysis of data requires a systematic 
process that acknowledges challenges of utilizing existing data and to take steps to reduce possible 
limitations.  
 
Despite initial reservations and a refocus of the systematic review, at the stage of excluding papers as 
based on the set criteria, it became apparent that the review did not include up-to-date empirical studies. 
I was aware that several other reviews had been conducted, and whilst on varying areas that related to 
treatment efficacy for psychopathic offenders, collectively they provided an overview of the literature 
that was being included in the current review.  Thus restricting the relevance and ability to offer 
enhanced understanding.  Whilst, I should have been aware of this prior to proposing the review, it is 
inevitable that this will be a challenge of conducting systematic reviews. I accepted the identified issues 
and I remained to persist with the review for a period of time. I eventually raised my concerns with my 
supervisor and through in-depth discussions it was decided that the focus of the review would change.   
Following this I spent time reviewing literature and having meaningful discussions with professionals 
(both practitioners and researchers) with expertise in the field of treatment for psychopathic offenders, 
and through the process I was able to identify a need to develop understanding into treatment attrition 
for psychopathic offenders.  Admittedly, I was disappointed with myself and felt frustrated about the 
time I had wasted.  Nevertheless, after a period of time, I reflected upon the process and acknowledged 
the learning that I had gained and how I could utilize this to support the completion of the new 
systematic review.  
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The systematic review is now complete, and whilst again I underestimated the time it would take, I am 
confident that the process followed was thorough and well thought-out. I demonstrated my ability to 
synthesise the evidence, critique selected papers and my review.  I am now in the process of making 
sense of the findings, and I am finding value in using the evidence to identify factors to support future 
practice.  
 
Whilst the systematic review was a challenging process, I now have a greater appreciation of 
conducting a systematic critique of literature and will keenly apply my developed skills in the future 
whilst reviewing literature. Through this process, I have recognized the importance of conducting SR’s, 
notably I am not creating new knowledge, arguments or theories but instead exploring what has already 
been published. Throughout, I have developed an awareness of appropriate sources for literature and 
have conducted advanced searches using a range of information. This has allowed me to appreciate the 
importance of searching broadly for literature to ensure I gain a comprehensive understanding to 
develop robust arguments. In addition, whilst conducting the SR I have learned the importance of 
proficient critical thinking skills to strive for independent thinking and to develop independent 
arguments based on evidence. Furthermore, I have engaged in a number of discussions with 
professionals who work with Personality Disordered offenders and feel more confident in discussing 
literature relating to the effectiveness of treatment for personality disordered offenders.  I now feel that 
I am doing important research by conducting this SR. By conducting this review in such a rigorous and 
robust manner I am hopeful that there is less chance that I have gaps in my knowledge by missing 
important pieces of work. Whilst I would not consider myself to be “proficient and confident in 
applying critical thinking skills”, I have certainly developed these skills to a point whereby I have a 
way of implementing independent and critical thinking to make sound and realistic judgements based 
on evidence available. As my SR progresses, I am confident that my evaluation of literature will 
continue to develop. 
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During the write-up of the thesis I quickly realized that writing succinctly for publication and now 
favoring the approach was a hinderance. I struggled to write in detail, and frequently questioned 
whether information provided benefit to arguments presented. This led to a process of reediting 
paragraphs. However, after further reflection I realized that I was striving for excellence in my work 
and this was contributing to a sense of self-doubt in my abilities. In response, a reviewed a number of 
theses and took a lead from the level detail provided within, this provided a standard to work towards. 
The length of submitted chapters for supervision was raised by my supervisor, and the word count of 
the thesis and for each chapter was discussed. I recognized that I had overlooked this and instantly 
raised a level of concern about achieving a high standard of work within the restricted word count. This 
concern remained for me, however over time the thesis structure and requirements became clearer, my 
concerns reduced and my ability to write succinctly became a strength of the write-up.  
 
Reflecting upon the research process so far, I have encountered a number of challenges and have 
struggled to commit sufficient time to support the studies progression.  Having a passion for this area 
of research and in turn persistence to make a future contribution to the larger body of research has 
maintained my motivation to move forward and continue. When I have encountered a barrier, I have 
had to remind myself not to be discouraged but to understand why I have been faced with the hurdle. 
Fully understanding the barrier has allowed me to identify effective solutions or a method of 
overcoming it.  The research process has also highlighted the importance of having an in-depth 
understanding of background literature to support critical decisions and therefore ensuring the research 
study conducted is as robust as possible. I have also come to realize that conducting this academic 
programme and in turn the research study is a lonely venture, however, I realize now that my lack of 
commitment to develop links with other students on this programme has not helped in reducing these 
feelings of isolation.  Whilst this is a regret, I am thankful for the support of my supervisory team who 
have utilized their knowledge and areas of expertise to support the research progression.   
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Individual learning plan post thesis submission:  
1. Contribute knowledge to enrich the research area of treatment efficacy by progressing both 
studies for publication and communicate findings to wider audiences. The necessity of research 
impact is a crucial element of this objective.  
2. Remain committed to research and continue to seek ways to develop own research agenda.  
3. Strengthen research skills, specifically analytical abilities and critical synthesis of literature.  
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Domain B:  Personal effectiveness 
 
Start of academic programme 
 
Reflecting on my experiences of conducting research it is apparent that whilst I find the process of 
research rewarding it is challenging. This has become more apparent whilst engaging with the process 
of publication. Nevertheless, whilst presented barriers have impacted upon my motivation and 
commitment, I equally thrive on developing greater insight in to applied research. My sense of 
achievement after conducting meaningful research and effectively managing encountered difficulties 
encourages me to continue moving forwards and persevering with research.  
 
Through my experience of conducting and supervising research, I consider myself to be confident in 
my abilities and indeed I have had experience of defending my research ideas in the past. I am aware 
of my boundaries in knowledge and skill within research and whilst I recognise outstanding areas of 
development for myself, I do tend to neglect the development of my competence in research. This is 
largely underpinned by feeling comfortable in conducting research within my skill base and rejecting 
opportunities for development due to time restraints. In addition, whilst reflecting on my practice as a 
Forensic Psychologist is a strength, I have come to realise that my practice of reflecting on research 
activities is at times curtailed.  
 
Whilst I normally pride myself on managing my time effectively, I have realised that this strength is 
related to my practice rather than research. I have in the past placed limited importance on research 
planning and frequently priorities other commitments. Upon reflection this is an area I need to 
concentrate on to maintain commitment and motivation.  
 
Career progression is a salient focus of mine and I do strive to network as a means to aid my 
progression. Nevertheless, I have come to appreciate the importance of networking within the academic 
field and whilst I have in the past made efforts to network with other researchers, I have not made this 
a priority. Upon reflection I am unsure whether this is related to a lack confidence or not having a desire 
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to progress within my research career. As a Registered Psychologist I also engage in continued 
professional development to ensure my practice and skills are up to date.  Although my research 
experience in terms of publications is limited, I am keen to develop a positive reputation within the 
academic field of Forensic Psychology.  
 
Current Phase 
 
B1  Personal Qualities = 2    
B2  Self-Management = 1    
B3  Professional and Career development = 2  
 
 
Interim Review Year 1 
 
Current Phase 
 
B1  Personal Qualities = 2    
B2  Self-Management = 2    
B3  Professional and Career development = 3    
 
 
Based on earlier reflections I spent time developing a research plan to aid the progression of my 
professional doctorate research study. This plan was shared and discussed with my supervisory team. 
The plan has recently been developed further to reflect all required tasks within the research process 
and this will be discussed within the next supervision session.   
 
My engagement in this academic programme, specifically discussions with my supervisory team has 
allowed me to identify that my approach to research to date has been haphazard. Through reflection I 
have acknowledged that I have allocated limited time to my research supervision and independent 
research activities in the past, this in turn has infringed upon the quality of the research undertaken and 
in turn research outcomes. Spending time understanding the requirements of the programme, 
developing a research plan and discussing this in supervision has provided a realistic overview of the 
requirements of conducting a well thought out and planned research project. This strategic approach 
has allowed me to prioritise research tasks alongside my other work commitments and regularly 
reviewing the plan critically has provided an opportunity to identify gaps and evaluate progress made 
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thus far. This approach has developed my commitment to this research project and indeed my overall 
commitment to the academic programme. Nevertheless, though my experiences so far and feedback 
from my supervisor team I am mindful of my need to enhance my time management and thus to strive 
for excellence in research. 
 
I pertinent opportunity for networking with fellow researchers was gained by attending a research 
forum with the National Offender Management Services (NOMS). The purpose of the meeting was to 
gain insight into NOMS (Offender Personality Disorder pathway) research plans and their drive to form 
collaborations with Universities to develop their research profile.  This meeting provided an 
opportunity to share information and research plans with academics and practitioners. Whilst resistant 
to contribute to discussions due to feeling unconfident, I pushed myself and shared the research plans 
for my thesis. This led to a meaningful discussion and a level of excitement about the findings.  This 
reinforced not only the importance of being confident in my own skills and ideas but also the necessity 
of the research being conducted.    
 
Whilst I have been a management member of the PORSCH committee I have not committed myself to 
the benefits of engaging with the members of a research group nor have I engaged within the research 
activities (conferences, workshops and collaborative research opportunities) attached with this group. 
Attending the recent research meeting by NOMS and talking with the varied professionals who attended 
has provided a clearer understanding of the potential benefits of effective networking. I can now 
understand that developing and maintaining co-operative networks and working relationships is 
fundamental.  
 
As I had realised that my research career progression was to some extent stagnating, I decided to arrange 
a research mentoring meeting with the Associate Dean of research. This provided an opportunity to 
reflect upon past research experiences, consider my current research plans to support self-improvement 
and consider my contribution to Research Excellent Framework (REF) 2020. Within the meeting we 
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discussed whether it would be viable for me to apply for an early career research scholarship with the 
criminal justice voluntary sector. Whilst it was acknowledged that I met the criteria for the application, 
an overarching concern was that a focus of our discussion was whether I would have the time to fully 
commit to this position. Upon reflection although this does appear to be an excellent opportunity for 
my research career, I remain concerned that I do not have the time to fully commit to this position and 
how this could be detrimental to my research career.  It was agreed that I would predominately focus 
on my current research agenda and continue to attend research mentoring meetings on a regular basis 
to support my career progression.        
 
Annual Review End Year 1 
 
Current Phase 
 
B1  Personal Qualities = 3   
B2 Self-Management = 2    
B3  Professional and Career development = 3  
 
 
As per my normal practice I have reflected greatly upon my research and clinical practice in order to 
identify areas of progression, strengths and weaknesses. With this I continuously seek ways to improve 
my performance and of those I supervise (both research and practice). During this period, I have 
recognised the importance of prioritising research and maintaining my commitment to research 
activities. I have also strengthened my time management skills to ensure that research projects are 
progressed and that I am able to respond effectively to challenges. In regards to gaining access to the 
secondary data for the research study, I have encountered a number of barriers which have impacted 
upon my ability to gain a full understanding of data available. This has impeded upon my ability to 
develop concrete plans in regards to the analytical strategy for this study. Nevertheless, due to having 
completed a number of research studies that have utilised data from the Westgate unit, I was aware that 
I will have access to clinical data (IPDE and PCL-R), demographic and offence data and pre and post 
treatment psychometric data for approximately 120 offenders who have engaged with the personality 
disorder treatment service and as such the Chromis programme. I had also been informed that 
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approximately 50 of these offenders have completed the Chromis programme in its entirety, 40 have 
been deselected from treatment at various stages and 30 are currently in treatment.  Whilst the 
aforementioned has been useful in formulating my research proposal, I remain to hold a number of 
apprehensions relating to inherit limitations of secondary data, particularly missing data.  Following 
ethical and research approval, it was agreed by the Westgate unit that I would gain access to the 
secondary data as of August 2017 and I was granted approval to visit the unit on two separate days to 
review the data. However, I was then informed of recent changes to the Westgate unit (HMP 
Frankland’s) data sharing agreement procedures for research and was informed that I would be unable 
to have further access to the data until I had completed HMP Frankland’s induction process, specifically 
safeguarding, data protection and security awareness. This placed a salient barrier to progression of the 
research, in particular meeting the deadline (October 2017) of having the data ready for analysis. Whilst 
initially frustrated by this, I recognised the importance of taking a strategic approach to research 
planning, and effectively evaluating and managing potential distractions.  By reviewing my research 
plan, I identified that the scheduled contingency time would allow the overall deadline for the research 
project to be met and for the deadline of having the data analysed and results available to Westgate 
(HMP Frankland) by April 2018 to be achievable. This experience has allowed me to appreciate my 
own time management skills, my ability to engage with change and to respond flexibly to barriers.  
 
Reflecting further on the research plan, it is important for me to recognise that due to my academic 
commitments and workload requirements, time available to progress with the structured review and 
research study between September 2017 and February 2018 will be limited. I have taken this into 
account within the research plan, therefore ensuring set deadlines are realistic and achievable. In 
recognising, the importance of allocating sufficient time to the progression and completion of the 
structured review and research study (thesis), I have informed Teesside University that I will be 
prioritising research relating to my thesis over other research activities (both supervision and research 
conducted by myself) and business engagement activity, thus research output during this period will be 
curtailed. This has been agreed.  Nevertheless, I will continue to engage with the research mentoring 
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scheme at my own organisation, continue to maintain and developing research networks and explore 
income and funding opportunities that could be commenced after submission.  
 
Due to my efforts in developing a professional and research network I was invited to a joint NHS and 
prison service research network meeting (Offender Personality Disorder). I perceived this as an 
excellent opportunity to strengthen my working relationship with other professionals and organisations.  
I circulated the invite to colleagues and less experienced researchers as I appreciate the importance of 
circulating external work opportunities.  However, due to other work commitments (teaching) I was 
unable to attend the meeting. Whilst disappointing, I realised that I have a number of other network 
opportunities that I need to pursue.  
 
During the reporting period I was asked by the Head of Department to apply for a Principle lecturer 
post for undergraduate provision in Psychology at my University. I gave considered thought to this 
position and the opportunities it could provide for my career progression, in particular management 
responsibilities. Nevertheless, I was equally mindful of the requirements of this role and time 
commitment and thus I identified that it would have an impact upon my other work commitments, 
notably research progression and practice. With this I recognised the importance of maintaining an 
acceptable work-life balance but being mindful of my overall career plans. If I was successful in gaining 
this post, I recognised that it would provide an immediate gain, however it would have an impact upon 
my long-term career plans. Thus I did not apply for the position and whilst I initially questioned this 
decision, three months on I have not had any regrets. I have recognised that in the process of 
establishing my career trajectory, it is important to have a holistic view to aid current decisions and the 
impact these decisions may have in the long-term. 
 
Interim Review Year 2 
 
Current Phase 
 
B1  Personal Qualities = 3   
B2  Self-Management = 3    
B3  Professional and Career development = 3    
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Reflections 
 
Reflections within this domain replicate those already discussed (previous interim and annual review), 
with on-going areas of strength and development.  However, during this time I have spent considerable 
time reflecting on my role as Senior Lecturer at Teesside University, and through this process I 
acknowledged that to some extent I was stagnating. I do not think that this has been intentional but a 
product of me trying to succeed in my academic role and also in practice.  Further to this, I realised that 
within my academic role, I have scoped out the work commitments (teaching and programme leading) 
that I feel are suited to my skills and knowledge, however this I feel has impeded upon my plans for 
development and progression, in essence I am comfortable within my role with no need to develop. 
Whilst in a strong position, it is impacting upon my desire to develop in others area. This thought out 
reflection was underpinned by being offered a new academic role at a different institution (Newcastle 
University).  Whilst I had not anticipated being offered this new job role, it did make me give considered 
thought to my current circumstance and career plans for the future.  Working alongside esteemed 
colleagues at Newcastle University will encourage me to give greater importance to my research 
activity. Whilst saddened by leaving Teesside university, I now realise that I need to remove myself 
from “feeling comfortable” and take opportunities offered at Newcastle to aid my academic career.   
 
 
Final Submission 
Phase required 
B1 2+ 
B2 2+ 
B3 1+ 
Current Phase 
 
B1  Personal Qualities = 4  
B2  Self-Management = 3    
B3  Professional and Career development = 3    
 
Final Reflections on Being a Researching Practitioner 
Throughout the process of this academic programme and reflecting upon my experience, I have 
acknowledged that in the past I have conducted research in isolation and I am resistant to seek support 
from others. I now appreciate that this approach has become detrimental to my progression and 
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development. Seeking guidance from supervision and during a mentoring process has allowed to 
appreciate the benefits of seeking guidance. I am now aware of my need to build a range and a variety 
of support structures to support my development and research progression. Thus, the most pertinent 
learning from this experience is the importance of seeking support and help. I have come to recognize 
that the admission of fallibility during research does go a long way in accomplishing the aims and goals 
effectively and assisting in retaining professional respect.  
 
Whilst always holding a level of enthusiasm for research and holding a desire to inspire others, as my 
confidence and indeed competence has developed over the length of this academic programme, my 
commitment to research has grown. I now actively seek feedback on my research performance and 
strive to respond to this as a means of working towards excellence in research, this is particularly 
relevant to peer review feedback. Whilst in the past such feedback would have knocked my confidence, 
now I use such feedback constructively to support my development and research outputs.  
 
Time management has been a difficulty throughout this programme and whilst I initially blamed myself 
for not committing enough time to my progression, I have come to realise that the core issue 
underpinning this was striving to achieve too much with balancing academic work, clinical practice, 
completing my thesis and also maintaining a work life balance. This has been a struggle throughout 
and despite attempting to rebalance my priorities, I have not been successful.  Nevertheless, I now 
recognise that I do have some established time management skills, however I need to maintain attention 
to my work-life balance.  
 
Throughout my career I have held a critical view of my own performance and whilst I perceived this 
to be related to an honest reflective approach, I have now realised that I need to have more confidence 
in my abilities. Thus, I now strive to have a balanced and more realistic view of my own potential in 
academic working and clinical practice. Furthermore, through my supervision of other researchers and 
trainee psychologists, I recognise that I am committed to supporting and encouraging the professional 
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development of others. Whilst this is a role I will continue to develop more specifically to create more 
opportunities for development and to support others to make their own informed decisions. Within the 
early stages of this academic programme, I recognised that I had created limited opportunities to 
network with other researchers and practitioners, favouring an approach of working in isolation. I 
reflected that this was underpinned by a lack of opportunities. During the early stages of time at 
Newcastle, I have strived to network with colleagues in and outside of my department, which in turn 
has created opportunities to attend networking events. I hope to continue with this to assist in 
developing professional rapport and gain further opportunities for research.  
 
Individual learning plan post thesis submission:  
1. Develop opportunities to improve own performance and that of less experienced 
researchers/practitioners.  
2. Strengthen research management skills whilst maintaining a work-life balance.  
3. Strengthen career trajectory by enhancing and utilising network opportunities.  
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Domain C:  Research Governance and Organisation 
 
Start of academic programme 
 
Throughout my practice and research, I have adhered to Ethical and Legal requirements. I consider 
myself confident in working independently and conducting applied research whilst not compromising 
my integrity or the Code of Ethics and Conduct. In addition, through my supervision and teaching I 
have gained extensive experience of educating and supporting others in the adherence to these 
principles.  Research management is an area that I need to develop, specifically allocating further time 
to research activity, developing robust research plans and prioritization of activities.  
 
Whilst I recognize the significance of income and funding generation for my University, to date I have 
no experience of funding or principles of financial management. With this in mind I need to make 
creative use of available resources with my University and cultivate useful connections in order to seek 
funding opportunities for research projects. However, I now recognise the importance of developing 
my competence in research prior to pursing a research funded project.  
 
Current RDF Phase 
C1   Professional Conduct = 3   
C2   Research Management = 1    
C3   Finance, funding and resources = 0   
 
 
 
Interim Review Year 1 
 
Current Phase 
 
C1   Professional Conduct = 3  
C2   Research Management = 2    
C3   Finance, funding and resources = 0  
 
 
Other than evidence already presented, there has been limited progression with the learning aims of 
this domain.   
Whilst to date there has been no meaningful development in my competence relating to professional 
conduct I am confident in my ethical practice and of those who I supervise.  A long-term goal in regards 
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to this domain is to develop my confidence and competence to support the development of policy and 
procedures of my own institution, nevertheless I must recognise that my current academic role does not 
provide opportunities for this.  It is imperative that a strength for development and explore opportunities 
to attend meetings within my university but also wider organisations. Utilising my theoretical 
understanding to support practice is a particular strength and need to ensure that I maintain this 
approach to support my professional development.  
 
In regards to attribution and co-authorship I have recently been asked for guidance by a colleague who 
at that time was experiencing difficulties on a decision to add a third person as a co-author to a paper. 
During these discussions I reflected upon my approach and highlighted a need to develop a formal 
arrangement of co-authorship at the commencement of research study. I provided my colleague with 
advice that reflected guidance from the COPE and ICMJE. Whilst confident in the advice I provided I 
reflected on difficulties whilst agreeing on co-authorship with papers and ultimately highlighted the 
importance of all co-authors being accountable for all aspects of the research work, including the 
accuracy and integrity of any part of the work and to be confident that the research was investigated 
appropriately. Reflecting upon this discussion encouraged me to consider the co-authorship of work 
conducted by students (both UG and PG) at my University. It became apparent that the university does 
not have clear policy or guidance in place to support co-authorship agreements. I have discussed this 
briefly with the Research Dean and have been assured that this will be considered.   
 
Annual Review End Year 1 
 
Current Phase 
 
C1   Professional Conduct = 3    
C2   Research Management = 2    
C3   Finance, funding and resources = 0   
 
 
Throughout my research and clinical practice, I continually adhere to ethical principles. I strive to 
educate and advise peers and those under my supervision regarding ethical practices and set clear 
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expectations as a means of support.  A long-term goal in regards to this domain is to develop my 
confidence and competence to support the development of policy and procedures of my own institution.  
 
 
Interim Review Year 2 
 
Current Phase 
 
C1   Professional Conduct = 3    
C2   Research Management = 2    
C3   Finance, funding and resources = 0   
 
 
Other than points already discussed there has been no further competence development within this 
domain area during the reporting period.  
 
Final Submission 
Required standard 
C1    1+ 
C2    3+ 
C3    1+ 
 
Current Phase 
 
C1   Professional Conduct                      3  
C2   Research Management                   3  
C3   Finance, funding and resources    1    
Final Reflections on Being a Researching Practitioner 
Throughout this domain the reflective entries are limited, and I appreciate that this is in part attributed 
to limited opportunities to develop competence (notably, Finance, funding and resources). However, it 
is also apparent that some of the competencies of this domain also relate to others (Professional Conduct 
and research management). Thus, to avoid replication, I have not repeated reflections.    
 
In regards to my professional conduct I pride myself on professionalism by adhering to standards and 
requirements. I also set expectations for those I am supervising and support less experienced researchers 
in health and safety, ethical principles and legal requirements.  Thus, competence in this area has not 
developed substantially during this length of this programme.  Nevertheless, I appreciate my need to 
strengthen my practice and those of wider organisations. Again, this will need to be area I develop into, 
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hopefully as my academic career progresses and I am provided with an opportunity to attend a broader 
range of university meetings.  
 
As reflected throughout, my time management has been problematic due to a range of factors.  
Nevertheless, throughout this process I have strengthened my research approach by ensuring research 
conducted is meaningful and contributes to wider field, and also meets the needs of stakeholders. In 
regards to the current thesis the organisation (Westgate unit) has provided limited guidance on their 
outcome expectations, as they openly explained that they trusted my approach with research and my 
understanding of their treatment unit. Ultimately implying that they were willing to give me full 
ownership of the research outcome. Whilst this reflected positively upon my reputation, I was keen to 
seek further guidance and thus arranged a meeting with the clinical lead to discuss the research 
requirements. Whilst a meaningful meeting which provided some key stake holder contribution, the 
discussion was led by myself.  I was mindful of this and encouraged for the stakeholders’ contributions 
when possible. I left the meeting believing that I had at least educated those who had attended the 
meeting about the importance of stakeholder involvement, however attempts to arrange a meeting to 
discuss the research outcome was rejected. They explained that whilst they valued the research 
completed, the findings at that time was not a priority and a request for a meeting later in the year was 
requested.  This was surprising as I was aware that the unit was in the process of making significant 
changes to the Chromis programme, and I believed that the research findings would provide needed 
evidence to support their decision making. With this in mind, I decided to submit an executive summary 
of findings to the organisation that highlighted practice implications as based on the research outcomes. 
The clinical lead responded to this and appreciated the valuable input, furthermore she provided further 
context to her decision for the findings not to be widely circulated across NOMs at that time.  It became 
clear that whilst research can support clinical practice and indeed decision making, there are wider 
issues that can impede on the communications of findings and to extent impact upon the applicability 
within clinical practice.  
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Since I commenced my academic role and until more recently I openly explained to others that I did 
not perceive myself as a “true academic”.  In others words whilst I had an agenda to conduct practice 
related research, I did not envisage research as being a priority, as I was mindful that being a practitioner 
was my primary drive. Nevertheless, throughout the time on this programme, my views have changed, 
and I now have a greater appreciation and a desire to conduct research. With this in mind, I have 
recently spent time speaking with colleagues and I have also attended a workshop about income and 
funding opportunities. Through this discussion I gained an opportunity to start developing an 
understanding of funding sources, grant application processes, financial management and the 
significance of income generation in regards to my own career progression. Whilst an excellent 
opportunity to develop learning, I reflected that my lack of confidence had hindered my willingness to 
source and pursue funding opportunities. A level of self-doubt remains, but I am now keen to progress 
with this and with appropriate mentoring I now realise that I do have the knowledge, skill and ability 
to source funding for research.  It is imperative that I make creative us of available resources and 
cultivate useful connections to support myself through this process.  
 
Individual learning plan post thesis submission:  
• Strengthen knowledge of key funding sources and grant application procedures. Work 
collaboratively with colleagues to apply for research grants.  
• Develop and apply project management strategies.  
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Domain D: Engagement, Influence and Impact 
 
Start of academic programme 
 
Within my academic and supervisory role, I spend a considerable amount of time coaching less 
experienced researchers and students in working effectively within a team. Throughout my career I 
have developed extensive experience of working within a team both multi and cross disciplinary. 
Throughout I have been consistently mindful of how my behaviour impacted upon others. Within my 
academic role it has been my experience that teamwork is somewhat limited, as colleagues tend to 
focus on their individual teaching and research activities. Nevertheless, as a programme leader for 
undergraduate and postgraduate programmes I pride myself on leading teams, recognizing colleague’s 
strengths and supporting others in the achievement of their individual and team goals.  Most recently I 
have organised a number of team meetings to assist our Forensic Psychology team to identify our goals 
in terms of progress in research, academic excellence, student recruitment and our programme delivery. 
These meetings so far have been somewhat challenging due to the varied priorities across the team, 
although through meaningful exploration we have identified a strategy to move forward. This 
experience alongside others demonstrated to me my competence in communicating confidently, 
leadership and negotiating with others.  
 
Through experience I have come to recognise the importance of disseminating research findings in a 
meaningful manner, therefore supporting the wider impact on policy development and practice.  Whilst 
I consider myself to present work in a confident manner, I equally recognize my need to develop skills 
in constructing arguments and articulating information clearly to a wide range of audiences. This is 
more so in regards to research, specifically developing confidence and competence in disseminating in 
a range of outlets, including professional and public.  
 
I have developed a sound understanding of the publication process and have started to publish research 
within the field of Forensic Psychology. Nevertheless, this is an area that I am keen to develop further, 
specifically developing an understanding of the range and diversity of outlets for publication, seeking 
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collaborative research opportunities and targeting appropriate journals/outlets to gain a track record of 
high-quality published research.   
 
I have gained extensive experience in teaching at Undergraduate and Post-graduate level. The 
knowledge disseminated in my teaching draws greatly from my research, as well as my experience in 
the forensic field. Through my continued professional development, I have strived to appraise my 
teaching, synthesise and evaluate a range of sources to reflect on my practice and identify areas for 
enhancement, plan and design inclusive learning opportunities, thus demonstrating a threshold of 
competence in facilitating face-to-face, group learning and lectures. I strongly advocate research 
informed teaching and believe it to be the most effective approach for ensuring quality information is 
delivered to students.  
 
Current Phase 
 
D1  Working with others = 2   
D2  Communication and Dissemination = 1   
D3  Engagement and Impact = 2   
 
 
Interim Review Year 1/Thesis Proposal 
 
Current Phase 
 
D1 Working with others = 2   
D2 Communication and Dissemination = 2    
D3 Engagement and Impact = 2    
 
 
I have actively pursued research publications and have developed a good understanding of how research 
is evaluated and published across a range of journals. Whilst I initially aim to submit papers to the most 
prestigious journals, my confidence in my own research abilities impedes upon my commitment to this 
and thus I aim for lower impact journals.  This remains as an area that I need to develop further, 
specifically developing an understanding of the range and diversity of outlets for publication, seeking 
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collaborative research opportunities and targeting appropriate journals/outlets to gain a track record of 
high-quality published research. 
 
Reviewer feedback from submitted papers in the past has provided an opportunity to develop my 
research knowledge and skills, and as such the quality of papers submitted.  Recent feedback received 
on a paper submitted (The violent accounts of men diagnosed with co-morbid anti-social and borderline 
personality disorders) held a number of themes, predominately the methodology of the study, and the 
reviewers uncertainty over whether the theme’s derived from the qualitative study were specific to the 
ASPD/BPD diagnoses or reflective of all personality disordered offenders. I reflected upon the 
feedback received by the reviewers and considered the impact of the paper and its findings. Whilst the 
feedback was genuinely helpful I spent considerable time reflecting upon the aims of the study, 
specifically that from a phenomenological perspective, we aimed to explore this specific group of men’s 
accounts of their violent offences.  IPA was chosen to allow us to explore the meaning these men made 
of their violent behaviour (Eatough & Smith, 2006; Willig, 2009).  This was an exploratory piece of 
work.  A comparison group was not considered as it was not within the scope or the aims of our 
study.  Also, I was also mindful that as a qualitative study, we would not typically expect to have a 
control group. Thus there was a salient obstacle in regards to responding to the feedback and preparing 
for resubmission, notably the expectation that we include a similar qualitative accounts of offenders 
without the BPD/ASPD diagnoses, and carefully examine the extent to which the themes raised are 
specific or non-specific. With this in mind I contacted the editor in order to seek clarification on how 
we could move forward with the resubmission whilst also defending our chosen methodology and 
seeking guidance on reasonable changes to the paper to meet the reviewer’s feedback. I acknowledged 
that there was a need to make the paper more impactful (i.e. as a hypothesis-generating device) and as 
such I acknowledged a need to consider how I could draw from the evidence to demonstrate more 
specificity of the derived theme’s to BPD/ASPD offenders. I suggested that within the revision of the 
paper we would include recommendations that further research into the violent offence accounts other 
groups of offenders would help resolve the question of specificity of themes.  The editor agreed with 
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our concerns and appreciated that a resubmission based on the reviewer’s feedback created a hurdle 
that was insurmountable. The reviewer agreed with our suggestions in terms of moving forward with 
this paper but with the clear caveat that such changes would not guarantee that our paper would be 
accepted.  Upon reflection, I believe that my approach to the feedback was pragmatic, I critically 
reviewed the study in-line with the feedback received and considered a defensible argument to support 
the methodology. Nevertheless, I remained open and considered alternative options to effectively 
respond to the feedback and more importantly identified suggestions to assist in developing the quality 
of the paper and the impact of the research outcomes. This process allowed me to identify my 
competence and my ability to defend research that I have undertaken. 
 
Attending and presenting at the BIGSPD conference was a challenging, yet positive learning 
experience. The conference provided an opportunity to develop an up-dated understanding of current 
practice within the field of Personality Disorder. This was beneficial in terms of my practice as a 
Psychologist but also my research focus. During the conference I delivered two research talks. The first 
focused on research studies conducted by myself (in collaboration with a colleague from the prison 
service) on co-morbidity between Personality, Psychopathy and Clinical Disorder within high risk, high 
treatment need personality disorder offenders. The second talk relayed findings on two treatment 
evaluation studies that I had supervised.  Presenting my research at the recent conference was an 
excellent but challenging learning experience. Whilst able to confidently present and effectively 
communicate the research to a diverse and non-specialist audience, I openly struggled to defend the 
study following the delegate’s questions. I was disappointed by this as I am able to construct coherent 
arguments and defend my decision within practice, however I struggled to do so within this arena. 
Unpicking this experience further within my reflections, allowed me to acknowledge that presenting 
research that I had predominately supervised was related to my limited ability to confidently defend 
the studies. Whilst I held a sound understanding of the research projects a more comprehensive 
understanding was needed to allow me to develop a robust response to the delegate’s questions.     
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To date I have gained an extensive experience of teaching at both undergraduate and postgraduate level 
albeit it has not been without its challenges. I am taking an opportunity over this period to reflect upon 
my teaching experience and to give further focus to my continued professional developmental within 
my teaching practices. Throughout this period of critical reflection, I acknowledged that I promote 
teaching through facilitation rather than transmitting information through a standard lecturing format.  
I have learned through experience that this approach requires a higher level of interpersonal skills to be 
able to facilitate the session rather than just delivering it. I perceive my role within a lecture to not only 
transform knowledge but to assist students to interpret and construct their own knowledge. Whilst there 
remains scope for further development in this area, which I anticipate will occur through reflective 
practice it is encouraging to receive positive feedback from students on my style of teaching and also 
feedback from colleague’s observations. Over the past year I have taken the role as Programme Leader 
of BSc in Forensic Psychology and Professional Doctorate in Psychology. Both programmes are varied 
and provide their own unique challenges nevertheless, they have both provided a valuable learning 
opportunity to lead teaching programmes and ensure they adhere to quality standards.  
 
Reflecting on my practice as an academic, I have strived to make sense of my experiences and learning, 
and how I would do it better the next time. This has formed a crucial part of my professional 
development as a teacher. It is notable that whilst my experiences of being an academic has not been 
without challenge, it has provided positive learning experience allowing me to develop my competence.  
Through my continued professional development, I have strived to appraise my teaching, synthesise 
and evaluate a range of sources to reflect on my practice and identify areas for enhancement, plan and 
design inclusive learning opportunities, thus demonstrating a threshold of competence (UKPSF, 2011) 
in facilitating face-to-face, group learning and sessions. The knowledge disseminated in my teaching 
draws greatly from my research, as well as my experience in the Forensic field. I strongly advocate 
research informed teaching and believe it to be the most effective approach for ensuring quality 
information is delivered to students. Taking into consideration that professional learning advocates 
academic development to change the conceptual basis upon which lectures practice (Ho, 2000) I have 
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developed a continued professional development plan (refer to appendix 7) to engage in meaningful 
learning activities in order to continue my development as an academic and ensure that my practice 
assists students to become confident, critical, creative, adaptable, articulate and aspiring. 
 
Annual Review End Year 1 
 
Current Phase 
 
Working with others = 3    
Communication and Dissemination = 2    
Engagement and Impact = 3    
 
 
Pursuing research for publication remains an area of difficulty for me, and whilst my confidence is 
increasing I remain to hold a number of apprehensions about submitting papers for peer review. 
Following the manuscript decline (‘The violent accounts of men diagnosed with co-morbid anti-social 
and borderline personality disorder’) in February 2017, I submitted the paper to another journal for 
review (Journal of Offender Therapy and Comparative Criminology). The paper was accepted for 
publication within its original format, with no suggested revisions by the reviewers. Whilst a positive 
outcome, the derived confidence of achieving this has been short-lived.  Upon reflection, this is directly 
related to what I perceive as critical feedback by reviewers on the separate paper (27/06/17) that 
highlighted fundamental issues relating to the study design, interpretation of findings and relevance of 
the study in developing knowledge. As yet, I have not considered the feedback received in depth nor 
have I progressed with redrafting the paper. Whilst an excuse for not progressing has been a lack of 
time, I equally recognise that a more salient barrier has been a lack of confidence in my abilities to 
meet the feedback of the reviewers.  With this in mind, I have identified my inaccurate perception of 
research as being a solitary pursuit, and as such I have acknowledged a need for me to talk to colleagues 
about their research experiences and reviewer comments.  This will allow me to develop a better 
understanding of the publication process and hopefully help me to perceive reviewer comments as 
being constructive rather than a critical evaluation of my research skills.  In addition, I need to strive 
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for high quality research outputs, thus I need to allocate further time to my research activates and 
challenge any need (personal and from my academic organisation) to produce publications quickly.  
 
Whilst I have gained extensive experience supervising research for UG and PG students, and 
professionals I have for a number of years supervised based on what I thought was good practice rather 
than truly thinking about my students and trainee psychologists needs and what actually was “good 
practice”.  With this in mind, I decided to develop a more theoretical understanding of supervision, 
focusing on various models of supervision. In summary I learned that supervisors are there to create an 
environment that provides effective teaching and learning to trainees in a safe setting. Through regular 
identification of learning opportunities appropriate to a trainee’s and student’s level of competence, 
and opportunities for feedback, supervisors can help students to develop their skills and competence. 
By acting as positive role model, supervisors can demonstrate good practice to their students.  I have 
also realised that a supervisors ethical and professional behaviour is modelled within the supervisory 
relationships, thus whilst I have in the past employed a relaxed and ‘friendly’ approach to supervision 
I have decided to present in a more professional manner in a hope that my students will learn to parallel 
this in their own research practice. I perceive supervision as a means of helping students to build 
confidence and competence as they grow in the profession and research, in turn I also get an opportunity 
to know more about my students. 
 
In addition, I have given considerable thought to my approach of providing feedback to students. I have 
come to recognise that I hold unrelenting standards and strive for perfection, nevertheless I have learned 
that this approach and subsequent feedback I send to students may have a detrimental impact upon their 
confidence, motivation and commitment to their research.  Thus, I have encouraged myself to be more 
mindful in my approach to feedback and I have strived to utilise more of a constructive model, thus to 
motive and develop my student’s knowledge and skills.  Rather than relying on written feedback to 
students, I have implemented supervision sessions to provide verbal feedback to avoid 
misunderstandings (the student perceiving feedback critically), provide an opportunity to discuss 
 190 
feedback meaningfully and thus aiding the students learning process. Whilst more time consuming 
initially, I have found that those students committed to their research have responded more effectively 
to feedback, thus producing higher quality outputs which in-turn has reduced supervision time at a later 
stage.  Whilst reflecting upon this approach, I have further learnt the importance of a teaching-learning-
research connection within supervision. 
 
Throughout my teaching I thrive to combine up to date and relevant theory with my practical knowledge 
and experiences. I strongly advocate research informed teaching and believe it to be the most effective 
approach for ensuring quality information is delivered to students; something that will be a priority for 
me in this post. As Psychology is a passion of mine I can enthusiastically communicate to the students, 
and creatively present material at the appropriate level of study. My commitment to effective teaching 
is supported by being nominated and being awarded a STAR award (Inspiring Supervisor and Lecturer) 
for two consecutive years (2016 and 2017).  These awards were nominated by the student body and 
chosen by the Universities Senior Executive Management Team.  
  
Within this academic year I was asked by senior management to mentor a new member of staff to our 
department who, similar to myself was a practitioner and who prior to this job had limited academic 
experience.  I was familiar with the new member of staff as I was on the interview panel who appointed 
the member of staff into post, and as such I had a good understanding of her past work and research 
experiences. Nevertheless, I made every effort to spend time developing a working relationship with 
my colleague.  I ensured that I was available to answer any questions she had and provided reflective 
advice as needed. Throughout our discussions I was mindful of the challenges I encountered whilst 
transitioning from a full-time practitioner working in the prison service to an academic field, and used 
these to reduce her anxieties.   Whilst I have had experiences mentoring and supervising other 
professionals, the challenges of mentoring a colleague soon became apparent. It was clear that my new 
colleague was struggling with academic working and whilst I attempted to understand her experiences, 
managing student complaints that were related to this colleague as the Programme Leader was placing 
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me into difficult and challenging situations whereby I had to support the students in their difficulties 
whilst also supporting my colleague.  Whilst creating a nurturing and supportive environment for my 
colleague was essential, it was equally important for me to develop an understanding of what was 
underpinning her difficulties. Through meaningful discussions it became clear that her expectations of 
academic working were not accurate and as such she was not fulfilling her job role.  I remained 
transparent and supported her in developing and implementing a development plan.  Following six 
months I was asked to provide evidence to senior management of my colleague’s performance and at 
this point my colleague resigned from her post. Again this was a difficult situation but allowed me to 
appreciate the importance of effective personal management, empowering others and explaining clearly 
the rationale behind procedures and decisions.  
 
On the 23.05.17 I had a meeting with the Enterprise and Business Engagement lead for my school.  
During the meeting I developed a clearer understanding of Enterprise and Business Engagement 
Activity and was able to identify activities within my academic and private practice that could support 
the Universities agenda.  Upon reflection I had underestimated the broad nature of Enterprise and 
Business Engagement and I had not considered the links I had formed with the Prison Service and NHS 
to be relevant to this work. As an outcome of the meeting I set myself action points to consider 
developing an UG work experience module that would utilise my links with forensic organisations and 
to pursue discussions with the Prison Service National Forensic Lead regarding bidding for a contract 
to deliver a Post graduate academic programme for Registered status.  
 
 
Interim Review Year 2 
 
Current Phase 
 
D1 Working with others = 3    
D2 Communication and Dissemination = 2    
D3 Engagement and Impact = 3   
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I received a request to collaborate on a research project with the School’s Associate Dean for research. 
The proposed research project was focused on the experiences of older offenders and I was asked to 
collaborate as a means of bringing the “psychological thread to the paper”. Whilst it was an honoured 
opportunity, I needed to be realistic on whether I would be able to commit to the proposed research 
project. I was aware of my other research commitments, notably my professional doctorate and whilst 
keen to build collaborative relationships with a range of colleagues I had to prioritise my current 
commitments.  I openly discussed this with my colleague, who appeared surprised by my decline, 
although I explained my current circumstance and she advised that following the submission of my 
Professional Doctorate thesis, I should book an appointment to discuss my research plans and 
progression.  Upon reflection, this opportunity allowed to acknowledge my need to build collaborative 
relationships, but also the importance of managing and negotiating collaborations and external 
relationships.  
 
During this period, I was also asked to join a PhD supervisory team. The proposed area of research was 
related to sexual risk assessment (both static and dynamic). This was an excellent opportunity, although 
I was apprehensive and questioned my own suitability.  I discussed this within my research mentor who 
reflected that my research skills/knowledge, supervision experience and practice knowledge within the 
research are would be of a great benefit to the PhD student.  Whilst this was positive to hear, I thought 
that being transparent with the supervisory team about my limited experience of supervising research 
at this level was crucial prior to agreeing to this opportunity. The discussion reduced my concerns and 
the importance of individual strengths to team was reiterated. During the early stages of supervision, I 
have found myself taking a lead drawing from knowledge of surrounding literature. Throughout this 
process I encouraged the student to develop an in-depth understanding of the surrounding literature to 
support her autonomous decisions regarding her proposed research studies. I also took time to review 
the Universities supervision policy and procedures.   
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Final Submission 
RDF standards 
D1   1+ 
D2   2+ 
D3   1+ 
Current Phase 
 
Working with others = 3    
Communication and Dissemination = 3   
Engagement and Impact = 3 
 
Final Reflections on Being a Researching Practitioner 
During this period, I worked collaboratively with colleagues on writing up a previously conducted 
study (An exploration of personality disordered offenders’ experiences of completing a social skills 
treatment component) for publication. Throughout I utilised my experience of writing for publication 
to provide guidance to my colleagues.  It was imperative that the paper was presented to a high standard, 
as we had aimed to submit the paper to a relatively high impact journal. It was equally important to 
ensure that the clinical implications of the study were clearly communicated to aid future practice.  I 
have developed confidence in my ability to write for publication and through the process was able to 
support my less experienced colleagues. The reviewer feedback included minor amendments which 
was positive and reinforced my confidence in my research abilities. A number of points raised did not 
appear to be relevant or applicable, thus rather than making unnecessary changes, in my opinion, I 
provided a considered rationale which was communicated to the reviewers. The paper was accepted on 
this basis. Whilst I remain to be apprehensive about submitting papers for publications, I now value 
reviewers’ feedback and feel able to provide justified reasons when I disagree with points raised. This 
I believe reflects the robustness of the research studies that I conducted, notably that they are well 
thought out and justified.  
 
I reluctantly accepted the opportunity to present at the BPS Division of Forensic Psychology 
conference. Whilst valuing the opportunity to communicate my thesis research to other professionals, 
I initially experienced a level of self-doubt. Nevertheless, during the process of preparing for the 
conference, I recognised that I had an in-depth understanding of my study and surrounding literature, 
which in-turn increased my confidence. I had not expected a large audience; however, the presentation 
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was well received with relevant questions posed. I felt able to confidently respond to questions which 
again reflected my developed theoretical understanding. Overall, this was a rewarding experience and 
unexpectedly, after the conference I received a number of correspondences from colleagues requesting 
advice regarding treatment with complex offenders and also research. I felt able to provide meaningful 
advice in response to these queries, but more importantly I felt confident in my abilities to do so.  At 
this point, I reflected upon my journey through my Professional Doctorate and acknowledged that 
whilst a challenging process, it has provided a range of opportunities to develop confidence and 
competence. I now consider myself to have an advanced level of knowledge within my field of research 
and I am able to communicate such knowledge to other professionals, thus supporting engagement. 
This reflection was further strengthened after providing a workshop to colleagues and other 
professionals at Newcastle University on my current research activates. Whilst those who attended 
were not from a Forensic Psychology background, they seemed to value the research I had been 
involved in, with one delegate stating that they were surprised that “a practitioner was so heavily 
involved in research”. This was initially a surprising comment, although after further thought I 
considered the accuracy and acknowledged that typically practicing psychologists, certainly from my 
experience, tend to have limited involvement in conducting research. This reiterated the importance of 
my research but also to continue supporting colleagues in progress with research projects to develop 
our practice.   
 
Reflecting on my academic experience, I am able to recognise my achievements, whilst also 
acknowledging areas of development. I have taught a range of psychology topics with the main focus 
being Forensic Psychology. I have acted as module leader for both the Postgraduate and Undergraduate 
modules. During my teaching experience, I continually strive to improve upon my approach and 
develop a wider repertoire of teaching styles. Nevertheless, more recently I identified that my approach 
has become stagnant with limited development, and I continue to take a greater ownership over students 
learning, rather than encouraging for independent learning. I discussed teaching approaches with fellow 
colleagues and was interested in one lecturers approach of “chalk and talk”. He explained that he does 
 195 
not prepare PowerPoint slides, but during his lecturers he raises the topic of discussion and writes key 
learning out points on the white board.  Whilst an alternative approach, I do value not being overly 
prepared to teach and taking a greater lead from students. Whilst this is an approach I aiming to employ, 
I do not think I would be able to utilise “chalk and talk” throughout the length of a lecture. These 
discussions have provided some motivation for me to strengthen my approach to teaching and to 
consider in greater depth the learners needs. 
 
 I have also gained valuable experience of leading programmes, beginning with the programme 
leadership of the BSc (Hons) Forensic Psychology programme. As part of my remit within this role, I 
was tasked with revising the programme structure to aid the students learning experience and to ensure 
the programme adhered to the BPS accreditation requirements. In addition, I was asked to develop the 
Professional Doctorate in Psychology programme, which was approved by the University. This was a 
unique opportunity that allowed me to develop valuable experience and understanding of developing 
academic programmes in adherence to regulation requirements at level 8. I have also been the 
Programme Leader for the Professional Doctorate in Psychology programme and MSc Forensic 
Psychology programme.  My strong programme leadership background and experience on the 
Psychology Programme Management Team, ensures that I have extensive experience of student support 
procedures and taking on a pastoral role.  Throughout my academic career, I have gained experience 
of contributing to and managing teaching and programmes, whilst also supporting the development of 
curriculums. This is an aspect of my role that I fully enjoy, and whilst programme management is not 
part of my job role at Newcastle University, I have discussed this with the Head of Department and 
opportunities are now being considered.  I do realise that my academic experience has provided me 
with a sound basis to integrate within the academic team at Newcastle University. Whilst to date I have 
not yet been involved with teaching, I have taken a proactive approach to the development of a new 
practitioner programme. Throughout my involvement I was transparent in my approach, notably to 
develop a programme of studies to provide students with a structured and time bound academic 
qualification to gain Registered Status through the HCPC, whilst ensuring the students develop the 
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necessary skills to become competent Psychologists.  Whilst I encountered a number of disagreements 
with colleagues, I strived to value other professionals opinions and when providing alternative views, 
I ensured they were well thought out and considered.   
 
Individual learning plan post thesis submission:  
• Continue to actively publish research within various outlets and strengthen dissemination 
approach.  
• Develop into a role of peer reviewer.  
• Continue to improve own teaching approach and develop wider repertoire of teaching styles 
and techniques.  
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& J. O. Nyholm (Eds.), Psychopathy and Law: A Practitioner’s Guide (pp. 19- 38). 
Chicester, UK: John Wiley and Sons Ltd.  
 228 
Vitacco, M. J., Neumann, C. S., & Jackson, R. L. (2005). Testing a four-factor model of 
psychopathy and its association with ethnicity, gender, intelligence, and violence. 
Journal of Consulting and Clinical Psychology, 73, 466-476.  
Vitacco, M. J., Rogers, R., Neumann, C. S., Harrison, K. S., & Vincent, G. (2005). A comparison 
of factor models of the PCL-R with mentally disordered offenders the development of a 
four-factor model. Criminal Justice and Behavior, 32, 526-545.  
Wakeling, H., C. (2007). The Psychometric Validation of the Social Problem-Solving 
Inventory—Revised with UK Incarcerated Sexual Offenders. Sex Abuse.  19, 217–236 
Waller, G., Meyer, C. and Ohanian, V. (2001) Psychometric properties of the long and short 
versions of the Young Schema Questionnaire: Core beliefs among bulimic and 
comparison women. Cognitive Therapy and Research, 25, 137-147. 
Walsh, Z., Swogger, M. T., & Kosson, D. S. (2009). Psychopathy and instrumental violence: 
Facet level relations. Journal of Personality Disorders, 23, 416–424.  
Walters, G. D. (2012). Psychopathy and crime: Testing the incremental validity of PCL-R-
measured psychopathy as a predictor of general and violent recidivism. Law and human 
behavior, 36(5), 404. 
Walters, G.D., Duncan, S. A., & Mitchell-Perez, K. (2007). The latent structure of psychopathy: 
A taxometric investigation of the Psychopathy Checklist Revised in a heterogenous 
sample of male prison inmates. Assessment, 14, 270-280.  
Walters, G. D., Knight, R. A., Grann, M., & Dahle, K. P. (2008). Incremental validity of the 
psychopathy checklist facet scores: Predicting release outcome in six samples. Journal 
of Abnormal Psychology, 117, 396-405.  
 229 
Walters, G. D., Wilson, N. J., & Glover, A. J. (2011). Predicting recidivism with the Psychopathy 
Checklist: Are factor score composites really necessary? Psychological 
Assessment, 23(2), 552. 
Wang, E. W., & Diamond, P.M. (1999). Empirically identifying factors related to violence risk 
in corrections. Behavioral Science and the Law, 17(3), 337-389. 
Ward, T., & Brown, M. (2004). The good lives model and conceptual issues in offender 
rehabilitation. Psychology, Crime, & Law, 10, 243-257.  
Ward, T., Day, A., Howells, K., & Birgden, A. (2004). The multifactor offender readiness model. 
Aggression and Violent Behavior, 9, 645-673. 
Warren, J., Burnette, M., South, S. C., Chauhan, R. B., Friend, R., & Van Patten, I. (2003). 
Psychopathy in women: Structural thinking and co-morbidity. International Journal of 
Law and Psychiatry, 372, 223-243.  
Weaver, C. M., Meyer, R. G., Van Nort, J. J., & Tristan, L. (2006). Two-three-, and four-factor 
PCL-R models applied in sex offender risk assessments. Assessment, 13, 208-216 
Webster, C. D., Douglas, K.S., Eaves, D., & Hart, S. (1997). HCR-20: Assessing risk for violence 
(Version 2). Burnaby, British Columbia, Canada: Simon Fraser University.  
Welburn, K., Corstine, M., Dagg, P., (2002) The schema questionnaire–short form: Factor 
analysis and relationships between schemas and symptoms. Cognitive Therapy and 
Research, 26: 519-530. 
Wierzbicki, M., & Pekarik, G. (1993). A meta-analysis of psychotherapy dropout. Professional 
Psychology: Research and Practice, 24, 190-195.  
Wilson, C. M., Desmarais, S. L., Nicholls, T. L., Hart, S. T., & Brink, J. (2013). Predictive 
validity of dynamic factors: Assessing violence risk in forensic psychiatric inpatients. 
Law and Human Behavior, 37, 377-388.  
 230 
Wilson, K., Freestone, M., Taylor, C., Blazey, F., & Hardman, F. (2014). Effectiveness of 
modified therapeutic community treatment within a medium-secure service for 
personality-disordered offenders. The Journal of Forensic Psychiatry & 
Psychology, 25(3), 243-261 
Wise, E. (2004). Methods for analysing psychotherapy outcomes: A review of clinical 
significance, reliable change and recommendations for future directions. Journal of 
Personality Assessment, 82 (1), 50-59.  
Wong, S. C. P. (2000). Psychopathic offenders. In S. Hodgins, & R. Muller-Isberner (Eds.), 
Violence, crime and mentally disordered offenders (pp. 87-112). Chichester, UK: Wiley. 
Wong, S. C. P., & Gordon, A. (2006). The Validity and Reliability of the Violence Risk Scale. 
Psychology, Public Policy & Law, 12(3), 279-309. 
Wong, S. C., Gordon, A., & Gu, D. (2007). Assessment and treatment of violence-prone forensic
 clients: An integrated approach. The British Journal of Psychiatry, 190(49), 66-74. 
Wong, S. C., Gordon, A., Gu, D., Lewis, K., & Olver, M. E. (2012). The effectiveness of violence 
reduction treatment for psychopathic offenders: Empirical evidence and a treatment 
model. International Journal of Forensic Mental Health, 11, 336-349. 
Wong, S. C. P., & Hare, R. D. (2005). Guidelines for a psychopathy treatment program. Toronto, 
Canada: Multi-Health Systems. 
Wong, S. C. P., & Olver, M. E. (2015). Risk reduction treatment of psychopathy and applications 
to mentally disordered offenders. CNS Spectrums, 20, 303-310. 
Wong, S. C. P., Olver, M. E., Nicholaichuk, T. P., & Gordon, A. E. (2003). The Violence Risk 
Scale – Sexual Offender version (VRS-SO). Saskatoon, SK, Canada: Regional Psychiatric 
Centre, Department of Psychology and Research.  
 231 
Woodworth, M., & Porter, S. (2002). In cold blood: Characteristics of criminal homicides as a 
function of psychopathy. Journal of Abnormal Psychology, 111, 436–445.  
Wormith, J. S., & Olver, M. E. (2002). Offender treatment attrition and its relationship with risk,
 responsivity, and recidivism. Criminal Justice and Behavior, 29(4), 447-471. 
Yang, M., Wong, S. C., & Coid, J. (2010). The efficacy of violence prediction: a meta-analytic 
comparison of nine risk assessment tools. Psychological Bulletin, 136, 740-767. 
Young, J. E. (1999). Cognitive therapy for personality disorders: A schema-focused approach. 
Sarasota, FL: Professional Resource Press. 
Young, J. E., & Brown, G. (1994). Young Schema Questionnaire (2nd ed.) New York: Cognitive 
Therapy Centre of New York.  
Young, J. E., & Brown, G. (1999). Young schema questionnaire: Short version. New York: 
Cognitive Therapy Centre of New York. 
Young, S., Hopkin, G., Perkins, D., Farr, C., Doidge, A., & Gudjonsson, G. (2013). A controlled 
trial of a cognitive skills program for personality-disordered offenders. Journal of 
Attention Disorders, 17(7), 598-607. 
Young, J. E., Klosko, J., & Weishaar, M. (2003). Schema Therapy: A Practitioner’s Guide. New 
York: Guilford. 
 
 
 
 
 
 
 
 
 
 232 
Appendices 
 
Appendix 1: Systematic review search strategy  
Searches were based on the following search strategy, with variations made to terms and syntax 
depending upon database requirements:  
 
(TEXT WORD) Psychopathic/ OR Psychopath*  
 
(TEXT WORD) Offender/ OR Offend* Prisoner* OR Inmate* OR Probation* 
 
(ALL TEXT) treatment* OR Intervention OR Therap* OR Psychotherap* OR psychoeducation 
OR psychosocial OR group-based treatment OR group therap* OR individual therap OR 
cognitive adj5 therap* OR behav* therap* 
 
(TEXT WORD) dropout/ OR dropout* OR non-complet* OR deselect* OR discontinuat* OR 
treatment termination OR attrition OR attendance OR engag* OR motivat* OR treatment 
received OR sessions attended OR Offender compliance OR dosage OR experience OR treatment 
retention  
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Appendix 2: Quality assessment form   
Scoring System:  
 
1 point for criteria that is high quality ‘Yes’ (Y) response 
0.5 point for criteria that is ‘Partial’ (P) or ‘Unclear’ (U) response  
0 points for criteria that are low quality ‘No’ (N) or ‘not applicable’ (N/A) response  
Study Validity Y P/U N (N/A) Comments 
Did the study address a clear focused issue?  
Are the hypotheses/aims of the study clearly 
presented?  
 
    
Sampling & Selection bias     
Was the sample recruited in an acceptable 
way?  
Any selection bias that might compromise the 
generalisability of the findings. Were the 
inclusion/exclusion criteria for participant 
selection explicit. 
 
    
Was the sample representative of a defined 
population (overall source population)?   
Review demographic and offence data.  Was 
the whole population studied, or a select 
sample? If selected, was this appropriate, 
explained and its relevance reflected upon?  
    
Sample size is sufficient for meaningful 
outcomes?  
Full sample and sub-sample of psychopathic 
offenders who met PCL-R diagnostic cut-off 
    
Intervention 
Intervention has been appropriately defined? 
 
Consider whether the intervention is covered in 
sufficient detail including reference to the 
theoretical underpinning and the potential 
impact on outcome within the target 
population.  
    
Clinical assessment (PCL-R)     
PCL-R assessments conducted appropriately? 
 
Is it reported who conducted the clinical 
assessment (appropriate personnel). Were 
assessments conducted appropriately 
(interview and file based) or conducted solely 
on file information?  
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PCL-R validation checks conducted?  
 
Was inter-rater reliability of clinical 
assessments checked and if so was it 
appropriate?  
    
Applied PCL-R cut off for diagnoses clinically 
appropriate? 
 
PCL-R  25 
 
    
Measures  (Detection bias)     
Were the measurements for outcomes 
objective? 
 
Are the measures valid, reliable and 
standardised. The outcome measures are 
clearly described along with their validity and 
reliability within the forensic population 
utilised in the study. If applicable, were 
measures of recidivism objective (official or 
self-report)?  
 
    
Were the outcomes assessed in the same way 
across groups?  
 
Were assessment procedures consistent across 
treatment completers/non-completers? 
 
    
Attrition bias     
Treatment non-completion defined and 
assessment procedure explained?  
 
Binary outcome or specific reasons for drop 
out? 
 
    
Attrition rates reported?  
 
Attrition rates are described for groups (e.g. 
psychopathic/non-psychopathic).  
    
Analysis bias 
Was the statistical analysis appropriate?  
 
Appropriate analysis for outcome measures? 
    
Power analysis, effect size or confidence 
intervals reported?  
 
Power calculation was completed using a 
reasonable effect size estimation, and or effect 
size/confidence intervals reported?  
    
Reporting bias 
Are the main findings of the study clearly 
described and the study’s proposed aims 
addressed?  
    
Are limitations of the study clearly reported?  
 
    
 
Total =   Percentage = %    Total no. U’s 
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Appendix 3: Quality assessment of included studies 
 
Author Sampling & selection 
process  
Intervention 
appropriately 
defined? 
Non-completion defined? 
 
Attrition 
reported? 
PCL-R assessment used? Analysis and reporting of findings Quality 
assessment 
score 
Bennett (2015) 
 
 
Recruitment based on those 
requiring specialist PDTS 
during a defined time period. 
Partial explanation of 
inclusion/exclusion criteria.  
  
Limited demographics 
reported. 
 
Yes  Offenders who 
subsequently left treatment 
for any reason and had not 
returned to treatment at the 
time of data collection.  
Yes No explanation of PCL-R assessment 
procedure or Inter-Rater Reliability 
(IRR) process. Author has clarified 
that the PCL-R assessments (clinical 
purposes) were based on interview 
and file information.  
 
 
Limited PCL-R score variances within the 
sample may have contributed to non-significant 
findings (PCL-R as a non-significant predictor of 
treatment non-completion). This should have 
been considered prior to subsequent analysis.   
 
The study was limited to clinical outcomes; 
including select PD diagnoses and PCL-R total 
score, (the predictive relevance of the PCL-R 
factor or facets to treatment non-completion was 
not examined). Thus, the conducted analysis is 
considered narrow, restricting the clinical 
applicability of the study’s findings and the 
relatability (direct comparison) of findings to 
other studies.  
 
53% 
Daffern et al., 
(2008) 
 
 
 
 
Recruitment based on those 
requiring medium-security 
inpatient care.  Inclusion/ 
exclusion criteria not 
reported. 
 
Limited demographics 
reported.   
Treatment unit 
described, although 
details of the 
interventions are not 
reported (lack of 
reference to the 
theoretical 
underpinning and 
procedure).  
 
Agency-initiated expulsion 
(removed for rule-breaking 
or disruptive behaviour), 
or client-initiated drop-out.  
No PCL-R conducted by trained 
psychiatric registrars prior to 
admission. Assessment procedure and 
IRR not reported.  
 
The proportion of the sample that met the PCL-R 
diagnostic cut-off is not explicitly reported, 
which impedes upon the interpretation of the 
results.  
 
The conducted analysis is narrow, providing 
restricted evidence for exploring the proposed 
aim of the study. There is a lack of clarity on the 
analysis conducted and statistical outcomes 
(including size/confidence intervals) are not 
consistently reported.  
 
A post hoc power calculation suggested that the 
study was unpowered. 
 
50% 
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Despite being an aim of the study, there is 
limited interpretation of findings relating to 
treatment non-completion.  
 
Daffern et al., 
(2013) 
 
 
Recruitment based on those 
requiring medium-security 
inpatient care. Inclusion/ 
exclusion criteria not 
reported. 
 
Limited demographics 
reported.   
 
 
Treatment unit 
described, although 
details of the 
interventions are not 
reported (lack of 
reference to the 
theoretical 
underpinning and 
procedure).  
 
Agency-initiated expulsion 
(removed for rule-breaking 
or disruptive behaviour), 
or client-initiated drop-out. 
 
No PCL-R conducted by trained 
psychologists and physicians. 
Assessment procedure or IRR not 
reported. 
 
The proportion of the sample that met the PCL-R 
diagnostic cut-off is not explicitly reported, 
which impedes upon the interpretation of the 
results.  
 
The quantitative analysis provides meaningful 
results. The follow-up period for reconviction 
data was variable (between 3.33 and 10.5 years) 
with no correction for time ‘at risk’ within the 
conducted analysis.  Effect size/confidence 
intervals not reported.  
 
47% 
Dickie (2003) 
 
 
Inclusion of all offenders 
admitted to the sex offender 
treatment programme. Partial 
explanation of 
inclusion/exclusion criteria.  
 
Limited demographics 
reported.   
 
 
Yes 
 
 
Voluntarily withdrew or 
involuntarily discharged.   
Yes No explanation of PCL-R assessment 
procedure or IRR.  
 
Due to a small sample size the planned analysis 
to explore psychopathy, treatment non-
completion and recidivism was omitted. There is 
a lack of clarity on the analysis conducted and 
results are not clearly explained (statistical 
outcomes, effect size and confidence intervals are 
partially reported).  
 
62% 
Hildebrand & 
de Ruiter 
(2012) 
 
 
 
 
Recruitment based on those 
requiring secure inpatient 
care who provided consent 
for research assessments. 
Partial explanation of 
inclusion/ exclusion criteria.  
 
Sample demographics 
reported. 
 
Yes Treatment compliance 
(sessions attended) 
No PCL-R independently scored by two 
assessors (profession not reported). 
Assessments conducted via semi-
structured interview and file 
information. Good PCL-R IRR 
reported.  
For the purpose of some analysis, a PCL-R ≥ 22 
cut-off was used, which is lower than the 
advocated cut-off. Thus, there is a potential for 
overrepresentation of psychopaths within the 
study sample, impacting upon outcome and the 
interpretation of results.    
 
The authors report the potential for lower 
statistical power and report a range of low effect 
sizes suggesting low practical significance.   
   
65% 
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Jeandarme et 
al., (2017) 
 
 
Recruitment based on those 
requiring medium-security 
inpatient care. Sample 
included those who had been 
PCL-R assessed, suggesting 
potential selection bias. 
Exclusion criteria reported 
and acceptable.  
 
Sample demographics 
reported. 
 
Yes Not defined Yes PCL-R assessed by professionals with 
a master’s or medical degree. 
Proportion of assessments completed 
with file review. Low IRR reported.  
Data from three units analysed with no controls 
over extraneous variables (e.g. variations in 
treatment approach, objective and treatment 
environment) that could have influenced 
outcome.  
 
Method of quantitative analysis used provides 
meaningful results of outcome (albeit effect 
size/confidence intervals not consistently 
reported). The analysis and outcome is described 
in sufficient detail.  
 
62% 
Langevin 
(2006) 
 
 
Participants recruited from 
involvement with psychiatric 
services. The recruitment 
process is unclear and may 
suggest potential selection 
bias.  Exclusion criteria not 
reported.  
 
Sample demographics 
reported.  
 
No  Not defined No Two rates scored PCL-R on a subset 
of 50 cases with good IRR reported. 
Proportion of assessments completed 
with file review. If all items not 
scored, the total score was prorated, 
which may reduce the reliability of 
outcome.  
 
Data from a variety of treatment units with no 
controls over extraneous variables (e.g. variations 
in treatment approach, objective and treatment 
environment). Limited analysis conducted to 
explore psychopathy and treatment non-
completion, albeit this was not an explicit aim of 
the study.  
 
Effect size and confidence intervals not reported.  
 
50% 
Ogloff, et al., 
(1990) 
 
 
 
Selected on basis of 
admission to TC during a 
defined time period. 
Inclusion/exclusion criteria 
not reported.  
 
Limited demographics 
reported.   
 
Partial explanation 
with a lack of 
reference to the 
theoretical 
underpinning.   
Not  defined No Two PCL-R assessors (profession not 
reported). Assessment process not 
reported. Good IRR reported.  
 
 
Whilst an aim of the study was to examine 
attrition rates, this was not explicitly examined 
(the study explored differences/associations in 
PCL-R scores and treatment length). PCL-R 
factor and facet scores were not examined, 
restricting the clinical applicability of findings.  
 
Effect size and confidence intervals not reported.  
 
41% 
 Olver (2003) 
 
 
Inclusion of all offenders 
admitted to the sex offender 
treatment programme. Partial 
explanation of inclusion/ 
exclusion criteria.  
 
Sample demographics 
reported.  
Partial explanation 
with a lack of 
reference to the 
theoretical 
underpinning.   
Premature withdrawal or 
termination from 
treatment, and consequent 
failure to successfully 
complete programme 
requirements. 
Yes PCL-R completed by lead researcher 
(trained) based on file information. 25 
PCL-R’s assessments were rated by 
two trained researcher assistants with 
satisfactory IRR reported.  
The study conducted correlation analysis 
(controlling for sex offender risk) to form 
predictive inferences between PCL-R total 
(factors and facets) scores and treatment non-
completion (the completion of a regression 
analysis would have been a more appropriate 
analytical approach). Effect size and confidence 
intervals not reported.  
68% 
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Olver & Wong 
(2009) 
 
 
Inclusion of all offenders 
admitted to the sex offender 
treatment programme.  
 
Inclusion/exclusion criteria 
not reported. 
 
Sample demographics 
reported.   
 
Yes Premature withdrawal or 
termination from treatment 
Yes PCL-R completed by lead researcher 
(trained) based on file information. 25 
PCL-R’s assessments were rated by 
two trained researcher assistants with 
good IRR reported. An additional 43 
PCL-R (total scores) were also 
included from a previous study with 
no explanation of assessment 
procedures provided for these 
additional assessments.   
 
Correlation analysis was conducted and 
predictive inferences between PCL-R total scores 
and treatment non-completion were drawn (the 
completion of a regression analysis would have 
been a more appropriate analytical approach). 
 
Effect sizes and confidence intervals not 
reported. 
  
68% 
Olver & Wong 
(2011) 
 
 
Inclusion of all offenders 
admitted to the sex offender 
treatment programme. 
Inclusion/exclusion criteria 
not reported. 
 
Sample demographics 
reported.  
 
Yes Premature withdrawal or 
termination from treatment 
No PCL-R completed by lead researcher 
(trained) based on file information. 25 
PCL-R’s assessments were rated by 
two trained researcher assistants with 
good IRR reported. 
Method of quantitative analysis used provides 
meaningful results of outcome (effect size and 
confidence intervals not consistently reported), 
the analysis and outcomes are described in 
sufficient detail.    
81% 
Sewall & Olver 
(2018) 
 
 
Inclusion of all offenders 
admitted to the sex offender 
treatment programme. 
Inclusion/exclusion criteria 
not reported. 
 
Sample demographics 
reported.  
 
Yes  Not attended the 
programme in its entirety  
 
 
  
Yes PCL-R assessment data from Wong 
and Olver (2011) study were used, 
alongside an additional 189 file based 
PCL-R assessments conducted by the 
lead researcher and research 
assistants. IRR conducted but 
outcome not reported.   
 
 
Method of quantitative analysis used provides 
meaningful results of outcome (confidence 
intervals reported for main analysis). Part of the 
results lack a level of clarity (with some 
statistical outcomes not reported). The regression 
analysis controls for risk of sexual violence.   
 
 
 
84% 
Shine & 
Hobson (2000) 
 
 
Selected on basis of 
admission to TC during a 
defined time period. The 
sample included 73% of 
Partial explanation 
with a lack of 
reference to the 
Not defined No PCL-R assessments based on 
interview and file information. 
Assessments conducted by the author. 
IRR not reported.  
The quantitative method of analysis is narrow 
although consistent with the presented aim of the 
study. Effect size and confidence intervals not 
reported.  
44% 
 239 
those admitted during 1995, 
with the remaining 27% not 
being included. The study 
reports no differences in 
demographic, criminological 
or psychometrics outcomes 
between sample and those 
not included, indicating no 
selection bias. Inclusion/ 
exclusion criteria not 
reported. 
 
No demographics reported.  
theoretical 
underpinning.   
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Appendix 6: Psychometric scale and subscale means and standard deviations for assessment 
stages 1 to 5 with mean change between assessment stages for moderate and high PCL-R groups 
and full sample (total).  
 
 
Appendix 6.1: SPSI-R subscale  
 
 n S1 S2 S3 S4 S5 Mean change 
  M(SD) M(SD) M(SD) M(SD) M(SD) S2-S3 S4-S5 S1-S5 
PPO          
Moderate  16 9.1 (4.3) 9.7 (4.2) 12.1 (4.4) 11.6 (4.7) 12.9 (4.1) 2.4 1.3 3.8 
High  16 9.5 (5.2) 9.6 (4.3) 14.3 (2.9) 12.3 (3.5) 14.1 (4.7) 4.7 1.8 4.6 
Total 32 9.3 (4.7) 9.7 (4.2) 13.2 (3.8) 12 (4) 13.5 (4.4) 3.5** 1.5 4.2** 
NPO          
Moderate  16 12.5 (8.2) 9.3 (6.3) 5.4 (4.7) 5 (4.3) 4.2 (3.4) - 3.9 0.8 -8.3 
High  16 12.7 (9.4) 12.5 (8.8) 5.2 (2.7) 4.2 (3.6) 5.9 (6.7) - 7.3 - 1.7 -6.8 
Total 32 12.6 (8.6) 10.8 (7.6) 5.3 (3.8) 4.6 (3.9) 5.0 (5.3) - 5.5** -0.4 -7.6** 
RPS           
Moderate  16 26.8 (17.9) 32 (16.3) 47.1 (16) 44.9 (17.5) 53 (13.9) 15.1 8.1 18.1 
High  16 37.5 (22.1) 39 (20.1) 55.8 (10.1) 51 (15.6) 56.6 (15.6) 16.8 5.6 13.5 
Total 32 32.2 (20.5) 35 (18) 51.4 (13.9) 48 (16.6) 54.8 (14.7) 16.4** 6.8 22.6** 
ICS          
Moderate  16 16.1 (10.2) 13.8 (10) 6.2 (5.8) 5.8 (4.9) 5.5 (6.4) - 7.6 - 0.3 -10.6 
High  16 15.3 (12.7) 14 (9.5) 5.7 (4.6) 6.3 (8) 5.8 (9.1) - 9.2 - 0.5 -9.5 
Total 32 15.7 (11.3) 13.9 (9.6) 6.0 (5.1) 6 (6.5) 5.7 (7.7) - 7.9** - 0.3 -10** 
AS          
Moderate  16 9.9 (5.9) 8.3 (5.9) 5.3 (4.4) 4.5 (4) 5.2 (4.3) - 3 - 0.7 - 4.7 
High  16 11 (8) 8.7 (6.4) 5.1 (3.8) 4.9 (4.5) 4.6 (4.9) - 3.6 - 0.3  - 6.4 
Total 32 10.5 (7) 8.5 (6.1) 5.2 (4) 4.7 (4.2) 4.9 (4.6) - 3.3 - 0.2  - 5.6** 
** significant at the .01 level * significant at the .05 level 
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Appendix 6.2: BIS total and subscales  
 
 n S1 S2 S3 S4 S5 Mean change 
  M (SD) M (SD) M (SD) M (SD) M (SD) S2-S3 S4-S5 S1-S5 
BIS Total          
Moderate  15 74.6 (11.8) 70 (13.4) 61.3 (11.4) 60.2 (10.7) 55.4 (11.8) - 8.7 - 4.8 - 19.4 
High  15 69.3 (15.5) 64 (10.8) 54.7 (5.6) 54.2 (10.2) 49.6 (8.8) - 9.3 - 4.6 - 19.7 
Total 30 71.9 (13.8) 67 (12.) 58 (9.5) 57.2 (10.7) 52.5 (10.3) - 9**  - 4.7 - 19.4** 
 MI          
Moderate  15 23.2 (6) 21.3 (5.6) 16.8 (2.9) 16.9 (3.2) 17 (4.9) - 4.5 - 0.1 - 6.2 
High  15 22.5 (5.7) 19.8 (3.9) 16.3 (2.9) 16 (3.2) 14.8 (3.3) - 3.5 - 1.2 - 7.7 
Total 30 22.9 (5.7) 20.6 (4.8) 16.6 (2.9) 15.4 (3.2) 15.9 (4.2) - 4** - 0.5 - 7** 
CI          
Moderate  15 25.2 (3.7) 23.9 (4.5) 21.7 (4.4) 21.4 (3.7) 19.8 (3.9) - 2.2 - 1.6 - 5.7 
High  15 24 (5.4) 22.2 (5) 19.3 (3.9) 18.6 (3.8) 18.1 (3.4) -.2.9 - 0.5 - 5.9 
Total 30 24.6 (4.6) 23 (4.7) 20.5 (4.3) 20 (4) 18.9 (3.7) - 2.5* - 1.1 - 5.7** 
NPI          
Moderate  16 26.1 (5) 24.7 (5) 22.7 (5.9) 21.9 (5.1) 18.6 (4.6) - 2 - 3.3 - 7.5 
High  15 22.8 (5.5) 21.9 (3.6) 19.1 (3) 19.6 (4.2) 16.6 (3.2) - 2.8 - 3 - 6.2 
Total 30 24.4 (5.4) 23.3 (4.5) 20.9 (4.9) 20.7 (4.8) 17.6 (4) - 2.4 - 3.1* - 6.8** 
** significant at the .01 level * significant at the .05 level 
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Appendix 6.3: NAS-PI total and subscales 
 
 n S1 S2 S3 S4 S5 Mean change 
  M(SD) M(SD) M(SD) M(SD) M(SD) S2-S3 S4-S5 S1-S5 
Cog          
Moderate  16 31 (6.28) 30.6 (5.2) 27.0 (5.9) 27.4 (5.4) 24.2 (5.1) -3.3 -3.1 -6.7 
High  18 30.5 (7.05) 28.7 (7.4) 25.7 (4.9) 25.5 (6.4) 23.6 (3.9) -2.9 -1.9 -6.8 
Total 34 30.7 (6.60) 29.6 (6.4) 26.3 (5.3) 26.4 (6.04) 23.9 (4.4) -3.2* -2.5 -6.8** 
Aro           
Moderate  16 31.5 (6) 30.1 (6.3) 26.6 (6.3) 27.3 (4.5) 24.1 (5.5) -3.4 -3.1 -7.3 
High  18 30.5 (9.2) 28.3 (8.9) 25 (5.8) 25.1 (7.4) 22.8 (4.5) -3.3 -2.2 -7.6 
Total 34 30.9 (7.7) 29.2 (7.7) 25.7 (6) 26.1 (6.2) 23.5 (5.01 -3.4* -2.6 -7.4** 
Beh          
Moderate  16 29.6 (5.4) 28.6 (5.4) 25 (5.9) 25.5 (4.8) 23.1 (5.2) -3.6 -2.3 -6.1 
High  18 29 (7.9) 25.4 (7.6) 22.8 (5.3) 22.2 (6.4) 21.5 (3.9) -2.6 -0.7 -7.4 
Total 34 29.3 (6.7) 26.9 (6.8) 23.9 (5.6) 23.8 (5.9) 22.3 (4.5) -3 -1.5 -7** 
AR          
Moderate  16 23.9 (3.9) 25.5 (3.9) 27.6 (4.2) 27.6 (4.4) 27.3 (3.9) 2.1 -0.2 3.4 
High  18 23.8 (4.3) 26.6 (4.7) 28.5 (4) 28.1 (4.6) 28.7 (5) 1.8 0.6 4.8 
Total 34 23.8 (4) 26 (4.3) 28 (4.1) 27.8 (4.4) 28 (4.5) 2.2 -.02 4.2** 
NAS 
Total 
         
Moderate  16 116.1 (16.5) 114.9 (15.5) 106.4 (13.9) 107.9 (11) 99 (14.8) -8.5 -8.93 17.1 
High  18 113.8 (20.3) 109.1 (19.6) 102.1 (13.0) 101.1 
(17.8) 
96.7 (10.6) -7 -4.34 17.0 
Total 34 114.1 (19.6) 111.8 (17.8) 104.1 (13.4) 104 (15.2) 97.8 (12.6) -7.7* -6.1 16.3** 
PI Total          
Moderate  15 59.6 (15.1) 54.6 (12.8) 50 (10.7) 50.9 (10.1) 46 (10.9) -4.6 -4.9 -13.6 
High  18 57.8 (19.3) 53.7 (18.0) 44.3 (14.2) 45 (13) 45.6 (11.6) -9.3 0.5 -12.2 
Total 34 58.7 (17.2) 54.1 (15.5) 47.0 (12.8) 47.8 (11.9) 45.8 (11.1) -7.1** -2 -12.9** 
** significant at the .01 level * significant at the .05 level 
 
 
Appendix 6.4: LoC total  
  
 n S1 S2 S3 S4 S5 Mean change 
  M (SD) M (SD) M (SD) M (SD) M (SD) S2-S3 S4-S5 S1-S5 
LoC total          
Moderate  17 48.6 (9.2) 44.2 (8.0) 54.4 (10.7) 55.0 (10.2) 55.0 (9.1) 10.2 0 6.4 
High  19 44.7 (10) 45.4 (8.2) 54.5 (8.03) 53.7 (9.6) 55.2 (8.4) 9.1 1.5 10.5 
Total 36 46.5 (9.8) 44.8 (8.09) 54.5 (9.25) 54.3 (9.7) 55 (8.6) 9.7** 0.7 8.5** 
** significant at the .01 level * significant at the .05 level 
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Appendix 6.5: YSQ-SF subscale  
 
 n S1 S2 S3 S4 S5 Mean change 
  M(SD) M(SD) M(SD) M(SD) M(SD) S2-S3 S4 -S5 S1-S5 
ED          
Moderate  16 15.3 (7.8) 14.7 (7.0) 16.3 (7.3) 18.4 (6.9) 16.7 (6.6) 1.6 -1.7 1.4 
High  18 16.7 (8.1) 17.5 (8.1) 17.0 (6.7) 15.7 (7.1) 18.1 (8.5) .5 2.4 1.4 
Total 34 16.0 (7.9) 16.2 (7.6) 16.7 (6.9) 17.0 (7.1) 17.5 (7.6) .5 .5 1.5 
Aba          
Moderate  16 12.1 (7.9) 12.5 (6.8) 11.1 (6.1) 12.8 (6.2) 8.8 (5.1) -1.4 -4 -3.3 
High  18 13.3 (7.8) 15.5 (8.7) 15.1 (9.8) 12.8 (6.4)  11.6 (7.4) -.4 -1.2 -1.7 
Total 34 12.7 (7.8) 14.0 (7.9) 13.2 (8.4) 12.8 (6.3) 10.2 (6.5) -.8 -2.6 -2.5* 
Mis          
Moderate  16 18.1 (7.3) 15.6 (8.4) 13.2 (8.7) 13.1 (7.1) 12.6 (6.2) -2.4 -.5 -5.5 
High  18 15.6 (8.9) 16.0 (8.3) 13.6 (9.1) 13.1 (7.1) 11.2 (7.2) -2.4 -1.9 -4.4 
Total 34 16.8 (8.2) 15.8 (8.3) 13.4 (8.8) 13.1 (7.1) 11.9 (6.7) -2.4 -1.2 -4.9** 
SI          
Moderate  16 15.6 (9.0) 14.0 (7.2) 10.3 (6.5) 11.2 (5.4) 8.9 (3.9) -3.7 -2.6 -6.7 
High  18 12.6 (8.6) 12.8 (8.1) 11.1 (8.7) 12.5 (8.7) 10.2 (7.6) -1.7 -2.3 -2.4 
Total 34 14.0 (8.8) 13.4 (7.6) 10.7 (7.7) 11.9 (7.3) 9.6 (6.1) -2.7 -2.3* -4.4** 
Def          
Moderate  16 12.4 (7.4) 10.7 (5.9) 10.6 (5.5) 10.3 (5.1) 8.6 (4.6) -.1 -1.7 -3.8 
High  18 13.6 (8.4) 13.1 (7.2) 12.0 (8.3) 12.0 (8.8) 10.1 (6.8) -1.1 -1.9 -3.5 
Total 34 13.0 (7.9) 12.0 (6.6) 11.3 (7.1) 11.2 (7.3) 9.4 (5.8) -.7 -1.8 -3.6** 
FA          
Moderate  16 11.3 (5.7) 10.0 (6.1) 10.0 (6.0) 10.1 (6.2) 7.8 (3.9) 0 -2.3 -3.5 
High  18 12.3 (6.5) 12.3 (5.8) 9.8 (5.3) 10.3 (6.3) 10.3 (6.1) -2.5 0 -2 
Total 34 11.9 (6.1) 11.2 (6.0) 9.9 (5.6) 10.2 (6.1) 9.2 (5.3) -1.3 -1 -2.7* 
De          
Moderate  16 10.8 (6.6) 10.6 (6.4) 9.1 (4.1) 10.4 (5.0) 8.0 (2.9) -1.5 -2.4 -2.8 
High  18 12.3 (6.1) 12.8 (6.5) 9.7 (4.3) 11.3 (6.2) 7.8 (2.7) -3.1 -3.5 -4.5 
Total 34 11.6 (6.3) 11.7 (6.4) 9.4 (4.2) 10.9 (5.6) 7.9 (2.8) -2.3 -3** -3.7** 
Vu          
Moderate  16 9.4 (4.3) 9.3 (4.4) 9.1 (4.7) 9.9 (4.9) 7.8 (3.2) -.2 -2.1 -1.6 
High  18 10.1 (6.0) 11.0 (7.4) 9.2 (7.5) 10.4 (7.0) 9.8 (7.8) -1.8 -.6 -0.3 
Total 34 9.8 (5.2) 10.2 (6.2) 9.1 (6.3) 10.2 (6.0) 8.9 (6.1) -1.1 -1.3 -.9 
Enm          
Moderate  16 5.5 (1.0) 5.5 (1.2) 5.6 (1.3) 5.7 (1.5) 6.1 (1.7) .1 .4 .6 
High  18 7.0 (3.2) 9.0 (6.5) 7.8 (5.9) 7.1 (4.9) 7.0 (3.3) -1.2 -.1 0 
Total 34 6.3 (2.5) 7.4 (5.0) 6.8 (4.4) 6.4 (3.7) 6.6 (2.7) -.6 .2 .3 
Sub          
Moderate  16 10.4 (4.1) 9.0 (3.6) 8.3 (3.0) 9.8 (4.3) 8.6 (3.0) -.7 -1.2 -1.8 
High  18 11.1 (6.7) 11.6 (6.1) 10.5 (6.8) 10.7 (6.8) 8.9 (3.5) -1.1 -1.8 -2.2 
Total 34 10.8 (5.6) 10.4 (5.2) 9.5 (5.4) 10.3 (5.7) 8.8 (3.2) -.9 -1.5 -2 
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SS          
Moderate  16 10.0 (3.6) 10.1 (3.9) 12.4 (4.4) 12.5 (4.6) 13.3 (3.0) 2.3 .8 3.3 
High  18 11.0 (5.2) 13.2 (6.2) 13.7 (6.4) 11.1 (5.3) 12.2 (6.4) -.5 1.1 2.2 
Total 34 10.5 (4.5) 11.7 (5.4) 13.1 (5.5) 11.7 (4.9) 12.7 (5.1) 1.4 1 2.2 
EI          
Moderate  16 13.3 (7.8) 11.5 (5.2) 9.5 (4.3) 10.7 (5.9) 9.4 (4.8) -2 -1.3 -3.9 
High  18 13.6 (8.0) 14.3 (7.8) 12.0 (8.0) 12.9 (8.9) 11.6 (7.1) -2.3 -1.3 -2 
Total 34 13.5 (7.8) 13.0 (6.8) 10.8 (6.5) 11.9 (7.6) 10.5 (6.1) -2.2 -1.3 -3* 
US          
Moderate  16 12.9 (5.5) 11.8 (5.3) 15.2 (6.7) 14.1 (5.5) 14.0 (5.3) 3.4 -.1 1.1 
High  18 16.5 (6.7) 17.3 (6.6) 16.9 (6.8) 17.5 (7.3) 17.1 (6.7) -.4 -.4 .6 
Total 34 14.8 (6.3) 14.7 (6.6) 16.1 (6.7) 15.9 (6.6) 15.6 (6.2) 1.4 .3 .8 
Ent          
Moderate  16 7.9 (3.0) 7.6 (3.0) 8.1 (3.6) 7.0 (2.6) 7.2 (2.3) .5 .2 -.7 
High  18 9.8 (4.8) 10.2 (5.5) 7.7 (3.0) 9.8 (5.6) 8.5 (3.4) -2.5 -1.3 -1.3 
Total 34 8.9 (4.1) 9.0 (4.6) 7.9 (3.3) 8.5 (4.6) 7.9 (3.) -1.1 -.6 -1 
IS          
Moderate  16 11.1 (6.8) 11.8 (7.0) 9.5 (6.0) 9.4 (5.9) 7.3 (2.5) -2.3 -2.1 -3.8 
High  18 12.2 (7.6) 12.1 (7.1) 8.7 (5.3) 10.0 (7.5) 8.7 (5.2) -3.4 -1.3 -3.5 
Total 34 11.7 (7.1) 12.0 (6.9) 9.1 (5.5) 9.4 (5.9) 8.1 (4.2) -2.9 -1.3 -3.6** 
** significant at the .01 level * significant at the .05 level 
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Appendix 7: Psychometric calculated reliable change pre-to post treatment for PCL-R group 
and Chi-square analysis outcome (reliable change categories (deterioration and uncertain 
change versus improvement) in moderate and high PCL-R groups)).  
 
Appendix 7.1: SPSI subscales  
 
 Reliable  
Deterioration 
Uncertain  
Change 
Reliable  
Improvement 
χ2   
effect sig.        
 n % n % n   %  
PPO        
Moderate  0 0 13 42.1 3 8.8  
.10 High  1 2.9 8 23.5 7 22.4 
Total  1 2.9 21 65.6 10 31.2  
NPO        
Moderate  0 0 9 29 8 24.3  
.63 High  1 3.2 8 25.8 6 19.4 
Total 1 3.1 17 53.1 14 43.7  
RPS        
Moderate  1 3.1 2 6.2 12 37.4  
.35 High  2 6.2 4 12.4 11 34.3 
Total 3 9.3 6 18.7 23 71.8  
ICS        
Moderate  1 3.1 7 21.8 8 24.9  
.75 High  1 3.1 8 24.9 7 21.8 
Total 2 6.2 15 46.8 15 46.8  
AS        
Moderate  3 9.3 4 12.4 9 28.1  
.16 High  1 3.1 5 15.6 10 31.2 
Total 4 12.5 9 28.1 19 59.3  
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Appendix 7.2: BIS total and subscales  
 
 Reliable  
Deterioration 
Uncertain  
Change 
Reliable  
Improvement 
 χ2   
effect sig.        
 n % n % n %  
BIS Total        
Moderate  0 0 3 9.7 12 38.7  
.38 High  0 0 5 16.1 11 35.5 
Total  0 0 8 25.8 23 74.2  
MI        
Moderate  0 0 8 25.8 7 22.6  
.56 High  0 0 8 25.8 8 25.8 
Total  0 0 16 51.6 15 48.4  
CI        
Moderate  0 0 10 32.3 5 16.1  
.41 High  0 0 9 29.0 7 22.6 
Total  0 0 19 61.3 12  38.7  
NPI        
Moderate  0 0 4 12.9 11 35.5  
.26 High  0 0 7 22.6 9 29 
Total 0 0 11 35.5 20  64.5  
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Appendix 7.3: NAS-PI total and subscales  
 
 Reliable  
Deterioration 
Uncertain  
Change 
Reliable  
Improvement 
χ2   
effect sig.        
 n % n % n %  
Cognitive        
Moderate  1 2.9 8 23.5 7 20.5  
.51 High  0 0 10 29.3 8 23.5 
Total  1 2.9 18 52.9 15 44.1  
Arousal         
Moderate  0 0 9 26.4 7 20.5  
.38 High  0 0 11 32.3 7 20.5 
Total  0 0 20 58.8 14 41.1  
Behavioural        
Moderate  0 0 9 26.4 6 17.6  
.48 High  0 0 10 29.3 9 26.5 
Total  0 0 19 55.8 15 44.2  
Anger        
Moderate  0 0 13 38.2 2 5.8  
.10 High  0 0 11 32.4 8 23.5 
Total 0 0 24 70.6 10 29.4  
NAS Total        
Moderate  2 5.8 7 20.6 7 20.6  
.24 High  0 0 10 29.4 8 23.6 
Total 2 5.8 17 50 15 44.2  
PI Total        
Moderate  2 5.9 5 14.7 9 26.5  
.34 High  1 2.9 10 29.4 7 20.6 
Total 3 8.8 15 44.1 16 47.1  
 
 
Appendix 7.4: LoC total  
 Reliable  
Deterioration 
Uncertain  
Change 
Reliable  
Improvement 
χ2   
effect sig.        
 n % n % n %  
LoC        
Moderate  0 0 12 33.3 5 13.9  
.14 High  1 2.8 8 22.2 10 27.8 
Total  1 2.8 20 55.5 15 41.7  
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Appendix 7.5: YSQ-SF subscales  
 
 Reliable  
Deterioration 
Uncertain  
Change 
Reliable  
Improvement 
χ2   
effect sig.        
 n % n % n %  
ED        
Moderate  2 5.9 10 29.4 4 11.7  
.96 High  2 5.9 12 35.3 4 11.7 
Total 4 11.8 22 64.7 8 23.5  
Aba        
Moderate  3 8.8 6 17.6 7 20.6  
.11 High  2 5.9 13 38.2 3 8.8 
Total 5 14.7 19 55.9 10 29.4  
Mis        
Moderate  0 0 8 23.5 8 23.5  
.16 High  0 0 13 32.2 5 14.7 
Total 0 0 21 61.8 13 38.2  
SI        
Moderate  0 0 6 17.6 10 29.4  
.13 High  0 0 14 41.2 4 11.8 
Total 0 0 20 58.8 14 41.2  
Def        
Moderate  0 0 11 32.4 5 14.7  
.41 High  1 2.9 14 41.2 3 8.8 
Total 1 2.9 25 73.5 8 23.5  
FA        
Moderate  0 0 11 32.4 5 14.7  
.41 High  1 2.9 14 41.2 3 8.8 
Total 1 2.9 25 73.5 8 23.5  
De        
Moderate  0 0 12 35.3 4 11.8  
.42 High  0 0 15 44.1 3 8.8 
Total 0 0 27 79.4 7 20.6  
Vu        
Moderate  0 0 14 41.2 2 5.9  
.32 High  2 5.9 15 44.1 1 2.9 
Total 2 5.9 29 85.3 3 8.8  
Enm        
Moderate  2 5.9 13 38.2 1 2.9  
.81 High  3 8.8 13 38.2 2 5.9 
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Total 5 14.7 26 76.5 3 8.8  
Sub        
Moderate  0 0 14 41.2 2 5.9  
.38 High  0 0 14 41.2 4 11.8 
Total 0 0 28 82.4 6 17.6  
SS        
Moderate  3 8.8 13 38.2 0 0  
.63 High  3 8.8 14 41.2 1 2.9 
Total 6 17.6 27 79.4 1 2.9  
EI        
Moderate   0 0 11 32.4 5 14.7  
.27 High  0 0 15 44,1 3 8.8 
Total 0 0 26 76.5 8 23.5  
US        
Moderate  1 2.9 14 41.2 1 2.9  
.99 High  1 2.9 16 47.1 1 2.9 
Total 2 5.9 30 88.2 2 5.9  
Ent        
Moderate 0 0 15 44.1 1 2.9  
.34 High  0 0 15 44.1 3 8.8 
Total 0 0 30 88.2 4 11.8  
IS        
Moderate  0 0 13 38.2 3 8.8  
.57 High  0 0 14 41.2 4 18 
Total 0 0 27 79.4 7 20.6  
 
 
 
 
